data_2aap_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2aap _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 16' ' ' CYS . . . . . . . . 0 N--CA 1.493 2.492 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.1 158.74 27.78 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.8 83.82 0.1 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.78 -0.836 . . . . 0.0 111.094 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.1 mtp 56.29 34.89 24.88 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.663 -0.648 . . . . 0.0 110.68 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.02 145.17 29.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.433 -0.792 . . . . 0.0 109.905 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.3 121.0 24.11 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.64 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -110.61 -61.01 1.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.618 -0.931 . . . . 0.0 110.121 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 t70 59.41 77.85 0.29 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.406 0.622 . . . . 0.0 110.605 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.82 121.86 1.34 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -66.06 -13.45 60.02 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.491 -1.005 . . . . 0.0 110.925 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 p -110.84 2.94 18.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.29 -0.882 . . . . 0.0 111.13 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.64 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 1.9 m -66.83 138.2 57.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.116 -0.99 . . . . 0.0 110.172 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -100.09 138.86 36.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.51 -0.744 . . . . 0.0 110.269 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 3' ' ' GLY . 33.7 m -80.88 -157.23 0.15 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.684 -0.635 . . . . 0.0 109.833 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 t -78.93 -70.66 0.49 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.092 -1.005 . . . . 0.0 110.332 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.1 p -163.69 123.08 2.06 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.558 -0.714 . . . . 0.0 109.819 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.95 -3.97 86.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.438 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 49.0 m-85 -103.24 169.88 8.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -1.179 . . . . 0.0 110.115 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -148.23 129.68 14.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.959 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 14.6 t -73.03 132.67 43.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.49 -0.756 . . . . 0.0 110.614 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -95.67 128.8 36.52 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.573 -0.704 . . . . 0.0 109.461 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.27 -21.67 26.47 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.784 1.412 . . . . 0.0 111.003 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.6 m -87.7 -28.3 21.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.316 -0.865 . . . . 0.0 110.741 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.494 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 11.1 m0 -108.43 -12.74 14.98 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.437 -0.789 . . . . 0.0 111.243 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? 61.88 29.55 17.91 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.583 -0.698 . . . . 0.0 112.27 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.494 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -136.66 171.0 15.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.839 -1.163 . . . . 0.0 110.671 178.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.3 m -102.14 123.87 46.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.382 -0.824 . . . . 0.0 110.492 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 m -132.89 -179.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.547 -0.72 . . . . 0.0 109.85 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -55.17 143.53 27.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.356 -0.84 . . . . 0.0 110.334 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.38 -0.825 . . . . 0.0 110.419 -179.546 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.566 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.83 155.71 26.44 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 58.5 91.42 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.794 -0.827 . . . . 0.0 111.0 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.4 mtt 55.64 35.39 25.15 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.733 -0.605 . . . . 0.0 110.591 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.24 93.92 9.18 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.499 -0.751 . . . . 0.0 109.698 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.14 106.66 0.77 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.466 ' HB2' HG22 ' A' ' 14' ' ' THR . 30.7 p -114.21 -37.2 4.47 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.595 -0.944 . . . . 0.0 110.772 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 t70 63.11 96.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.421 0.629 . . . . 0.0 110.791 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.02 117.67 0.6 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -63.17 -17.5 62.45 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.622 -0.928 . . . . 0.0 110.759 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 t -119.93 27.96 8.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.368 -0.832 . . . . 0.0 110.372 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 9' ' ' CYS . 17.0 m -83.31 132.53 35.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.298 -0.876 . . . . 0.0 109.875 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -86.26 160.47 19.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.478 -0.764 . . . . 0.0 110.442 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.1 m -124.84 -164.83 1.31 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.535 -0.728 . . . . 0.0 110.498 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.7 t -74.0 -86.99 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.306 -0.871 . . . . 0.0 110.698 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.5 m -151.05 122.39 7.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.141 -0.974 . . . . 0.0 109.988 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.77 24.78 66.34 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.608 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 42.1 m-85 -130.67 140.11 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.454 -1.027 . . . . 0.0 109.831 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.73 128.6 39.24 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.434 -0.791 . . . . 0.0 110.627 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.4 m -71.12 120.26 16.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.666 -0.646 . . . . 0.0 110.008 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.523 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 5.5 t -82.44 140.08 44.85 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.401 -0.812 . . . . 0.0 110.255 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.38 -29.21 11.47 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.962 1.506 . . . . 0.0 110.854 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.0 m -86.05 -32.51 21.38 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.741 . . . . 0.0 110.464 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.686 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 34.5 m0 -93.31 -23.96 18.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.405 -0.809 . . . . 0.0 110.703 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER 72.35 1.78 4.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.851 -0.531 . . . . 0.0 111.973 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.686 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -121.96 168.07 12.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.919 -1.113 . . . . 0.0 109.999 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.608 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 4.4 t -94.71 144.09 25.9 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.454 -0.779 . . . . 0.0 110.839 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.491 HG13 ' CD1' ' A' ' 28' ' ' TRP . 0.8 OUTLIER -148.96 167.46 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -49.56 134.37 19.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.453 -0.779 . . . . 0.0 110.337 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.864 0 O-C-N 121.353 -0.842 . . . . 0.0 110.599 -179.309 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.533 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.89 149.38 21.39 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.55 95.63 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.917 -0.755 . . . . 0.0 110.635 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 15.1 mmt 58.04 38.28 26.65 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.729 -0.607 . . . . 0.0 110.471 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.84 140.74 29.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.609 -0.682 . . . . 0.0 109.871 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.4 116.28 8.88 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.621 ' SG ' HG22 ' A' ' 14' ' ' THR . 1.1 t -106.12 -70.42 0.79 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.691 -0.888 . . . . 0.0 109.316 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.504 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 7.2 t70 49.19 73.18 0.25 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.322 0.582 . . . . 0.0 110.729 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.63 120.85 1.87 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -62.51 -14.3 40.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.653 -0.91 . . . . 0.0 110.676 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.9 t -97.46 22.68 8.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.41 -0.806 . . . . 0.0 110.37 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.621 HG22 ' SG ' ' A' ' 9' ' ' CYS . 4.7 t -71.93 -179.05 2.56 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.225 -0.922 . . . . 0.0 110.244 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.76 94.95 3.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.308 -0.87 . . . . 0.0 110.326 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -78.09 -179.49 6.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.403 -0.81 . . . . 0.0 109.929 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.0 m -83.02 -100.36 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.115 -0.99 . . . . 0.0 110.508 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.09 117.56 11.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.063 -1.023 . . . . 0.0 110.083 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.44 32.7 12.95 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 63.3 m-85 -130.09 142.9 50.56 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.218 -1.166 . . . . 0.0 110.601 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -123.13 133.94 54.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.578 -0.701 . . . . 0.0 110.091 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.5 t -82.12 130.67 35.15 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.555 -0.715 . . . . 0.0 110.396 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.511 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -92.29 140.49 24.34 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.339 -0.85 . . . . 0.0 110.009 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.75 -31.02 8.88 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.862 1.454 . . . . 0.0 111.178 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 m -88.93 -38.21 14.68 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.353 -0.842 . . . . 0.0 110.613 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.675 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 36.2 m0 -82.66 -26.6 31.98 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.406 -0.809 . . . . 0.0 110.672 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HG3' ' HA ' ' A' ' 10' ' ' ASP . 15.2 tptt 69.33 19.56 7.68 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.741 -0.599 . . . . 0.0 112.196 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.675 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.1 p90 -133.26 173.19 11.72 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.814 -1.179 . . . . 0.0 110.571 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.1 t -107.55 128.19 54.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.394 -0.816 . . . . 0.0 110.453 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' A' ' 28' ' ' TRP . 4.5 m -129.75 173.17 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.601 -0.687 . . . . 0.0 110.061 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -52.61 127.49 23.08 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.351 -0.843 . . . . 0.0 110.643 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.825 0 O-C-N 121.582 -0.699 . . . . 0.0 110.253 179.877 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.552 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.83 130.99 3.68 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 6' ' ' MET . 0.5 OUTLIER 59.55 95.34 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.86 -0.788 . . . . 0.0 111.205 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 12.9 mtt 57.67 43.82 21.64 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.484 0.659 . . . . 0.0 110.376 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 29' ' ' CYS . . . -89.21 127.58 35.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.547 -0.721 . . . . 0.0 109.876 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -49.95 118.09 5.41 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.609 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 3.0 t -105.82 -66.68 0.97 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.613 -0.933 . . . . 0.0 109.608 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 t0 53.25 66.52 1.21 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.831 -0.543 . . . . 0.0 111.092 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.15 127.48 0.89 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -14.35 62.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.572 -0.958 . . . . 0.0 110.886 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 t -117.3 22.18 12.64 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.296 -0.878 . . . . 0.0 110.374 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.609 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 4.8 m -86.59 132.15 33.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -104.54 154.34 20.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.55 -0.719 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 20' ' ' TYR . 34.0 m -87.44 -154.75 0.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.492 -0.755 . . . . 0.0 109.983 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.2 t -89.01 -70.76 0.63 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.211 -0.931 . . . . 0.0 110.615 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.4 p -158.24 113.5 2.65 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.449 -0.782 . . . . 0.0 110.339 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.36 24.38 36.89 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.442 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 89.1 m-85 -137.58 159.06 43.02 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.394 -1.062 . . . . 0.0 110.015 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -137.62 136.6 37.67 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.36 -0.837 . . . . 0.0 110.577 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 9.1 t -65.15 147.33 53.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.488 -0.758 . . . . 0.0 110.154 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 m -111.31 131.41 22.27 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.45 -0.781 . . . . 0.0 109.902 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.88 -26.36 11.25 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.887 1.467 . . . . 0.0 111.002 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.3 m -91.07 -25.87 19.43 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.453 -0.78 . . . . 0.0 110.925 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.659 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 72.6 m95 -102.65 -14.91 16.52 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.295 -0.878 . . . . 0.0 110.741 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.72 13.68 9.3 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.674 -0.641 . . . . 0.0 112.642 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.659 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -138.14 175.2 9.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.696 -1.252 . . . . 0.0 110.696 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.3 m -88.54 135.52 33.45 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.347 -0.845 . . . . 0.0 110.702 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.4 m -123.47 -175.59 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.9 -0.5 . . . . 0.0 109.708 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.91 149.16 48.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.354 -0.841 . . . . 0.0 110.4 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.534 -0.729 . . . . 0.0 110.115 179.832 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.56 139.36 6.47 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 58.1 89.12 0.05 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.85 -0.794 . . . . 0.0 111.193 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.3 mmt 55.62 42.14 29.82 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.438 0.637 . . . . 0.0 110.192 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.16 129.95 35.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.529 -0.732 . . . . 0.0 110.188 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.92 106.73 1.17 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 5.0 m -95.51 -50.0 5.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.502 -0.999 . . . . 0.0 110.206 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 t0 62.97 52.48 2.6 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.405 0.622 . . . . 0.0 109.993 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.6 125.23 0.91 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -17.44 62.29 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.448 -1.03 . . . . 0.0 110.817 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.36 25.18 11.75 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 110.607 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 m -80.24 132.59 35.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.279 -0.888 . . . . 0.0 109.758 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -81.72 139.24 35.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.462 -0.774 . . . . 0.0 110.212 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.435 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 29.2 m -109.26 -166.81 1.14 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.461 -0.774 . . . . 0.0 110.306 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -74.27 0.22 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.156 -0.965 . . . . 0.0 111.169 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.53 125.87 4.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.138 -0.976 . . . . 0.0 110.639 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.36 24.26 75.55 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.622 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 38.7 m-85 -129.49 137.81 51.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.42 -1.047 . . . . 0.0 109.999 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -125.56 130.64 52.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.465 -0.772 . . . . 0.0 110.331 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.435 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 76.9 m -68.24 149.76 49.1 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.578 -0.701 . . . . 0.0 110.314 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 55.7 m -107.77 137.38 19.73 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.447 -0.783 . . . . 0.0 110.055 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -75.26 -33.47 4.31 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.812 1.428 . . . . 0.0 111.065 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.1 m -88.78 -40.41 13.21 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.504 -0.747 . . . . 0.0 110.306 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.7 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 24.6 m0 -84.67 -23.31 29.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.563 -0.711 . . . . 0.0 110.407 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 5.5 tttt 70.6 10.19 7.06 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.854 -0.529 . . . . 0.0 112.368 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.7 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -127.45 167.29 16.45 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.62 -1.3 . . . . 0.0 110.937 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.6 t -92.97 143.57 26.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.445 -0.785 . . . . 0.0 110.694 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.494 HG12 ' CD1' ' A' ' 28' ' ' TRP . 26.3 m -139.58 163.91 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.528 -0.732 . . . . 0.0 109.818 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.14 137.5 58.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.423 -0.798 . . . . 0.0 110.412 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.89 0 O-C-N 121.666 -0.646 . . . . 0.0 110.596 -179.725 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.511 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 29' ' ' CYS . . . 167.22 -175.62 42.31 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.443 HD22 ' CE1' ' A' ' 20' ' ' TYR . 1.7 mm? 52.51 72.55 0.4 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.737 -0.861 . . . . 0.0 110.647 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.442 ' HA ' ' CD1' ' A' ' 28' ' ' TRP . 6.2 ttm 60.87 42.0 13.71 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.609 -0.682 . . . . 0.0 110.533 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.85 100.51 10.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.446 -0.784 . . . . 0.0 109.793 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.73 109.05 1.6 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.9 p -114.71 -36.69 4.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.549 -0.971 . . . . 0.0 110.54 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.12 72.06 0.51 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.637 -0.664 . . . . 0.0 110.4 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.57 121.78 1.04 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -13.06 59.76 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.523 -0.986 . . . . 0.0 110.772 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.2 p -102.2 23.68 11.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 110.799 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.408 HG22 ' SG ' ' A' ' 22' ' ' CYS . 15.4 t -72.58 -169.79 0.59 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.144 -0.973 . . . . 0.0 109.991 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -133.64 107.41 7.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.166 -0.959 . . . . 0.0 110.53 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -98.62 -160.52 0.81 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.637 -0.664 . . . . 0.0 109.991 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -69.23 -77.12 0.08 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.078 -1.014 . . . . 0.0 110.569 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 p -164.7 -46.67 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.487 -0.758 . . . . 0.0 109.987 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.34 29.91 11.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 84.0 m-85 -129.2 125.94 38.09 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.912 . . . . 0.0 109.643 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -116.51 139.03 50.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -0.787 . . . . 0.0 110.319 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.2 m -75.6 128.57 35.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.461 -0.774 . . . . 0.0 110.426 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.78 136.66 36.48 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.739 -0.601 . . . . 0.0 110.315 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.1 -27.74 11.55 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.923 1.486 . . . . 0.0 110.75 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.8 m -84.47 -29.56 25.95 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.433 -0.792 . . . . 0.0 110.627 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.651 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 78.3 m95 -100.53 -16.71 17.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.417 -0.802 . . . . 0.0 110.927 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.9 tptt 69.06 9.76 7.56 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.651 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -132.57 169.79 16.11 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.598 -1.314 . . . . 0.0 110.957 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.7 OUTLIER -89.32 140.62 29.31 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.632 0.729 . . . . 0.0 111.531 -178.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 28' ' ' TRP . 3.1 m -140.31 178.24 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.92 149.74 11.15 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.256 -0.903 . . . . 0.0 110.518 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.907 0 O-C-N 121.527 -0.733 . . . . 0.0 110.667 -179.723 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.402 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.529 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.51 121.62 1.42 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 tp 66.88 101.08 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.858 -0.789 . . . . 0.0 111.055 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.65 26.09 15.83 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.871 -0.518 . . . . 0.0 111.022 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 28' ' ' TRP . . . -91.07 135.98 33.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.99 127.46 44.88 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 1.4 t -120.58 -71.16 0.75 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.719 -0.871 . . . . 0.0 109.635 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 55.44 77.63 0.22 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.716 -0.615 . . . . 0.0 110.813 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.53 121.01 0.56 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -19.15 64.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.605 -0.938 . . . . 0.0 110.444 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -110.79 21.31 16.65 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.383 -0.823 . . . . 0.0 110.515 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.513 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 8.9 m -83.52 135.18 34.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.319 -0.863 . . . . 0.0 110.068 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.55 141.07 37.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.657 -0.652 . . . . 0.0 110.098 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 20' ' ' TYR . 72.8 m -81.34 -165.12 0.87 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.459 -0.776 . . . . 0.0 110.081 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -74.97 0.32 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.212 -0.93 . . . . 0.0 110.89 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.6 m -152.28 116.95 5.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.292 -0.88 . . . . 0.0 110.356 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.47 31.43 45.89 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.448 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 58.8 m-85 -138.08 158.15 44.9 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.469 -1.018 . . . . 0.0 110.103 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -139.52 138.25 36.16 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.0 110.274 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 41.3 t -69.74 126.95 31.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.353 -0.842 . . . . 0.0 110.775 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.72 131.73 42.61 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.633 -0.667 . . . . 0.0 109.821 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.84 -26.29 13.54 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.836 1.44 . . . . 0.0 111.304 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.9 m -83.07 -38.11 22.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.329 -0.857 . . . . 0.0 110.771 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.63 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 80.8 m95 -98.14 -9.54 25.62 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.384 -0.823 . . . . 0.0 111.012 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 3.1 mmmm 59.31 34.2 22.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.557 -0.714 . . . . 0.0 111.752 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.63 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -143.43 174.5 10.7 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.955 -1.091 . . . . 0.0 110.685 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.3 m -89.57 133.84 34.41 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.98 -1.075 . . . . 0.0 109.854 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 28' ' ' TRP . 17.5 m -132.14 173.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.465 -0.772 . . . . 0.0 110.505 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -62.02 127.28 30.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.445 -0.785 . . . . 0.0 110.227 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.875 0 O-C-N 121.536 -0.727 . . . . 0.0 110.461 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.505 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.72 143.94 11.82 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.21 93.07 0.05 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.917 -0.755 . . . . 0.0 111.02 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.9 mtt 58.46 32.58 22.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.706 -0.621 . . . . 0.0 110.99 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.95 131.53 35.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.38 -0.825 . . . . 0.0 109.553 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -50.74 116.45 4.32 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -100.43 -60.1 1.59 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.621 -0.929 . . . . 0.0 109.494 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.475 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 2.3 m-20 46.58 77.74 0.08 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.191 0.519 . . . . 0.0 111.446 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.38 128.32 2.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -16.4 59.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.602 -0.94 . . . . 0.0 110.776 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 p -121.45 38.24 4.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.497 -0.752 . . . . 0.0 109.621 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -63.33 157.37 23.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.544 -0.722 . . . . 0.0 110.741 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.23 94.47 5.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.419 -0.801 . . . . 0.0 110.05 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.5 m -78.51 -162.45 0.36 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.611 -0.68 . . . . 0.0 110.375 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -90.65 -84.64 0.24 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.216 -0.927 . . . . 0.0 110.25 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.5 p -155.93 111.5 3.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.46 40.88 6.69 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.464 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 58.9 m-85 -132.92 156.86 46.48 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.32 -1.106 . . . . 0.0 110.038 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.14 132.96 34.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 110.543 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.6 126.67 29.09 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.503 -0.748 . . . . 0.0 110.05 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.5 m -77.0 137.92 65.51 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.499 -0.751 . . . . 0.0 110.424 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.33 -23.72 17.37 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.933 1.491 . . . . 0.0 111.198 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.2 m -101.12 -39.67 7.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.293 -0.879 . . . . 0.0 110.694 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.669 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 81.8 m95 -87.98 -19.57 27.05 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.337 -0.852 . . . . 0.0 111.207 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 67.86 14.71 9.48 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.597 -0.689 . . . . 0.0 112.302 179.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.669 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -121.39 166.35 14.21 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.747 -1.22 . . . . 0.0 110.323 178.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -89.39 124.13 34.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.116 -0.99 . . . . 0.0 110.78 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.4 m -119.74 170.86 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.796 -0.565 . . . . 0.0 109.681 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -54.4 125.7 20.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.291 -0.88 . . . . 0.0 110.342 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.587 -0.696 . . . . 0.0 109.98 179.795 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.558 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.48 148.74 20.0 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.91 93.29 0.05 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.716 -0.873 . . . . 0.0 110.633 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 56.67 41.52 28.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.62 -0.675 . . . . 0.0 110.137 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.47 113.79 23.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.559 -0.713 . . . . 0.0 110.058 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.23 110.99 1.33 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.5 m -95.55 -52.82 3.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.567 -0.96 . . . . 0.0 109.691 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.73 54.43 4.42 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.374 0.606 . . . . 0.0 110.483 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.34 127.21 0.87 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -15.75 62.07 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.644 -0.915 . . . . 0.0 110.898 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.55 30.34 6.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.237 -0.915 . . . . 0.0 110.254 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -90.67 143.11 27.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.75 173.96 6.08 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.43 -0.794 . . . . 0.0 110.131 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.3 m -133.52 -164.67 1.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.387 -0.821 . . . . 0.0 110.592 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.4 m -75.26 -87.49 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.274 -0.891 . . . . 0.0 110.47 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -149.3 118.66 6.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.351 -0.843 . . . . 0.0 110.269 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.12 26.25 45.22 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.561 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 57.3 m-85 -133.29 150.12 51.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.383 -1.069 . . . . 0.0 109.911 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.15 140.37 37.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.452 -0.78 . . . . 0.0 110.541 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 76.6 m -73.48 142.75 46.8 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.441 -0.787 . . . . 0.0 109.97 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m -103.62 143.37 26.51 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.588 -0.695 . . . . 0.0 110.369 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.42 -33.04 4.47 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.012 1.533 . . . . 0.0 111.172 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.0 m -84.46 -39.69 18.62 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.45 -0.781 . . . . 0.0 110.79 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.677 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 17.9 m0 -88.61 -22.54 23.43 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.526 -0.734 . . . . 0.0 110.877 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 71.63 2.0 4.1 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.71 -0.619 . . . . 0.0 111.925 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.677 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -120.57 170.38 9.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.747 -1.221 . . . . 0.0 110.509 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 6.3 t -89.08 143.12 27.07 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.533 -0.729 . . . . 0.0 111.102 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.1 m -137.08 178.3 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.861 -0.524 . . . . 0.0 109.591 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -61.5 119.03 7.8 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 109.863 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.571 -0.705 . . . . 0.0 110.702 -179.477 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.584 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.61 152.1 24.11 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.87 93.29 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.664 -0.904 . . . . 0.0 110.623 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 mtp 57.09 41.34 27.51 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.66 -0.65 . . . . 0.0 109.775 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.04 122.99 32.28 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.579 -0.701 . . . . 0.0 110.376 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.29 108.81 1.95 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 p -114.73 -40.48 3.55 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.567 -0.961 . . . . 0.0 110.866 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t70 56.92 69.28 0.76 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.647 -0.658 . . . . 0.0 110.447 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.45 115.7 1.3 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.22 -20.18 39.64 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.371 -1.076 . . . . 0.0 110.56 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.8 t -78.43 -19.98 52.04 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.485 -0.76 . . . . 0.0 110.537 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.2 m -56.7 133.12 53.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.469 -0.769 . . . . 0.0 110.089 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -85.31 152.9 22.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 110.505 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -118.82 -161.11 0.83 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.58 -0.7 . . . . 0.0 110.334 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.0 m -71.94 -82.28 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.264 -0.897 . . . . 0.0 110.46 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.7 p -159.03 115.96 2.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.548 -0.72 . . . . 0.0 109.702 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.0 -4.54 78.25 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.88 143.45 38.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.199 -1.177 . . . . 0.0 110.062 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -132.31 135.4 46.18 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.348 -0.845 . . . . 0.0 110.2 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 45.3 t -59.51 140.07 56.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.629 -0.669 . . . . 0.0 110.829 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.12 128.22 27.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.634 -0.666 . . . . 0.0 110.017 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.79 -20.83 19.5 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.908 1.478 . . . . 0.0 111.166 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.2 m -89.08 -34.83 16.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.234 -0.916 . . . . 0.0 110.751 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.674 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 86.3 m95 -102.04 -10.14 19.98 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.338 -0.851 . . . . 0.0 111.202 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 tptm 69.29 8.01 6.55 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.622 -0.674 . . . . 0.0 112.708 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.674 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -131.39 167.89 18.52 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.585 -1.322 . . . . 0.0 110.698 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 5.8 t -89.02 139.71 30.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.492 -0.755 . . . . 0.0 110.639 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.424 HG12 ' CD1' ' A' ' 28' ' ' TRP . 12.2 m -134.03 175.83 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.718 -0.614 . . . . 0.0 110.029 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.82 125.58 25.8 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.387 -0.82 . . . . 0.0 110.36 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.646 -0.659 . . . . 0.0 110.017 179.939 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 16' ' ' CYS . . . . . . . . 0 N--CA 1.494 2.509 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.39 133.14 4.33 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.46 97.05 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.76 -0.847 . . . . 0.0 111.222 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 mpp? 54.02 34.71 20.37 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.656 -0.653 . . . . 0.0 110.291 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.22 127.51 36.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.525 -0.734 . . . . 0.0 110.5 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.11 112.18 3.98 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.5 p -115.38 -45.34 2.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.519 -0.989 . . . . 0.0 110.328 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.41 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER 54.87 87.06 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.291 0.567 . . . . 0.0 110.427 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.15 115.34 0.77 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HG2' ' HB3' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -62.37 -18.67 62.11 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.577 -0.955 . . . . 0.0 110.36 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.22 -17.87 26.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.365 -0.834 . . . . 0.0 110.537 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.7 m -58.76 120.93 9.87 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.263 -0.898 . . . . 0.0 109.978 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.413 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 39.8 t80 -94.61 20.58 8.34 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.527 -0.733 . . . . 0.0 110.852 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 20' ' ' TYR . 6.2 m 56.37 -149.51 0.46 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.027 -1.046 . . . . 0.0 110.045 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.04 -65.75 0.97 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.164 -0.96 . . . . 0.0 110.085 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 t -162.24 117.88 1.94 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.507 -0.746 . . . . 0.0 110.397 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.41 30.46 33.49 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 16' ' ' CYS . 64.9 m-85 -136.92 168.27 19.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.419 -1.048 . . . . 0.0 110.137 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.88 124.05 16.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -0.78 . . . . 0.0 110.21 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.18 117.26 12.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.572 -0.705 . . . . 0.0 110.092 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 19.9 m -74.23 131.22 81.08 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.552 -0.718 . . . . 0.0 110.188 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HB3' ' HG2' ' A' ' 12' ' ' LYS . 46.5 Cg_endo -73.28 -23.07 18.18 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.988 1.52 . . . . 0.0 111.093 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.3 m -96.24 -35.56 11.22 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.24 -0.913 . . . . 0.0 110.69 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.568 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 26.1 m0 -92.27 -19.08 22.55 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.348 -0.845 . . . . 0.0 110.876 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 70.76 7.21 6.14 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.568 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -118.68 163.44 16.83 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.755 -1.215 . . . . 0.0 110.665 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.3 m -96.42 124.0 40.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.599 -0.688 . . . . 0.0 110.895 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.489 HG12 ' CD1' ' A' ' 28' ' ' TRP . 2.1 m -121.29 170.39 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.588 -0.695 . . . . 0.0 110.14 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -52.67 146.41 10.29 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.432 -0.793 . . . . 0.0 110.627 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.359 -0.838 . . . . 0.0 110.233 -179.725 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.432 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 29' ' ' CYS . . . -160.66 175.92 37.33 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 58.28 87.2 0.07 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.719 -0.871 . . . . 0.0 110.873 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 46.5 mmm 54.91 37.08 28.12 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.643 -0.661 . . . . 0.0 110.233 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.31 97.01 10.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.5 -0.75 . . . . 0.0 110.114 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.12 104.64 0.55 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.558 ' HB2' HG22 ' A' ' 14' ' ' THR . 21.8 p -110.23 -32.57 6.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.604 -0.939 . . . . 0.0 110.805 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 t70 65.0 99.03 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.696 -0.628 . . . . 0.0 110.603 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.36 117.53 1.54 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -66.07 -14.04 61.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.597 -0.943 . . . . 0.0 110.581 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.3 p -107.12 11.35 29.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.833 . . . . 0.0 110.792 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.558 HG22 ' HB2' ' A' ' 9' ' ' CYS . 19.9 m -74.03 141.42 45.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.139 -0.975 . . . . 0.0 110.012 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.84 163.34 15.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.455 -0.778 . . . . 0.0 110.351 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.0 m -129.89 -160.51 1.04 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.539 -0.726 . . . . 0.0 109.863 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.7 t -66.03 -66.36 0.56 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 t -171.4 -46.61 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.45 -0.781 . . . . 0.0 110.43 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.13 29.66 11.27 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.473 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 66.9 m-85 -130.94 158.9 39.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.468 -1.019 . . . . 0.0 110.155 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.47 129.35 18.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.369 -0.832 . . . . 0.0 110.398 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 2.3 m -67.1 127.23 31.81 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.507 -0.745 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.587 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 7.9 t -83.87 141.54 41.13 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.473 -0.767 . . . . 0.0 110.193 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.78 -24.96 15.04 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.891 1.469 . . . . 0.0 111.299 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.3 m -99.36 -31.68 11.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.161 -0.962 . . . . 0.0 110.962 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.688 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 36.6 m0 -87.97 -21.72 24.71 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.33 -0.856 . . . . 0.0 110.982 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 73.26 -2.08 2.85 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.707 -0.621 . . . . 0.0 112.042 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.688 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.9 p90 -122.46 165.56 16.16 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.609 -1.307 . . . . 0.0 110.67 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 5.0 t -89.32 133.92 34.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.517 -0.739 . . . . 0.0 111.106 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 33.1 m -126.27 -170.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.38 134.17 56.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.208 -0.932 . . . . 0.0 110.073 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.9 0 O-C-N 121.508 -0.745 . . . . 0.0 110.497 -179.733 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -145.61 150.52 22.74 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.34 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.697 -0.884 . . . . 0.0 110.789 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.2 mtm 59.42 37.8 23.02 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.658 -0.651 . . . . 0.0 110.405 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.19 112.34 23.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.452 -0.78 . . . . 0.0 110.01 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -50.62 107.71 0.41 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.547 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 5.4 p -109.76 -42.17 4.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.691 -0.888 . . . . 0.0 110.334 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 55.0 72.42 0.47 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.78 -0.575 . . . . 0.0 111.032 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.32 126.6 2.7 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -11.38 57.11 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.587 -0.949 . . . . 0.0 110.435 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t -94.14 13.87 21.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.364 -0.835 . . . . 0.0 110.547 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.547 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 14.7 t -73.34 -173.75 1.45 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.184 -0.948 . . . . 0.0 110.166 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 96.78 4.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.018 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.2 m -77.64 -169.64 1.55 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.414 -0.804 . . . . 0.0 110.188 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -79.32 -94.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.248 -0.907 . . . . 0.0 110.255 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 p -144.3 113.13 6.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.062 -1.024 . . . . 0.0 110.574 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.38 37.5 9.7 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -132.18 148.32 52.46 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.361 -1.082 . . . . 0.0 110.055 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -124.1 128.11 48.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.498 -0.751 . . . . 0.0 110.485 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 42.3 t -69.39 121.1 16.27 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.608 -0.682 . . . . 0.0 109.971 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.557 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 58.4 m -76.23 129.64 79.79 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.521 -0.737 . . . . 0.0 110.199 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.45 -24.27 19.38 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.875 1.461 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -98.8 -36.2 9.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.302 -0.874 . . . . 0.0 110.492 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.703 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 50.6 m0 -85.18 -19.05 32.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.455 -0.778 . . . . 0.0 110.955 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 70.81 9.01 6.74 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.672 -0.643 . . . . 0.0 112.273 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.703 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -130.5 161.05 32.32 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.798 -1.188 . . . . 0.0 110.506 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.9 t -89.46 133.6 34.48 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.497 -0.752 . . . . 0.0 111.08 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.2 m -126.03 -177.55 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.74 -0.6 . . . . 0.0 109.518 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.45 135.75 57.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.212 -0.93 . . . . 0.0 110.209 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.489 -0.757 . . . . 0.0 110.632 -179.753 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.584 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.89 159.9 28.2 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 55.36 85.67 0.06 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.749 -0.854 . . . . 0.0 111.104 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.3 mtp 58.55 37.37 25.47 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.682 -0.636 . . . . 0.0 110.661 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.99 125.72 33.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.43 108.05 0.81 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.542 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 25.9 p -109.41 -41.35 4.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.551 -0.97 . . . . 0.0 110.583 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.1 t70 46.65 76.64 0.1 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.751 -0.593 . . . . 0.0 111.339 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.65 125.28 2.22 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -12.88 52.7 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.606 -0.938 . . . . 0.0 110.722 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.5 t -113.13 32.01 6.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.917 . . . . 0.0 110.244 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.542 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 15.0 t -72.58 -168.97 0.49 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.432 -0.793 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -127.04 92.38 3.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.489 -0.757 . . . . 0.0 110.429 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -82.17 -172.9 4.22 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.481 -0.762 . . . . 0.0 109.829 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 t -80.76 -75.49 0.27 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.07 -1.019 . . . . 0.0 110.751 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.0 p -162.78 125.23 2.71 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.281 -0.887 . . . . 0.0 110.141 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.28 28.34 64.19 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.475 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.3 m-85 -126.49 126.04 43.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.268 -1.136 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -105.47 132.3 51.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 110.187 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 4.8 t -85.24 130.12 34.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.567 -0.708 . . . . 0.0 110.162 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -92.39 136.58 25.35 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.525 -0.734 . . . . 0.0 109.968 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.32 -28.3 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.808 1.425 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 m -86.72 -34.68 19.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.383 -0.823 . . . . 0.0 110.213 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.647 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 46.9 m0 -88.22 -22.24 24.09 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.548 -0.72 . . . . 0.0 110.664 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 21.1 mmmt 66.96 15.36 10.13 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.85 -0.531 . . . . 0.0 112.032 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.647 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -131.66 166.97 20.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.804 -1.185 . . . . 0.0 110.803 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 3.8 t -104.9 133.08 50.31 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.431 -0.793 . . . . 0.0 110.639 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG13 ' CD1' ' A' ' 28' ' ' TRP . 4.3 m -136.02 171.96 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.627 -0.671 . . . . 0.0 109.967 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -49.86 142.62 8.67 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.36 -0.838 . . . . 0.0 110.728 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 -179.4 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.512 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.2 140.57 10.73 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.427 HD22 ' HE1' ' A' ' 20' ' ' TYR . 0.9 OUTLIER 61.35 93.22 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.91 -0.759 . . . . 0.0 110.959 179.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.61 40.78 23.19 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.708 -0.62 . . . . 0.0 110.475 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.1 130.6 34.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.425 -0.797 . . . . 0.0 109.916 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.3 110.84 1.72 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' A' ' 14' ' ' THR . 2.0 t -105.3 -72.3 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.655 -0.909 . . . . 0.0 109.553 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.0 t70 53.48 63.57 2.16 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.381 0.61 . . . . 0.0 110.822 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.48 126.2 0.93 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.56 -14.33 60.87 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.476 -1.014 . . . . 0.0 110.889 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.6 p -93.96 11.69 28.72 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.246 -0.909 . . . . 0.0 111.149 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.55 HG23 ' HB2' ' A' ' 22' ' ' CYS . 6.1 t -64.96 155.96 32.76 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.109 -0.994 . . . . 0.0 109.813 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -111.35 -18.92 12.79 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.311 -0.868 . . . . 0.0 111.257 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.6 m 55.62 -155.81 0.27 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.43 -0.794 . . . . 0.0 110.055 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.9 t -99.54 -104.47 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.131 -0.981 . . . . 0.0 109.412 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 t -131.7 106.0 7.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.989 -1.069 . . . . 0.0 109.753 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.37 53.53 2.61 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.454 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 75.0 m-85 -138.5 147.56 43.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.443 -1.033 . . . . 0.0 110.303 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -119.88 130.37 54.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.589 -0.694 . . . . 0.0 110.155 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.55 ' HB2' HG23 ' A' ' 14' ' ' THR . 37.9 t -74.94 138.29 42.23 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.544 -0.723 . . . . 0.0 110.158 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -100.9 133.33 21.14 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.729 . . . . 0.0 110.24 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.29 -42.14 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 124.007 1.53 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.7 m -80.89 -24.68 38.12 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.55 -0.719 . . . . 0.0 110.865 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.594 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 45.3 m95 -98.96 -19.33 17.36 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.338 -0.851 . . . . 0.0 110.881 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.22 8.46 6.82 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.594 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -131.45 163.37 28.09 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.627 -1.296 . . . . 0.0 111.099 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.7 t -91.41 138.01 31.91 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.49 -0.757 . . . . 0.0 110.575 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.53 173.84 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.515 -0.74 . . . . 0.0 109.698 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -58.04 133.01 55.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.326 -0.859 . . . . 0.0 110.169 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.574 -0.703 . . . . 0.0 110.501 -179.639 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.733 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.44 159.35 30.06 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.84 90.55 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.696 -0.885 . . . . 0.0 110.622 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.13 34.31 23.24 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.657 -0.652 . . . . 0.0 110.405 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.5 133.93 34.87 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.466 -0.771 . . . . 0.0 109.795 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.31 114.45 5.86 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.01 -61.48 1.4 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.842 . . . . 0.0 109.677 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.443 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 1.1 t70 54.11 56.23 7.28 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.766 -0.584 . . . . 0.0 111.164 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.11 127.22 1.01 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -16.08 56.19 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.491 -1.005 . . . . 0.0 111.247 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.74 35.49 4.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.244 -0.91 . . . . 0.0 110.209 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 t -71.66 178.28 3.66 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.482 -0.761 . . . . 0.0 110.533 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -117.34 120.27 37.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.458 -0.776 . . . . 0.0 110.461 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m -115.16 -171.12 1.89 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.535 -0.728 . . . . 0.0 110.038 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.8 m -81.37 -102.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.264 -0.897 . . . . 0.0 109.94 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.75 121.18 10.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.168 -0.958 . . . . 0.0 109.776 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 24.63 32.78 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -128.51 126.38 40.31 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.356 -1.085 . . . . 0.0 109.539 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.41 143.24 43.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.4 -0.812 . . . . 0.0 110.713 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 19.4 t -78.77 126.4 30.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.687 -0.633 . . . . 0.0 110.155 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.13 137.33 42.98 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.469 -0.769 . . . . 0.0 110.147 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.57 -32.06 5.05 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.898 1.473 . . . . 0.0 110.964 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.6 m -86.44 -28.89 23.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.506 -0.746 . . . . 0.0 110.979 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.63 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 52.2 m95 -101.53 -22.89 14.4 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.388 -0.82 . . . . 0.0 111.061 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.443 ' HG3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 67.94 28.24 6.95 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.647 -0.658 . . . . 0.0 112.374 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.63 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -135.77 171.27 14.71 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.772 -1.205 . . . . 0.0 110.412 178.055 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -97.53 125.11 42.05 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.088 -1.008 . . . . 0.0 110.145 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.449 HG12 ' CD1' ' A' ' 28' ' ' TRP . 15.6 m -124.72 163.44 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.543 -0.723 . . . . 0.0 110.241 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.83 131.1 49.85 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.537 -0.727 . . . . 0.0 110.399 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.653 -0.654 . . . . 0.0 110.362 -179.841 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.406 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.92 149.85 21.82 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 57.54 84.83 0.09 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.737 -0.861 . . . . 0.0 111.574 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 ttt 56.87 37.1 28.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.701 -0.624 . . . . 0.0 110.98 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.15 101.71 14.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.492 -0.755 . . . . 0.0 110.09 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 28' ' ' TRP . . . -54.63 110.3 1.58 Allowed Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.4 ' SG ' HG22 ' A' ' 14' ' ' THR . 23.4 p -105.89 -40.53 5.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.476 -1.014 . . . . 0.0 110.285 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.9 t70 54.64 95.54 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.326 0.584 . . . . 0.0 111.311 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.2 120.07 1.04 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -17.42 62.43 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.642 -0.917 . . . . 0.0 110.228 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 t -117.4 31.15 6.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.449 -0.782 . . . . 0.0 110.022 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.4 HG22 ' SG ' ' A' ' 9' ' ' CYS . 11.1 t -78.97 158.75 27.91 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.251 -0.906 . . . . 0.0 109.997 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.62 112.88 23.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.8 m -81.01 -165.78 0.99 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.442 -0.787 . . . . 0.0 110.109 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -79.58 -77.61 0.18 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.084 -1.01 . . . . 0.0 110.266 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.87 123.14 1.18 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.387 -0.82 . . . . 0.0 109.694 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.49 29.91 54.67 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.473 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.6 m-85 -126.77 150.59 49.03 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.366 -1.079 . . . . 0.0 110.212 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -126.05 130.51 51.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 110.315 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 1.3 m -86.97 129.55 34.83 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.386 -0.821 . . . . 0.0 110.119 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.96 144.58 30.29 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.515 -0.741 . . . . 0.0 110.239 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.62 -41.51 1.11 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.83 1.437 . . . . 0.0 111.121 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.4 m -76.94 -34.35 57.64 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.521 -0.737 . . . . 0.0 110.729 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.644 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 42.0 m0 -89.51 -28.58 19.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.405 -0.809 . . . . 0.0 110.683 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 1.3 tppt? 70.33 10.29 7.21 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.914 -0.491 . . . . 0.0 112.185 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.644 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -120.79 166.51 13.65 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.767 -1.208 . . . . 0.0 110.827 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 1.7 t -101.83 129.24 48.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.637 -0.664 . . . . 0.0 110.385 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 28' ' ' TRP . 4.4 m -124.18 175.36 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.56 -0.713 . . . . 0.0 109.961 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.4 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -62.68 138.21 58.45 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.389 -0.819 . . . . 0.0 110.498 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.548 -0.72 . . . . 0.0 110.169 179.707 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.559 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.64 150.34 22.13 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.5 87.76 0.09 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.722 -0.869 . . . . 0.0 110.906 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.8 mtt 56.77 37.22 28.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.752 -0.592 . . . . 0.0 110.479 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.37 114.69 23.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.443 -0.785 . . . . 0.0 109.698 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.63 98.21 0.06 OUTLIER Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.572 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 9.1 p -87.21 -38.42 16.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.573 -0.957 . . . . 0.0 110.097 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.476 ' HA ' ' HD2' ' A' ' 27' ' ' LYS . 22.5 m-20 51.12 82.78 0.06 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.267 0.556 . . . . 0.0 111.433 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 131.93 124.21 2.54 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -10.62 40.36 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.644 -0.915 . . . . 0.0 110.734 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 m -106.6 26.88 9.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.231 -0.918 . . . . 0.0 110.248 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.572 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 14.1 t -77.36 -179.7 5.89 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.291 -0.88 . . . . 0.0 110.716 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.24 105.52 7.71 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.514 -0.742 . . . . 0.0 110.009 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.9 m -82.47 -171.27 3.38 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 110.484 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.68 -76.06 0.32 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.217 -0.927 . . . . 0.0 110.683 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.3 p -163.8 131.97 3.62 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.345 -0.847 . . . . 0.0 110.237 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.32 24.23 77.17 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.547 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 30.0 m-85 -125.15 142.92 51.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.395 -1.062 . . . . 0.0 109.785 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.0 117.8 27.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.801 . . . . 0.0 110.316 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.528 ' SG ' HG23 ' A' ' 14' ' ' THR . 2.2 t -75.12 108.13 7.66 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.525 -0.735 . . . . 0.0 109.718 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -72.98 136.17 79.89 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 0.0 109.955 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.51 -28.79 14.16 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.95 1.5 . . . . 0.0 110.672 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -87.18 -35.08 18.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.39 -0.819 . . . . 0.0 110.255 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.649 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 47.3 m0 -87.38 -15.76 36.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.51 -0.744 . . . . 0.0 110.934 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 32.3 mmtm 61.68 15.84 7.26 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.723 -0.611 . . . . 0.0 112.344 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.649 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -132.55 167.29 20.27 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.838 -1.164 . . . . 0.0 110.6 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 3.6 t -107.86 127.94 54.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.632 -0.667 . . . . 0.0 110.218 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.404 HG11 ' CD1' ' A' ' 28' ' ' TRP . 3.6 m -131.89 165.48 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.537 -0.727 . . . . 0.0 110.584 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -45.79 142.29 2.58 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.654 -0.654 . . . . 0.0 110.883 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 0.0 110.579 -179.408 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.444 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.32 140.77 4.5 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 61.17 93.93 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.851 -0.793 . . . . 0.0 111.061 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.2 mtp 55.91 42.61 28.61 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.679 -0.638 . . . . 0.0 109.979 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.18 115.7 23.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.608 -0.683 . . . . 0.0 110.049 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.9 110.16 2.24 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.514 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 7.4 p -113.67 -36.17 4.97 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.677 -0.896 . . . . 0.0 110.599 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.32 59.32 4.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.666 -0.647 . . . . 0.0 110.976 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.76 117.56 0.43 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -21.54 52.78 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.494 -1.003 . . . . 0.0 110.899 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -99.2 -12.41 20.46 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.434 -0.791 . . . . 0.0 110.806 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.514 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 54.1 m -56.67 132.97 53.46 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.348 -0.845 . . . . 0.0 110.506 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -94.26 175.41 6.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.576 -0.703 . . . . 0.0 110.347 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.9 m -124.68 -148.11 0.39 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.509 -0.744 . . . . 0.0 110.128 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 t -88.7 -71.51 0.59 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.084 -1.01 . . . . 0.0 110.782 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.9 p -161.45 119.83 2.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.411 -0.805 . . . . 0.0 110.342 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.43 26.03 48.76 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.667 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 74.9 m-85 -139.4 152.14 46.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.474 -1.015 . . . . 0.0 109.547 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.4 130.26 26.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.324 -0.86 . . . . 0.0 110.645 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 16.9 t -68.63 149.38 49.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.521 -0.737 . . . . 0.0 110.304 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.67 140.63 30.84 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.507 -0.746 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.29 -41.08 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.713 1.375 . . . . 0.0 111.185 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.0 m -72.63 -31.91 65.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.398 -0.814 . . . . 0.0 110.839 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.605 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 54.1 m95 -96.76 -20.43 18.23 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.399 -0.813 . . . . 0.0 110.475 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 5.5 tptt 70.37 8.81 6.77 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.673 -0.642 . . . . 0.0 112.25 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.605 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.7 p90 -136.77 169.0 18.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.723 -1.236 . . . . 0.0 110.757 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.667 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 11.4 t -89.17 145.6 25.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.557 -0.714 . . . . 0.0 110.922 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 27.8 m -132.69 -179.21 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -66.41 131.25 45.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.239 -0.913 . . . . 0.0 110.367 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.586 -0.696 . . . . 0.0 110.645 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.474 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.31 161.68 30.99 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 55.4 84.28 0.08 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.74 -0.859 . . . . 0.0 111.109 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 56.25 40.48 29.94 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.62 -0.675 . . . . 0.0 110.46 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.49 107.4 19.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.511 -0.743 . . . . 0.0 110.455 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.45 108.79 1.97 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.557 ' SG ' HG23 ' A' ' 14' ' ' THR . 27.2 p -110.61 -32.3 6.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.583 -0.951 . . . . 0.0 110.92 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 t70 59.86 73.46 0.48 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.653 -0.654 . . . . 0.0 110.584 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 174.01 124.27 0.78 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -61.67 -19.01 61.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.727 -0.867 . . . . 0.0 111.007 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.439 ' N ' ' HG2' ' A' ' 12' ' ' LYS . 64.6 p -134.54 35.15 3.19 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.449 -0.782 . . . . 0.0 110.063 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.557 HG23 ' SG ' ' A' ' 9' ' ' CYS . 12.3 t -64.95 161.69 18.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.435 -0.791 . . . . 0.0 110.595 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -100.6 115.21 29.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.407 -0.808 . . . . 0.0 110.296 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.5 m -94.39 -163.99 1.12 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.627 -0.671 . . . . 0.0 109.911 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.74 -76.79 0.22 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.05 -1.031 . . . . 0.0 110.6 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 p -163.47 126.75 2.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.483 -0.76 . . . . 0.0 109.917 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.04 17.21 80.28 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.409 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 38.4 m-85 -124.67 126.82 46.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.183 -1.186 . . . . 0.0 109.977 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.73 135.84 53.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.665 -0.647 . . . . 0.0 109.787 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -85.1 138.36 32.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.587 -0.696 . . . . 0.0 110.332 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 9.3 t -98.47 140.19 21.66 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.643 -0.661 . . . . 0.0 110.436 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.24 -28.78 15.0 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.818 1.43 . . . . 0.0 110.9 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -86.28 -27.81 24.16 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.366 -0.834 . . . . 0.0 110.756 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.598 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 21.2 m0 -99.01 -27.54 13.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.279 -0.888 . . . . 0.0 110.701 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.8 OUTLIER 75.01 -3.9 2.5 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.598 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -109.15 170.0 8.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.73 -1.231 . . . . 0.0 110.678 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 5.5 t -105.7 129.97 53.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.717 . . . . 0.0 110.032 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.416 HG11 ' CD1' ' A' ' 28' ' ' TRP . 3.3 m -135.73 174.33 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.682 -0.636 . . . . 0.0 109.929 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -54.71 128.53 33.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.452 -0.78 . . . . 0.0 110.724 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.966 0 O-C-N 121.645 -0.659 . . . . 0.0 110.583 -179.718 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.4 t -119.3 110.84 17.46 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.544 -0.974 . . . . 0.0 110.082 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 16' ' ' CYS . . . -134.74 135.25 7.82 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.1 158.74 27.78 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.8 83.82 0.1 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.78 -0.836 . . . . 0.0 111.094 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.1 mtp 56.29 34.89 24.88 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.663 -0.648 . . . . 0.0 110.68 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.02 145.17 29.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.433 -0.792 . . . . 0.0 109.905 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.3 121.0 24.11 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.64 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -110.61 -61.01 1.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.618 -0.931 . . . . 0.0 110.121 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 t70 59.41 77.85 0.29 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.406 0.622 . . . . 0.0 110.605 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.82 121.86 1.34 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -66.06 -13.45 60.02 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.491 -1.005 . . . . 0.0 110.925 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 p -110.84 2.94 18.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.29 -0.882 . . . . 0.0 111.13 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.64 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 1.9 m -66.83 138.2 57.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.116 -0.99 . . . . 0.0 110.172 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -100.09 138.86 36.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.51 -0.744 . . . . 0.0 110.269 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 3' ' ' GLY . 33.7 m -80.88 -157.23 0.15 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.684 -0.635 . . . . 0.0 109.833 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 t -78.93 -70.66 0.49 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.092 -1.005 . . . . 0.0 110.332 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.1 p -163.69 123.08 2.06 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.558 -0.714 . . . . 0.0 109.819 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.95 -3.97 86.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.438 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 49.0 m-85 -103.24 169.88 8.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -1.179 . . . . 0.0 110.115 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -148.23 129.68 14.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.959 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 14.6 t -73.03 132.67 43.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.49 -0.756 . . . . 0.0 110.614 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -95.67 128.8 36.52 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.573 -0.704 . . . . 0.0 109.461 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.27 -21.67 26.47 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.784 1.412 . . . . 0.0 111.003 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.6 m -87.7 -28.3 21.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.316 -0.865 . . . . 0.0 110.741 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.494 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 11.1 m0 -108.43 -12.74 14.98 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.437 -0.789 . . . . 0.0 111.243 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? 61.88 29.55 17.91 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.583 -0.698 . . . . 0.0 112.27 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.494 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -136.66 171.0 15.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.839 -1.163 . . . . 0.0 110.671 178.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.3 m -102.14 123.87 46.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.382 -0.824 . . . . 0.0 110.492 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 m -132.89 -179.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.547 -0.72 . . . . 0.0 109.85 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -55.17 143.53 27.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.356 -0.84 . . . . 0.0 110.334 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.41 141.13 29.04 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.38 -0.825 . . . . 0.0 110.419 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -149.65 86.59 5.37 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.501 -0.749 . . . . 0.0 110.085 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 C--N 1.311 -1.395 0 O-C-N 123.81 1.426 . . . . 0.0 110.898 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.443 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -139.19 100.38 4.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.421 -1.046 . . . . 0.0 110.394 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.5 134.25 11.89 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.83 155.71 26.44 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 58.5 91.42 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.794 -0.827 . . . . 0.0 111.0 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.4 mtt 55.64 35.39 25.15 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.733 -0.605 . . . . 0.0 110.591 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.24 93.92 9.18 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.499 -0.751 . . . . 0.0 109.698 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.14 106.66 0.77 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.466 ' HB2' HG22 ' A' ' 14' ' ' THR . 30.7 p -114.21 -37.2 4.47 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.595 -0.944 . . . . 0.0 110.772 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 t70 63.11 96.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.421 0.629 . . . . 0.0 110.791 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.02 117.67 0.6 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -63.17 -17.5 62.45 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.622 -0.928 . . . . 0.0 110.759 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 t -119.93 27.96 8.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.368 -0.832 . . . . 0.0 110.372 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 9' ' ' CYS . 17.0 m -83.31 132.53 35.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.298 -0.876 . . . . 0.0 109.875 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -86.26 160.47 19.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.478 -0.764 . . . . 0.0 110.442 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.1 m -124.84 -164.83 1.31 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.535 -0.728 . . . . 0.0 110.498 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HB2' ' CA ' ' A' ' 2' ' ' CYS . 23.7 t -74.0 -86.99 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.306 -0.871 . . . . 0.0 110.698 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.5 m -151.05 122.39 7.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.141 -0.974 . . . . 0.0 109.988 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.77 24.78 66.34 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.608 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 42.1 m-85 -130.67 140.11 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.454 -1.027 . . . . 0.0 109.831 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.73 128.6 39.24 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.434 -0.791 . . . . 0.0 110.627 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.4 m -71.12 120.26 16.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.666 -0.646 . . . . 0.0 110.008 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.523 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 5.5 t -82.44 140.08 44.85 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.401 -0.812 . . . . 0.0 110.255 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.38 -29.21 11.47 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.962 1.506 . . . . 0.0 110.854 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.0 m -86.05 -32.51 21.38 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.741 . . . . 0.0 110.464 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.686 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 34.5 m0 -93.31 -23.96 18.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.405 -0.809 . . . . 0.0 110.703 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER 72.35 1.78 4.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.851 -0.531 . . . . 0.0 111.973 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.686 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -121.96 168.07 12.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.919 -1.113 . . . . 0.0 109.999 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.608 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 4.4 t -94.71 144.09 25.9 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.454 -0.779 . . . . 0.0 110.839 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.491 HG13 ' CD1' ' A' ' 28' ' ' TRP . 0.8 OUTLIER -148.96 167.46 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -49.56 134.37 19.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.453 -0.779 . . . . 0.0 110.337 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.17 163.53 20.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.353 -0.842 . . . . 0.0 110.599 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.42 134.88 25.88 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.602 -0.686 . . . . 0.0 110.049 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 C--N 1.313 -1.311 0 O-C-N 123.842 1.443 . . . . 0.0 110.661 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.409 ' HB2' ' C ' ' A' ' 16' ' ' CYS . 29.0 p -90.19 173.72 8.0 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.513 -0.993 . . . . 0.0 110.692 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -134.8 146.5 18.52 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.89 149.38 21.39 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.55 95.63 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.917 -0.755 . . . . 0.0 110.635 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 15.1 mmt 58.04 38.28 26.65 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.729 -0.607 . . . . 0.0 110.471 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.84 140.74 29.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.609 -0.682 . . . . 0.0 109.871 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.4 116.28 8.88 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.621 ' SG ' HG22 ' A' ' 14' ' ' THR . 1.1 t -106.12 -70.42 0.79 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.691 -0.888 . . . . 0.0 109.316 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.504 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 7.2 t70 49.19 73.18 0.25 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.322 0.582 . . . . 0.0 110.729 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.63 120.85 1.87 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -62.51 -14.3 40.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.653 -0.91 . . . . 0.0 110.676 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.9 t -97.46 22.68 8.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.41 -0.806 . . . . 0.0 110.37 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.621 HG22 ' SG ' ' A' ' 9' ' ' CYS . 4.7 t -71.93 -179.05 2.56 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.225 -0.922 . . . . 0.0 110.244 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.76 94.95 3.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.308 -0.87 . . . . 0.0 110.326 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.409 ' C ' ' HB2' ' A' ' 2' ' ' CYS . 91.5 m -78.09 -179.49 6.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.403 -0.81 . . . . 0.0 109.929 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.0 m -83.02 -100.36 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.115 -0.99 . . . . 0.0 110.508 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.09 117.56 11.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.063 -1.023 . . . . 0.0 110.083 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.44 32.7 12.95 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 63.3 m-85 -130.09 142.9 50.56 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.218 -1.166 . . . . 0.0 110.601 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -123.13 133.94 54.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.578 -0.701 . . . . 0.0 110.091 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.5 t -82.12 130.67 35.15 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.555 -0.715 . . . . 0.0 110.396 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.511 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -92.29 140.49 24.34 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.339 -0.85 . . . . 0.0 110.009 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.75 -31.02 8.88 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.862 1.454 . . . . 0.0 111.178 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 m -88.93 -38.21 14.68 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.353 -0.842 . . . . 0.0 110.613 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.675 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 36.2 m0 -82.66 -26.6 31.98 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.406 -0.809 . . . . 0.0 110.672 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HG3' ' HA ' ' A' ' 10' ' ' ASP . 15.2 tptt 69.33 19.56 7.68 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.741 -0.599 . . . . 0.0 112.196 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.675 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.1 p90 -133.26 173.19 11.72 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.814 -1.179 . . . . 0.0 110.571 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.1 t -107.55 128.19 54.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.394 -0.816 . . . . 0.0 110.453 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' A' ' 28' ' ' TRP . 4.5 m -129.75 173.17 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.601 -0.687 . . . . 0.0 110.061 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -52.61 127.49 23.08 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.351 -0.843 . . . . 0.0 110.643 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.02 -179.82 6.55 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.582 -0.699 . . . . 0.0 110.253 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -134.77 140.7 36.07 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.267 -0.896 . . . . 0.0 110.452 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 C--N 1.315 -1.229 0 O-C-N 123.825 1.434 . . . . 0.0 110.796 179.891 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.63 107.37 7.93 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.513 -0.992 . . . . 0.0 110.403 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.01 137.95 14.47 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.83 130.99 3.68 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 6' ' ' MET . 0.5 OUTLIER 59.55 95.34 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.86 -0.788 . . . . 0.0 111.205 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 12.9 mtt 57.67 43.82 21.64 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.484 0.659 . . . . 0.0 110.376 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 29' ' ' CYS . . . -89.21 127.58 35.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.547 -0.721 . . . . 0.0 109.876 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -49.95 118.09 5.41 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.609 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 3.0 t -105.82 -66.68 0.97 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.613 -0.933 . . . . 0.0 109.608 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 t0 53.25 66.52 1.21 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.831 -0.543 . . . . 0.0 111.092 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.15 127.48 0.89 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -14.35 62.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.572 -0.958 . . . . 0.0 110.886 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 t -117.3 22.18 12.64 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.296 -0.878 . . . . 0.0 110.374 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.609 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 4.8 m -86.59 132.15 33.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -104.54 154.34 20.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.55 -0.719 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 20' ' ' TYR . 34.0 m -87.44 -154.75 0.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.492 -0.755 . . . . 0.0 109.983 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.2 t -89.01 -70.76 0.63 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.211 -0.931 . . . . 0.0 110.615 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.4 p -158.24 113.5 2.65 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.449 -0.782 . . . . 0.0 110.339 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.36 24.38 36.89 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.442 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 89.1 m-85 -137.58 159.06 43.02 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.394 -1.062 . . . . 0.0 110.015 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -137.62 136.6 37.67 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.36 -0.837 . . . . 0.0 110.577 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 9.1 t -65.15 147.33 53.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.488 -0.758 . . . . 0.0 110.154 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 m -111.31 131.41 22.27 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.45 -0.781 . . . . 0.0 109.902 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.88 -26.36 11.25 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.887 1.467 . . . . 0.0 111.002 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.3 m -91.07 -25.87 19.43 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.453 -0.78 . . . . 0.0 110.925 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.659 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 72.6 m95 -102.65 -14.91 16.52 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.295 -0.878 . . . . 0.0 110.741 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.72 13.68 9.3 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.674 -0.641 . . . . 0.0 112.642 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.659 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -138.14 175.2 9.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.696 -1.252 . . . . 0.0 110.696 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.3 m -88.54 135.52 33.45 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.347 -0.845 . . . . 0.0 110.702 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.4 m -123.47 -175.59 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.9 -0.5 . . . . 0.0 109.708 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.91 149.16 48.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.354 -0.841 . . . . 0.0 110.4 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.0 113.56 10.17 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.534 -0.729 . . . . 0.0 110.115 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -66.4 -54.96 21.47 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.502 -0.749 . . . . 0.0 110.634 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 33' ' ' ARG . 45.2 Cg_endo . . . . . 0 N--CA 1.487 1.094 0 O-C-N 123.607 1.319 . . . . 0.0 110.733 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.0 t -114.22 76.95 1.02 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.503 -0.998 . . . . 0.0 110.185 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.96 132.71 11.03 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.56 139.36 6.47 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 58.1 89.12 0.05 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.85 -0.794 . . . . 0.0 111.193 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.3 mmt 55.62 42.14 29.82 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.438 0.637 . . . . 0.0 110.192 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.16 129.95 35.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.529 -0.732 . . . . 0.0 110.188 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.92 106.73 1.17 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 5.0 m -95.51 -50.0 5.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.502 -0.999 . . . . 0.0 110.206 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 t0 62.97 52.48 2.6 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.405 0.622 . . . . 0.0 109.993 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.6 125.23 0.91 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -17.44 62.29 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.448 -1.03 . . . . 0.0 110.817 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.36 25.18 11.75 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 110.607 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 m -80.24 132.59 35.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.279 -0.888 . . . . 0.0 109.758 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -81.72 139.24 35.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.462 -0.774 . . . . 0.0 110.212 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.435 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 29.2 m -109.26 -166.81 1.14 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.461 -0.774 . . . . 0.0 110.306 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -74.27 0.22 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.156 -0.965 . . . . 0.0 111.169 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.53 125.87 4.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.138 -0.976 . . . . 0.0 110.639 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.36 24.26 75.55 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.622 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 38.7 m-85 -129.49 137.81 51.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.42 -1.047 . . . . 0.0 109.999 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -125.56 130.64 52.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.465 -0.772 . . . . 0.0 110.331 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.435 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 76.9 m -68.24 149.76 49.1 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.578 -0.701 . . . . 0.0 110.314 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 55.7 m -107.77 137.38 19.73 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.447 -0.783 . . . . 0.0 110.055 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -75.26 -33.47 4.31 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.812 1.428 . . . . 0.0 111.065 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.1 m -88.78 -40.41 13.21 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.504 -0.747 . . . . 0.0 110.306 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.7 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 24.6 m0 -84.67 -23.31 29.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.563 -0.711 . . . . 0.0 110.407 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 5.5 tttt 70.6 10.19 7.06 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.854 -0.529 . . . . 0.0 112.368 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.7 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -127.45 167.29 16.45 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.62 -1.3 . . . . 0.0 110.937 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.6 t -92.97 143.57 26.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.445 -0.785 . . . . 0.0 110.694 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.494 HG12 ' CD1' ' A' ' 28' ' ' TRP . 26.3 m -139.58 163.91 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.528 -0.732 . . . . 0.0 109.818 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.14 137.5 58.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.423 -0.798 . . . . 0.0 110.412 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.97 147.18 35.03 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.666 -0.646 . . . . 0.0 110.596 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -132.68 66.17 76.01 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.55 -0.719 . . . . 0.0 110.576 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 C--N 1.314 -1.269 0 O-C-N 123.634 1.334 . . . . 0.0 110.785 179.813 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 1.2 m -103.87 103.29 13.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.422 -1.046 . . . . 0.0 110.229 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.32 147.3 20.69 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 29' ' ' CYS . . . 167.22 -175.62 42.31 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.443 HD22 ' CE1' ' A' ' 20' ' ' TYR . 1.7 mm? 52.51 72.55 0.4 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.737 -0.861 . . . . 0.0 110.647 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.442 ' HA ' ' CD1' ' A' ' 28' ' ' TRP . 6.2 ttm 60.87 42.0 13.71 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.609 -0.682 . . . . 0.0 110.533 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.85 100.51 10.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.446 -0.784 . . . . 0.0 109.793 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.73 109.05 1.6 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.9 p -114.71 -36.69 4.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.549 -0.971 . . . . 0.0 110.54 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.12 72.06 0.51 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.637 -0.664 . . . . 0.0 110.4 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.57 121.78 1.04 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -13.06 59.76 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.523 -0.986 . . . . 0.0 110.772 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.2 p -102.2 23.68 11.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 110.799 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.408 HG22 ' SG ' ' A' ' 22' ' ' CYS . 15.4 t -72.58 -169.79 0.59 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.144 -0.973 . . . . 0.0 109.991 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -133.64 107.41 7.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.166 -0.959 . . . . 0.0 110.53 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -98.62 -160.52 0.81 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.637 -0.664 . . . . 0.0 109.991 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 47.6 t -69.23 -77.12 0.08 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.078 -1.014 . . . . 0.0 110.569 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 p -164.7 -46.67 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.487 -0.758 . . . . 0.0 109.987 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.34 29.91 11.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 84.0 m-85 -129.2 125.94 38.09 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.912 . . . . 0.0 109.643 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -116.51 139.03 50.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -0.787 . . . . 0.0 110.319 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.2 m -75.6 128.57 35.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.461 -0.774 . . . . 0.0 110.426 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.78 136.66 36.48 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.739 -0.601 . . . . 0.0 110.315 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.1 -27.74 11.55 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.923 1.486 . . . . 0.0 110.75 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.8 m -84.47 -29.56 25.95 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.433 -0.792 . . . . 0.0 110.627 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.651 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 78.3 m95 -100.53 -16.71 17.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.417 -0.802 . . . . 0.0 110.927 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.9 tptt 69.06 9.76 7.56 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.651 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -132.57 169.79 16.11 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.598 -1.314 . . . . 0.0 110.957 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.7 OUTLIER -89.32 140.62 29.31 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.632 0.729 . . . . 0.0 111.531 -178.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 28' ' ' TRP . 3.1 m -140.31 178.24 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.92 149.74 11.15 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.256 -0.903 . . . . 0.0 110.518 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.21 166.89 21.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.527 -0.733 . . . . 0.0 110.667 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -108.36 144.05 28.69 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.755 . . . . 0.0 110.41 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 C--N 1.314 -1.242 0 O-C-N 123.859 1.452 . . . . 0.0 110.803 179.919 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.9 p -127.02 177.97 6.29 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.66 -0.906 . . . . 0.0 110.309 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.402 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . -141.63 138.92 9.01 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.51 121.62 1.42 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 tp 66.88 101.08 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.858 -0.789 . . . . 0.0 111.055 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.65 26.09 15.83 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.871 -0.518 . . . . 0.0 111.022 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 28' ' ' TRP . . . -91.07 135.98 33.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.99 127.46 44.88 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 1.4 t -120.58 -71.16 0.75 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.719 -0.871 . . . . 0.0 109.635 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 55.44 77.63 0.22 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.716 -0.615 . . . . 0.0 110.813 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.53 121.01 0.56 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -19.15 64.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.605 -0.938 . . . . 0.0 110.444 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -110.79 21.31 16.65 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.383 -0.823 . . . . 0.0 110.515 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.513 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 8.9 m -83.52 135.18 34.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.319 -0.863 . . . . 0.0 110.068 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.55 141.07 37.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.657 -0.652 . . . . 0.0 110.098 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 20' ' ' TYR . 72.8 m -81.34 -165.12 0.87 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.459 -0.776 . . . . 0.0 110.081 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -74.97 0.32 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.212 -0.93 . . . . 0.0 110.89 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.6 m -152.28 116.95 5.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.292 -0.88 . . . . 0.0 110.356 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.47 31.43 45.89 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.448 ' HB2' ' HB3' ' A' ' 16' ' ' CYS . 58.8 m-85 -138.08 158.15 44.9 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.469 -1.018 . . . . 0.0 110.103 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -139.52 138.25 36.16 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.0 110.274 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 41.3 t -69.74 126.95 31.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.353 -0.842 . . . . 0.0 110.775 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.72 131.73 42.61 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.633 -0.667 . . . . 0.0 109.821 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.84 -26.29 13.54 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.836 1.44 . . . . 0.0 111.304 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.9 m -83.07 -38.11 22.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.329 -0.857 . . . . 0.0 110.771 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.63 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 80.8 m95 -98.14 -9.54 25.62 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.384 -0.823 . . . . 0.0 111.012 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 3.1 mmmm 59.31 34.2 22.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.557 -0.714 . . . . 0.0 111.752 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.63 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -143.43 174.5 10.7 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.955 -1.091 . . . . 0.0 110.685 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.3 m -89.57 133.84 34.41 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.98 -1.075 . . . . 0.0 109.854 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 28' ' ' TRP . 17.5 m -132.14 173.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.465 -0.772 . . . . 0.0 110.505 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -62.02 127.28 30.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.445 -0.785 . . . . 0.0 110.227 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 143.69 54.29 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.536 -0.727 . . . . 0.0 110.461 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -65.06 153.22 89.54 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.48 -0.762 . . . . 0.0 110.419 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.312 -1.386 0 O-C-N 124.037 1.546 . . . . 0.0 110.694 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.433 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -97.62 106.89 19.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.491 -1.005 . . . . 0.0 110.193 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.02 112.74 4.52 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.72 143.94 11.82 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.21 93.07 0.05 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.917 -0.755 . . . . 0.0 111.02 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.9 mtt 58.46 32.58 22.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.706 -0.621 . . . . 0.0 110.99 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.95 131.53 35.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.38 -0.825 . . . . 0.0 109.553 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -50.74 116.45 4.32 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -100.43 -60.1 1.59 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.621 -0.929 . . . . 0.0 109.494 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.475 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 2.3 m-20 46.58 77.74 0.08 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.191 0.519 . . . . 0.0 111.446 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.38 128.32 2.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -16.4 59.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.602 -0.94 . . . . 0.0 110.776 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 p -121.45 38.24 4.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.497 -0.752 . . . . 0.0 109.621 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -63.33 157.37 23.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.544 -0.722 . . . . 0.0 110.741 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.23 94.47 5.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.419 -0.801 . . . . 0.0 110.05 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.5 m -78.51 -162.45 0.36 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.611 -0.68 . . . . 0.0 110.375 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -90.65 -84.64 0.24 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.216 -0.927 . . . . 0.0 110.25 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.5 p -155.93 111.5 3.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.46 40.88 6.69 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.464 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 58.9 m-85 -132.92 156.86 46.48 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.32 -1.106 . . . . 0.0 110.038 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.14 132.96 34.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 110.543 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.6 126.67 29.09 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.503 -0.748 . . . . 0.0 110.05 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.5 m -77.0 137.92 65.51 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.499 -0.751 . . . . 0.0 110.424 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.33 -23.72 17.37 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.933 1.491 . . . . 0.0 111.198 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.2 m -101.12 -39.67 7.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.293 -0.879 . . . . 0.0 110.694 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.669 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 81.8 m95 -87.98 -19.57 27.05 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.337 -0.852 . . . . 0.0 111.207 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 67.86 14.71 9.48 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.597 -0.689 . . . . 0.0 112.302 179.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.669 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -121.39 166.35 14.21 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.747 -1.22 . . . . 0.0 110.323 178.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -89.39 124.13 34.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.116 -0.99 . . . . 0.0 110.78 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.4 m -119.74 170.86 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.796 -0.565 . . . . 0.0 109.681 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -54.4 125.7 20.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.291 -0.88 . . . . 0.0 110.342 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.79 123.84 28.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.587 -0.696 . . . . 0.0 109.98 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.37 132.29 89.75 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.501 -0.749 . . . . 0.0 110.2 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 C--N 1.314 -1.276 0 O-C-N 123.875 1.46 . . . . 0.0 110.653 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.425 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p -119.05 179.06 4.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.984 . . . . 0.0 110.261 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -134.98 151.46 20.45 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.48 148.74 20.0 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.91 93.29 0.05 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.716 -0.873 . . . . 0.0 110.633 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 56.67 41.52 28.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.62 -0.675 . . . . 0.0 110.137 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.47 113.79 23.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.559 -0.713 . . . . 0.0 110.058 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.23 110.99 1.33 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.5 m -95.55 -52.82 3.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.567 -0.96 . . . . 0.0 109.691 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.73 54.43 4.42 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.374 0.606 . . . . 0.0 110.483 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.34 127.21 0.87 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -15.75 62.07 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.644 -0.915 . . . . 0.0 110.898 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.55 30.34 6.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.237 -0.915 . . . . 0.0 110.254 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -90.67 143.11 27.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.75 173.96 6.08 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.43 -0.794 . . . . 0.0 110.131 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.3 m -133.52 -164.67 1.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.387 -0.821 . . . . 0.0 110.592 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.4 m -75.26 -87.49 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.274 -0.891 . . . . 0.0 110.47 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -149.3 118.66 6.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.351 -0.843 . . . . 0.0 110.269 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.12 26.25 45.22 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.561 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 57.3 m-85 -133.29 150.12 51.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.383 -1.069 . . . . 0.0 109.911 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.15 140.37 37.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.452 -0.78 . . . . 0.0 110.541 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 76.6 m -73.48 142.75 46.8 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.441 -0.787 . . . . 0.0 109.97 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m -103.62 143.37 26.51 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.588 -0.695 . . . . 0.0 110.369 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.42 -33.04 4.47 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.012 1.533 . . . . 0.0 111.172 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.0 m -84.46 -39.69 18.62 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.45 -0.781 . . . . 0.0 110.79 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.677 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 17.9 m0 -88.61 -22.54 23.43 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.526 -0.734 . . . . 0.0 110.877 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 71.63 2.0 4.1 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.71 -0.619 . . . . 0.0 111.925 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.677 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -120.57 170.38 9.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.747 -1.221 . . . . 0.0 110.509 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 6.3 t -89.08 143.12 27.07 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.533 -0.729 . . . . 0.0 111.102 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.1 m -137.08 178.3 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.861 -0.524 . . . . 0.0 109.591 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -61.5 119.03 7.8 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 109.863 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.19 145.87 49.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.571 -0.705 . . . . 0.0 110.702 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.2 65.92 65.32 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.674 -0.641 . . . . 0.0 110.108 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.314 -1.265 0 O-C-N 123.696 1.366 . . . . 0.0 110.663 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.8 p -141.18 176.73 8.6 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.544 -0.974 . . . . 0.0 110.377 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -128.86 139.44 10.98 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.61 152.1 24.11 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.87 93.29 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.664 -0.904 . . . . 0.0 110.623 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 mtp 57.09 41.34 27.51 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.66 -0.65 . . . . 0.0 109.775 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.04 122.99 32.28 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.579 -0.701 . . . . 0.0 110.376 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.29 108.81 1.95 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 p -114.73 -40.48 3.55 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.567 -0.961 . . . . 0.0 110.866 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t70 56.92 69.28 0.76 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.647 -0.658 . . . . 0.0 110.447 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.45 115.7 1.3 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.22 -20.18 39.64 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.371 -1.076 . . . . 0.0 110.56 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.8 t -78.43 -19.98 52.04 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.485 -0.76 . . . . 0.0 110.537 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.2 m -56.7 133.12 53.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.469 -0.769 . . . . 0.0 110.089 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -85.31 152.9 22.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 110.505 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -118.82 -161.11 0.83 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.58 -0.7 . . . . 0.0 110.334 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.0 m -71.94 -82.28 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.264 -0.897 . . . . 0.0 110.46 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.7 p -159.03 115.96 2.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.548 -0.72 . . . . 0.0 109.702 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.0 -4.54 78.25 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.88 143.45 38.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.199 -1.177 . . . . 0.0 110.062 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -132.31 135.4 46.18 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.348 -0.845 . . . . 0.0 110.2 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 45.3 t -59.51 140.07 56.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.629 -0.669 . . . . 0.0 110.829 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.12 128.22 27.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.634 -0.666 . . . . 0.0 110.017 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.79 -20.83 19.5 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.908 1.478 . . . . 0.0 111.166 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.2 m -89.08 -34.83 16.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.234 -0.916 . . . . 0.0 110.751 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.674 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 86.3 m95 -102.04 -10.14 19.98 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.338 -0.851 . . . . 0.0 111.202 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 tptm 69.29 8.01 6.55 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.622 -0.674 . . . . 0.0 112.708 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.674 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -131.39 167.89 18.52 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.585 -1.322 . . . . 0.0 110.698 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 5.8 t -89.02 139.71 30.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.492 -0.755 . . . . 0.0 110.639 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.424 HG12 ' CD1' ' A' ' 28' ' ' TRP . 12.2 m -134.03 175.83 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.718 -0.614 . . . . 0.0 110.029 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.82 125.58 25.8 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.387 -0.82 . . . . 0.0 110.36 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.05 69.15 1.29 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.646 -0.659 . . . . 0.0 110.017 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.32 146.23 77.51 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.388 -0.82 . . . . 0.0 110.386 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 C--N 1.312 -1.36 0 O-C-N 123.974 1.513 . . . . 0.0 110.625 -179.916 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.548 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 17' ' ' CYS . 15.3 p -124.06 -176.0 3.38 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.515 -0.991 . . . . 0.0 110.542 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 16' ' ' CYS . . . -156.03 155.07 26.02 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.39 133.14 4.33 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.46 97.05 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.76 -0.847 . . . . 0.0 111.222 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 mpp? 54.02 34.71 20.37 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.656 -0.653 . . . . 0.0 110.291 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.22 127.51 36.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.525 -0.734 . . . . 0.0 110.5 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.11 112.18 3.98 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.5 p -115.38 -45.34 2.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.519 -0.989 . . . . 0.0 110.328 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.41 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER 54.87 87.06 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.291 0.567 . . . . 0.0 110.427 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.15 115.34 0.77 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HG2' ' HB3' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -62.37 -18.67 62.11 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.577 -0.955 . . . . 0.0 110.36 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.22 -17.87 26.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.365 -0.834 . . . . 0.0 110.537 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.7 m -58.76 120.93 9.87 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.263 -0.898 . . . . 0.0 109.978 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.413 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 39.8 t80 -94.61 20.58 8.34 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.527 -0.733 . . . . 0.0 110.852 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 20' ' ' TYR . 6.2 m 56.37 -149.51 0.46 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.027 -1.046 . . . . 0.0 110.045 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -93.04 -65.75 0.97 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.164 -0.96 . . . . 0.0 110.085 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 t -162.24 117.88 1.94 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.507 -0.746 . . . . 0.0 110.397 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.41 30.46 33.49 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 16' ' ' CYS . 64.9 m-85 -136.92 168.27 19.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.419 -1.048 . . . . 0.0 110.137 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.88 124.05 16.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -0.78 . . . . 0.0 110.21 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.18 117.26 12.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.572 -0.705 . . . . 0.0 110.092 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 19.9 m -74.23 131.22 81.08 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.552 -0.718 . . . . 0.0 110.188 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HB3' ' HG2' ' A' ' 12' ' ' LYS . 46.5 Cg_endo -73.28 -23.07 18.18 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.988 1.52 . . . . 0.0 111.093 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.3 m -96.24 -35.56 11.22 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.24 -0.913 . . . . 0.0 110.69 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.568 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 26.1 m0 -92.27 -19.08 22.55 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.348 -0.845 . . . . 0.0 110.876 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 70.76 7.21 6.14 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.568 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -118.68 163.44 16.83 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.755 -1.215 . . . . 0.0 110.665 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.3 m -96.42 124.0 40.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.599 -0.688 . . . . 0.0 110.895 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.489 HG12 ' CD1' ' A' ' 28' ' ' TRP . 2.1 m -121.29 170.39 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.588 -0.695 . . . . 0.0 110.14 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -52.67 146.41 10.29 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.432 -0.793 . . . . 0.0 110.627 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.23 98.49 8.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.359 -0.838 . . . . 0.0 110.233 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -150.28 90.37 4.37 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.444 -0.785 . . . . 0.0 110.225 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.313 -1.329 0 O-C-N 123.861 1.453 . . . . 0.0 110.734 179.853 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 9.0 t -119.48 103.62 9.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.611 -0.934 . . . . 0.0 110.12 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.59 123.11 4.4 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 29' ' ' CYS . . . -160.66 175.92 37.33 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 58.28 87.2 0.07 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.719 -0.871 . . . . 0.0 110.873 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 46.5 mmm 54.91 37.08 28.12 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.643 -0.661 . . . . 0.0 110.233 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.31 97.01 10.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.5 -0.75 . . . . 0.0 110.114 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.12 104.64 0.55 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.558 ' HB2' HG22 ' A' ' 14' ' ' THR . 21.8 p -110.23 -32.57 6.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.604 -0.939 . . . . 0.0 110.805 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 t70 65.0 99.03 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.696 -0.628 . . . . 0.0 110.603 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.36 117.53 1.54 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -66.07 -14.04 61.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.597 -0.943 . . . . 0.0 110.581 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.3 p -107.12 11.35 29.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.833 . . . . 0.0 110.792 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.558 HG22 ' HB2' ' A' ' 9' ' ' CYS . 19.9 m -74.03 141.42 45.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.139 -0.975 . . . . 0.0 110.012 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.84 163.34 15.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.455 -0.778 . . . . 0.0 110.351 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.0 m -129.89 -160.51 1.04 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.539 -0.726 . . . . 0.0 109.863 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 3.7 t -66.03 -66.36 0.56 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 t -171.4 -46.61 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.45 -0.781 . . . . 0.0 110.43 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.13 29.66 11.27 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.473 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 66.9 m-85 -130.94 158.9 39.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.468 -1.019 . . . . 0.0 110.155 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.47 129.35 18.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.369 -0.832 . . . . 0.0 110.398 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 2.3 m -67.1 127.23 31.81 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.507 -0.745 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.587 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 7.9 t -83.87 141.54 41.13 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.473 -0.767 . . . . 0.0 110.193 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.78 -24.96 15.04 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.891 1.469 . . . . 0.0 111.299 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.3 m -99.36 -31.68 11.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.161 -0.962 . . . . 0.0 110.962 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.688 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 36.6 m0 -87.97 -21.72 24.71 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.33 -0.856 . . . . 0.0 110.982 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 73.26 -2.08 2.85 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.707 -0.621 . . . . 0.0 112.042 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.688 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.9 p90 -122.46 165.56 16.16 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.609 -1.307 . . . . 0.0 110.67 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 5.0 t -89.32 133.92 34.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.517 -0.739 . . . . 0.0 111.106 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 33.1 m -126.27 -170.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.38 134.17 56.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.208 -0.932 . . . . 0.0 110.073 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.87 129.65 42.88 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.508 -0.745 . . . . 0.0 110.497 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -126.36 113.07 23.42 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.569 -0.707 . . . . 0.0 110.195 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 C--N 1.314 -1.27 0 O-C-N 123.775 1.408 . . . . 0.0 110.67 179.855 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.2 p -126.18 177.05 6.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.49 -1.006 . . . . 0.0 110.549 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.94 138.87 10.25 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -145.61 150.52 22.74 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.34 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.697 -0.884 . . . . 0.0 110.789 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.2 mtm 59.42 37.8 23.02 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.658 -0.651 . . . . 0.0 110.405 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.19 112.34 23.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.452 -0.78 . . . . 0.0 110.01 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -50.62 107.71 0.41 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.547 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 5.4 p -109.76 -42.17 4.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.691 -0.888 . . . . 0.0 110.334 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 55.0 72.42 0.47 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.78 -0.575 . . . . 0.0 111.032 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.32 126.6 2.7 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -11.38 57.11 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.587 -0.949 . . . . 0.0 110.435 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t -94.14 13.87 21.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.364 -0.835 . . . . 0.0 110.547 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.547 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 14.7 t -73.34 -173.75 1.45 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.184 -0.948 . . . . 0.0 110.166 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 96.78 4.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.018 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.2 m -77.64 -169.64 1.55 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.414 -0.804 . . . . 0.0 110.188 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -79.32 -94.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.248 -0.907 . . . . 0.0 110.255 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 p -144.3 113.13 6.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.062 -1.024 . . . . 0.0 110.574 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.38 37.5 9.7 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -132.18 148.32 52.46 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.361 -1.082 . . . . 0.0 110.055 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -124.1 128.11 48.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.498 -0.751 . . . . 0.0 110.485 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 42.3 t -69.39 121.1 16.27 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.608 -0.682 . . . . 0.0 109.971 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.557 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 58.4 m -76.23 129.64 79.79 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.521 -0.737 . . . . 0.0 110.199 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.45 -24.27 19.38 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.875 1.461 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -98.8 -36.2 9.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.302 -0.874 . . . . 0.0 110.492 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.703 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 50.6 m0 -85.18 -19.05 32.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.455 -0.778 . . . . 0.0 110.955 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 70.81 9.01 6.74 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.672 -0.643 . . . . 0.0 112.273 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.703 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -130.5 161.05 32.32 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.798 -1.188 . . . . 0.0 110.506 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.9 t -89.46 133.6 34.48 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.497 -0.752 . . . . 0.0 111.08 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.2 m -126.03 -177.55 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.74 -0.6 . . . . 0.0 109.518 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.45 135.75 57.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.212 -0.93 . . . . 0.0 110.209 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.04 -179.05 3.51 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.489 -0.757 . . . . 0.0 110.632 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 58.47 86.51 0.16 Allowed Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.718 -0.614 . . . . 0.0 110.641 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--N 1.312 -1.379 0 O-C-N 123.909 1.479 . . . . 0.0 110.678 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.479 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.9 t -110.88 90.02 3.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.501 -1.0 . . . . 0.0 110.301 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.15 121.96 5.47 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.89 159.9 28.2 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 55.36 85.67 0.06 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.749 -0.854 . . . . 0.0 111.104 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.3 mtp 58.55 37.37 25.47 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.682 -0.636 . . . . 0.0 110.661 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.99 125.72 33.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.43 108.05 0.81 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.542 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 25.9 p -109.41 -41.35 4.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.551 -0.97 . . . . 0.0 110.583 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.1 t70 46.65 76.64 0.1 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.751 -0.593 . . . . 0.0 111.339 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.65 125.28 2.22 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -12.88 52.7 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.606 -0.938 . . . . 0.0 110.722 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.5 t -113.13 32.01 6.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.917 . . . . 0.0 110.244 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.542 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 15.0 t -72.58 -168.97 0.49 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.432 -0.793 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -127.04 92.38 3.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.489 -0.757 . . . . 0.0 110.429 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -82.17 -172.9 4.22 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.481 -0.762 . . . . 0.0 109.829 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 t -80.76 -75.49 0.27 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.07 -1.019 . . . . 0.0 110.751 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.0 p -162.78 125.23 2.71 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.281 -0.887 . . . . 0.0 110.141 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.28 28.34 64.19 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.475 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.3 m-85 -126.49 126.04 43.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.268 -1.136 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -105.47 132.3 51.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 110.187 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 4.8 t -85.24 130.12 34.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.567 -0.708 . . . . 0.0 110.162 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -92.39 136.58 25.35 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.525 -0.734 . . . . 0.0 109.968 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.32 -28.3 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.808 1.425 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 m -86.72 -34.68 19.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.383 -0.823 . . . . 0.0 110.213 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.647 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 46.9 m0 -88.22 -22.24 24.09 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.548 -0.72 . . . . 0.0 110.664 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 21.1 mmmt 66.96 15.36 10.13 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.85 -0.531 . . . . 0.0 112.032 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.647 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -131.66 166.97 20.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.804 -1.185 . . . . 0.0 110.803 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 3.8 t -104.9 133.08 50.31 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.431 -0.793 . . . . 0.0 110.639 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG13 ' CD1' ' A' ' 28' ' ' TRP . 4.3 m -136.02 171.96 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.627 -0.671 . . . . 0.0 109.967 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -49.86 142.62 8.67 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.36 -0.838 . . . . 0.0 110.728 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.05 177.84 4.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -129.09 68.87 80.54 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.474 -0.766 . . . . 0.0 110.19 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.315 -1.228 0 O-C-N 123.659 1.347 . . . . 0.0 110.534 -179.918 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.92 100.47 9.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.616 -0.932 . . . . 0.0 109.801 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.86 108.01 3.48 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.2 140.57 10.73 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.427 HD22 ' HE1' ' A' ' 20' ' ' TYR . 0.9 OUTLIER 61.35 93.22 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.91 -0.759 . . . . 0.0 110.959 179.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.61 40.78 23.19 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.708 -0.62 . . . . 0.0 110.475 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.1 130.6 34.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.425 -0.797 . . . . 0.0 109.916 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.3 110.84 1.72 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' A' ' 14' ' ' THR . 2.0 t -105.3 -72.3 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.655 -0.909 . . . . 0.0 109.553 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.0 t70 53.48 63.57 2.16 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.381 0.61 . . . . 0.0 110.822 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.48 126.2 0.93 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.56 -14.33 60.87 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.476 -1.014 . . . . 0.0 110.889 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.6 p -93.96 11.69 28.72 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.246 -0.909 . . . . 0.0 111.149 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.55 HG23 ' HB2' ' A' ' 22' ' ' CYS . 6.1 t -64.96 155.96 32.76 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.109 -0.994 . . . . 0.0 109.813 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -111.35 -18.92 12.79 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.311 -0.868 . . . . 0.0 111.257 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.6 m 55.62 -155.81 0.27 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.43 -0.794 . . . . 0.0 110.055 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.9 t -99.54 -104.47 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.131 -0.981 . . . . 0.0 109.412 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 t -131.7 106.0 7.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.989 -1.069 . . . . 0.0 109.753 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.37 53.53 2.61 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.454 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 75.0 m-85 -138.5 147.56 43.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.443 -1.033 . . . . 0.0 110.303 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -119.88 130.37 54.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.589 -0.694 . . . . 0.0 110.155 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.55 ' HB2' HG23 ' A' ' 14' ' ' THR . 37.9 t -74.94 138.29 42.23 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.544 -0.723 . . . . 0.0 110.158 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -100.9 133.33 21.14 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.729 . . . . 0.0 110.24 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.29 -42.14 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 124.007 1.53 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.7 m -80.89 -24.68 38.12 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.55 -0.719 . . . . 0.0 110.865 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.594 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 45.3 m95 -98.96 -19.33 17.36 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.338 -0.851 . . . . 0.0 110.881 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.22 8.46 6.82 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.594 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -131.45 163.37 28.09 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.627 -1.296 . . . . 0.0 111.099 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.7 t -91.41 138.01 31.91 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.49 -0.757 . . . . 0.0 110.575 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.53 173.84 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.515 -0.74 . . . . 0.0 109.698 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -58.04 133.01 55.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.326 -0.859 . . . . 0.0 110.169 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.47 131.41 48.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.574 -0.703 . . . . 0.0 110.501 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -120.77 118.8 30.43 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.527 -0.733 . . . . 0.0 110.304 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 C--N 1.315 -1.224 0 O-C-N 123.797 1.419 . . . . 0.0 111.307 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 28.2 p -127.06 177.84 6.38 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.569 -0.959 . . . . 0.0 110.679 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.29 147.09 16.43 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.44 159.35 30.06 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.84 90.55 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.696 -0.885 . . . . 0.0 110.622 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.13 34.31 23.24 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.657 -0.652 . . . . 0.0 110.405 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.5 133.93 34.87 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.466 -0.771 . . . . 0.0 109.795 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.31 114.45 5.86 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.01 -61.48 1.4 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.842 . . . . 0.0 109.677 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.443 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 1.1 t70 54.11 56.23 7.28 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.766 -0.584 . . . . 0.0 111.164 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.11 127.22 1.01 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -16.08 56.19 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.491 -1.005 . . . . 0.0 111.247 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.74 35.49 4.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.244 -0.91 . . . . 0.0 110.209 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 t -71.66 178.28 3.66 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.482 -0.761 . . . . 0.0 110.533 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -117.34 120.27 37.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.458 -0.776 . . . . 0.0 110.461 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m -115.16 -171.12 1.89 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.535 -0.728 . . . . 0.0 110.038 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.8 m -81.37 -102.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.264 -0.897 . . . . 0.0 109.94 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.75 121.18 10.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.168 -0.958 . . . . 0.0 109.776 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 24.63 32.78 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -128.51 126.38 40.31 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.356 -1.085 . . . . 0.0 109.539 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.41 143.24 43.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.4 -0.812 . . . . 0.0 110.713 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 19.4 t -78.77 126.4 30.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.687 -0.633 . . . . 0.0 110.155 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.13 137.33 42.98 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.469 -0.769 . . . . 0.0 110.147 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.57 -32.06 5.05 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.898 1.473 . . . . 0.0 110.964 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.6 m -86.44 -28.89 23.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.506 -0.746 . . . . 0.0 110.979 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.63 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 52.2 m95 -101.53 -22.89 14.4 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.388 -0.82 . . . . 0.0 111.061 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.443 ' HG3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 67.94 28.24 6.95 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.647 -0.658 . . . . 0.0 112.374 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.63 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -135.77 171.27 14.71 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.772 -1.205 . . . . 0.0 110.412 178.055 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -97.53 125.11 42.05 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.088 -1.008 . . . . 0.0 110.145 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.449 HG12 ' CD1' ' A' ' 28' ' ' TRP . 15.6 m -124.72 163.44 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.543 -0.723 . . . . 0.0 110.241 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.83 131.1 49.85 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.537 -0.727 . . . . 0.0 110.399 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.99 154.49 20.53 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.653 -0.654 . . . . 0.0 110.362 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -124.72 123.96 25.62 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.38 -0.825 . . . . 0.0 110.352 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--N 1.313 -1.3 0 O-C-N 123.923 1.486 . . . . 0.0 110.809 179.871 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.528 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -108.07 97.48 7.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.602 -0.94 . . . . 0.0 109.92 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.05 111.97 4.19 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.92 149.85 21.82 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 57.54 84.83 0.09 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.737 -0.861 . . . . 0.0 111.574 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 ttt 56.87 37.1 28.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.701 -0.624 . . . . 0.0 110.98 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.15 101.71 14.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.492 -0.755 . . . . 0.0 110.09 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 28' ' ' TRP . . . -54.63 110.3 1.58 Allowed Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.4 ' SG ' HG22 ' A' ' 14' ' ' THR . 23.4 p -105.89 -40.53 5.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.476 -1.014 . . . . 0.0 110.285 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.9 t70 54.64 95.54 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.326 0.584 . . . . 0.0 111.311 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.2 120.07 1.04 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -17.42 62.43 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.642 -0.917 . . . . 0.0 110.228 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 t -117.4 31.15 6.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.449 -0.782 . . . . 0.0 110.022 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.4 HG22 ' SG ' ' A' ' 9' ' ' CYS . 11.1 t -78.97 158.75 27.91 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.251 -0.906 . . . . 0.0 109.997 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.62 112.88 23.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.8 m -81.01 -165.78 0.99 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.442 -0.787 . . . . 0.0 110.109 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -79.58 -77.61 0.18 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.084 -1.01 . . . . 0.0 110.266 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.87 123.14 1.18 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.387 -0.82 . . . . 0.0 109.694 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.49 29.91 54.67 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.473 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.6 m-85 -126.77 150.59 49.03 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.366 -1.079 . . . . 0.0 110.212 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -126.05 130.51 51.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 110.315 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 1.3 m -86.97 129.55 34.83 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.386 -0.821 . . . . 0.0 110.119 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.96 144.58 30.29 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.515 -0.741 . . . . 0.0 110.239 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.62 -41.51 1.11 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.83 1.437 . . . . 0.0 111.121 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.4 m -76.94 -34.35 57.64 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.521 -0.737 . . . . 0.0 110.729 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.644 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 42.0 m0 -89.51 -28.58 19.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.405 -0.809 . . . . 0.0 110.683 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 1.3 tppt? 70.33 10.29 7.21 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.914 -0.491 . . . . 0.0 112.185 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.644 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -120.79 166.51 13.65 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.767 -1.208 . . . . 0.0 110.827 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 1.7 t -101.83 129.24 48.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.637 -0.664 . . . . 0.0 110.385 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 28' ' ' TRP . 4.4 m -124.18 175.36 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.56 -0.713 . . . . 0.0 109.961 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.4 ' HA ' ' HD1' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -62.68 138.21 58.45 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.389 -0.819 . . . . 0.0 110.498 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.63 -168.01 0.78 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.548 -0.72 . . . . 0.0 110.169 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -117.63 67.87 5.67 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.459 -0.775 . . . . 0.0 110.474 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 N--CA 1.488 1.16 0 O-C-N 123.585 1.308 . . . . 0.0 110.841 179.799 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.4 p -106.68 176.28 5.22 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.559 -0.965 . . . . 0.0 110.33 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.39 137.09 9.19 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.64 150.34 22.13 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.5 87.76 0.09 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.722 -0.869 . . . . 0.0 110.906 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.8 mtt 56.77 37.22 28.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.752 -0.592 . . . . 0.0 110.479 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.37 114.69 23.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.443 -0.785 . . . . 0.0 109.698 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.63 98.21 0.06 OUTLIER Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.572 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 9.1 p -87.21 -38.42 16.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.573 -0.957 . . . . 0.0 110.097 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.476 ' HA ' ' HD2' ' A' ' 27' ' ' LYS . 22.5 m-20 51.12 82.78 0.06 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.267 0.556 . . . . 0.0 111.433 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 131.93 124.21 2.54 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -10.62 40.36 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.644 -0.915 . . . . 0.0 110.734 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 m -106.6 26.88 9.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.231 -0.918 . . . . 0.0 110.248 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.572 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 14.1 t -77.36 -179.7 5.89 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.291 -0.88 . . . . 0.0 110.716 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.24 105.52 7.71 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.514 -0.742 . . . . 0.0 110.009 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.9 m -82.47 -171.27 3.38 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 110.484 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.68 -76.06 0.32 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.217 -0.927 . . . . 0.0 110.683 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.3 p -163.8 131.97 3.62 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.345 -0.847 . . . . 0.0 110.237 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.32 24.23 77.17 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.547 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 30.0 m-85 -125.15 142.92 51.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.395 -1.062 . . . . 0.0 109.785 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.0 117.8 27.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.801 . . . . 0.0 110.316 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.528 ' SG ' HG23 ' A' ' 14' ' ' THR . 2.2 t -75.12 108.13 7.66 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.525 -0.735 . . . . 0.0 109.718 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -72.98 136.17 79.89 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 0.0 109.955 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.51 -28.79 14.16 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.95 1.5 . . . . 0.0 110.672 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -87.18 -35.08 18.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.39 -0.819 . . . . 0.0 110.255 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.649 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 47.3 m0 -87.38 -15.76 36.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.51 -0.744 . . . . 0.0 110.934 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 32.3 mmtm 61.68 15.84 7.26 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.723 -0.611 . . . . 0.0 112.344 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.649 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -132.55 167.29 20.27 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.838 -1.164 . . . . 0.0 110.6 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 3.6 t -107.86 127.94 54.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.632 -0.667 . . . . 0.0 110.218 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.404 HG11 ' CD1' ' A' ' 28' ' ' TRP . 3.6 m -131.89 165.48 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.537 -0.727 . . . . 0.0 110.584 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -45.79 142.29 2.58 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.654 -0.654 . . . . 0.0 110.883 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.02 144.02 50.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 0.0 110.579 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.93 131.19 27.12 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.555 -0.715 . . . . 0.0 110.056 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.314 -1.288 0 O-C-N 123.837 1.44 . . . . 0.0 110.645 -179.918 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.464 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.0 t -97.52 92.84 6.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.541 -0.976 . . . . 0.0 109.938 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -116.53 163.82 12.4 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.32 140.77 4.5 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 61.17 93.93 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.851 -0.793 . . . . 0.0 111.061 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.2 mtp 55.91 42.61 28.61 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.679 -0.638 . . . . 0.0 109.979 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.18 115.7 23.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.608 -0.683 . . . . 0.0 110.049 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.9 110.16 2.24 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.514 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 7.4 p -113.67 -36.17 4.97 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.677 -0.896 . . . . 0.0 110.599 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.32 59.32 4.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.666 -0.647 . . . . 0.0 110.976 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.76 117.56 0.43 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -21.54 52.78 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.494 -1.003 . . . . 0.0 110.899 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -99.2 -12.41 20.46 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.434 -0.791 . . . . 0.0 110.806 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.514 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 54.1 m -56.67 132.97 53.46 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.348 -0.845 . . . . 0.0 110.506 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -94.26 175.41 6.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.576 -0.703 . . . . 0.0 110.347 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.9 m -124.68 -148.11 0.39 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.509 -0.744 . . . . 0.0 110.128 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 t -88.7 -71.51 0.59 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.084 -1.01 . . . . 0.0 110.782 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.9 p -161.45 119.83 2.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.411 -0.805 . . . . 0.0 110.342 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.43 26.03 48.76 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.667 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 74.9 m-85 -139.4 152.14 46.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.474 -1.015 . . . . 0.0 109.547 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.4 130.26 26.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.324 -0.86 . . . . 0.0 110.645 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 16.9 t -68.63 149.38 49.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.521 -0.737 . . . . 0.0 110.304 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.67 140.63 30.84 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.507 -0.746 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.29 -41.08 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.713 1.375 . . . . 0.0 111.185 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.0 m -72.63 -31.91 65.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.398 -0.814 . . . . 0.0 110.839 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.605 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 54.1 m95 -96.76 -20.43 18.23 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.399 -0.813 . . . . 0.0 110.475 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 5.5 tptt 70.37 8.81 6.77 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.673 -0.642 . . . . 0.0 112.25 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.605 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.7 p90 -136.77 169.0 18.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.723 -1.236 . . . . 0.0 110.757 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.667 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 11.4 t -89.17 145.6 25.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.557 -0.714 . . . . 0.0 110.922 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 27.8 m -132.69 -179.21 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -66.41 131.25 45.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.239 -0.913 . . . . 0.0 110.367 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.35 149.71 49.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.586 -0.696 . . . . 0.0 110.645 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -140.25 159.61 63.11 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.52 -0.737 . . . . 0.0 110.654 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 C--N 1.313 -1.307 0 O-C-N 123.937 1.493 . . . . 0.0 110.654 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.56 137.52 51.46 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.537 -0.978 . . . . 0.0 110.257 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.59 125.27 1.89 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.31 161.68 30.99 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 55.4 84.28 0.08 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.74 -0.859 . . . . 0.0 111.109 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 56.25 40.48 29.94 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.62 -0.675 . . . . 0.0 110.46 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.49 107.4 19.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.511 -0.743 . . . . 0.0 110.455 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.45 108.79 1.97 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.557 ' SG ' HG23 ' A' ' 14' ' ' THR . 27.2 p -110.61 -32.3 6.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.583 -0.951 . . . . 0.0 110.92 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 t70 59.86 73.46 0.48 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.653 -0.654 . . . . 0.0 110.584 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 174.01 124.27 0.78 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -61.67 -19.01 61.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.727 -0.867 . . . . 0.0 111.007 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.439 ' N ' ' HG2' ' A' ' 12' ' ' LYS . 64.6 p -134.54 35.15 3.19 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.449 -0.782 . . . . 0.0 110.063 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.557 HG23 ' SG ' ' A' ' 9' ' ' CYS . 12.3 t -64.95 161.69 18.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.435 -0.791 . . . . 0.0 110.595 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -100.6 115.21 29.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.407 -0.808 . . . . 0.0 110.296 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.5 m -94.39 -163.99 1.12 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.627 -0.671 . . . . 0.0 109.911 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.74 -76.79 0.22 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.05 -1.031 . . . . 0.0 110.6 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 p -163.47 126.75 2.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.483 -0.76 . . . . 0.0 109.917 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.04 17.21 80.28 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.409 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 38.4 m-85 -124.67 126.82 46.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.183 -1.186 . . . . 0.0 109.977 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.73 135.84 53.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.665 -0.647 . . . . 0.0 109.787 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -85.1 138.36 32.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.587 -0.696 . . . . 0.0 110.332 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 9.3 t -98.47 140.19 21.66 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.643 -0.661 . . . . 0.0 110.436 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.24 -28.78 15.0 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.818 1.43 . . . . 0.0 110.9 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -86.28 -27.81 24.16 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.366 -0.834 . . . . 0.0 110.756 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.598 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 21.2 m0 -99.01 -27.54 13.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.279 -0.888 . . . . 0.0 110.701 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.8 OUTLIER 75.01 -3.9 2.5 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.598 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -109.15 170.0 8.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.73 -1.231 . . . . 0.0 110.678 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 5.5 t -105.7 129.97 53.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.717 . . . . 0.0 110.032 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.416 HG11 ' CD1' ' A' ' 28' ' ' TRP . 3.3 m -135.73 174.33 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.682 -0.636 . . . . 0.0 109.929 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -54.71 128.53 33.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.452 -0.78 . . . . 0.0 110.724 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.46 167.63 15.31 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.645 -0.659 . . . . 0.0 110.583 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -140.33 140.35 22.95 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.499 -0.75 . . . . 0.0 110.306 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 O-C-N 123.718 1.378 . . . . 0.0 110.811 -179.87 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 16' ' ' CYS . . . . . . . . 0 N--CA 1.493 2.492 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.1 158.74 27.78 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.8 83.82 0.1 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.78 -0.836 . . . . 0.0 111.094 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.1 mtp 56.29 34.89 24.88 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.663 -0.648 . . . . 0.0 110.68 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -83.02 145.17 29.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.433 -0.792 . . . . 0.0 109.905 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.3 121.0 24.11 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.648 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -110.61 -61.01 1.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.618 -0.931 . . . . 0.0 110.121 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 t70 59.41 77.85 0.29 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.406 0.622 . . . . 0.0 110.605 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.82 121.86 1.34 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -66.06 -13.45 60.02 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.491 -1.005 . . . . 0.0 110.925 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 p -110.84 2.94 18.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.29 -0.882 . . . . 0.0 111.13 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.648 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 1.9 m -66.83 138.2 57.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.116 -0.99 . . . . 0.0 110.172 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -100.09 138.86 36.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.51 -0.744 . . . . 0.0 110.269 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 3' ' ' GLY . 33.7 m -80.88 -157.23 0.15 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.684 -0.635 . . . . 0.0 109.833 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 t -78.93 -70.66 0.49 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.092 -1.005 . . . . 0.0 110.332 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.1 p -163.69 123.08 2.06 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.558 -0.714 . . . . 0.0 109.819 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.95 -3.97 86.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 49.0 m-85 -103.24 169.88 8.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -1.179 . . . . 0.0 110.115 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -148.23 129.68 14.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.959 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 14.6 t -73.03 132.67 43.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.49 -0.756 . . . . 0.0 110.614 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -95.67 128.8 36.52 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.573 -0.704 . . . . 0.0 109.461 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.27 -21.67 26.47 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.784 1.412 . . . . 0.0 111.003 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.6 m -87.7 -28.3 21.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.316 -0.865 . . . . 0.0 110.741 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.519 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 11.1 m0 -108.43 -12.74 14.98 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.437 -0.789 . . . . 0.0 111.243 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? 61.88 29.55 17.91 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.583 -0.698 . . . . 0.0 112.27 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.519 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -136.66 171.0 15.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.839 -1.163 . . . . 0.0 110.671 178.203 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -102.14 123.87 46.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.382 -0.824 . . . . 0.0 110.492 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.465 HG13 ' CD1' ' A' ' 28' ' ' TRP . 1.6 m -132.89 -179.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.547 -0.72 . . . . 0.0 109.85 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -55.17 143.53 27.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.356 -0.84 . . . . 0.0 110.334 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.38 -0.825 . . . . 0.0 110.419 -179.546 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.566 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.83 155.71 26.44 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 58.5 91.42 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.794 -0.827 . . . . 0.0 111.0 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.4 mtt 55.64 35.39 25.15 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.733 -0.605 . . . . 0.0 110.591 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -86.24 93.92 9.18 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.499 -0.751 . . . . 0.0 109.698 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.14 106.66 0.77 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.962 ' HB2' HG21 ' A' ' 14' ' ' THR . 30.7 p -114.21 -37.2 4.47 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.595 -0.944 . . . . 0.0 110.772 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 t70 63.11 96.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.421 0.629 . . . . 0.0 110.791 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.02 117.67 0.6 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -63.17 -17.5 62.45 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.622 -0.928 . . . . 0.0 110.759 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 t -119.93 27.96 8.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.368 -0.832 . . . . 0.0 110.372 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.962 HG21 ' HB2' ' A' ' 9' ' ' CYS . 17.0 m -83.31 132.53 35.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.298 -0.876 . . . . 0.0 109.875 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -86.26 160.47 19.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.478 -0.764 . . . . 0.0 110.442 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.1 m -124.84 -164.83 1.31 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.535 -0.728 . . . . 0.0 110.498 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.7 t -74.0 -86.99 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.306 -0.871 . . . . 0.0 110.698 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.5 m -151.05 122.39 7.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.141 -0.974 . . . . 0.0 109.988 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.77 24.78 66.34 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.625 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 42.1 m-85 -130.67 140.11 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.454 -1.027 . . . . 0.0 109.831 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.73 128.6 39.24 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.434 -0.791 . . . . 0.0 110.627 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.4 m -71.12 120.26 16.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.666 -0.646 . . . . 0.0 110.008 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 5.5 t -82.44 140.08 44.85 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.401 -0.812 . . . . 0.0 110.255 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.38 -29.21 11.47 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.962 1.506 . . . . 0.0 110.854 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.0 m -86.05 -32.51 21.38 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.741 . . . . 0.0 110.464 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.707 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 34.5 m0 -93.31 -23.96 18.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.405 -0.809 . . . . 0.0 110.703 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER 72.35 1.78 4.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.851 -0.531 . . . . 0.0 111.973 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.707 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -121.96 168.07 12.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.919 -1.113 . . . . 0.0 109.999 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.625 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 4.4 t -94.71 144.09 25.9 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.454 -0.779 . . . . 0.0 110.839 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.469 HG13 ' CD1' ' A' ' 28' ' ' TRP . 0.8 OUTLIER -148.96 167.46 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -49.56 134.37 19.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.453 -0.779 . . . . 0.0 110.337 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.864 0 O-C-N 121.353 -0.842 . . . . 0.0 110.599 -179.309 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.6 ' N ' ' HG ' ' A' ' 17' ' ' CYS . . . . . . . . 0 N--CA 1.494 2.533 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.89 149.38 21.39 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.55 95.63 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.917 -0.755 . . . . 0.0 110.635 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 15.1 mmt 58.04 38.28 26.65 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.729 -0.607 . . . . 0.0 110.471 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.84 140.74 29.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.609 -0.682 . . . . 0.0 109.871 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.4 116.28 8.88 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.442 ' SG ' HG21 ' A' ' 14' ' ' THR . 1.1 t -106.12 -70.42 0.79 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.691 -0.888 . . . . 0.0 109.316 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.464 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 7.2 t70 49.19 73.18 0.25 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.322 0.582 . . . . 0.0 110.729 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.63 120.85 1.87 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -62.51 -14.3 40.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.653 -0.91 . . . . 0.0 110.676 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.9 t -97.46 22.68 8.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.41 -0.806 . . . . 0.0 110.37 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.442 HG21 ' SG ' ' A' ' 9' ' ' CYS . 4.7 t -71.93 -179.05 2.56 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.225 -0.922 . . . . 0.0 110.244 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.76 94.95 3.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.308 -0.87 . . . . 0.0 110.326 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 20' ' ' TYR . 91.5 m -78.09 -179.49 6.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.403 -0.81 . . . . 0.0 109.929 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.6 ' HG ' ' N ' ' A' ' 3' ' ' GLY . 70.0 m -83.02 -100.36 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.115 -0.99 . . . . 0.0 110.508 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.09 117.56 11.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.063 -1.023 . . . . 0.0 110.083 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.44 32.7 12.95 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.486 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 63.3 m-85 -130.09 142.9 50.56 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.218 -1.166 . . . . 0.0 110.601 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -123.13 133.94 54.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.578 -0.701 . . . . 0.0 110.091 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 8.5 t -82.12 130.67 35.15 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.555 -0.715 . . . . 0.0 110.396 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.523 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -92.29 140.49 24.34 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.339 -0.85 . . . . 0.0 110.009 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.75 -31.02 8.88 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.862 1.454 . . . . 0.0 111.178 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 m -88.93 -38.21 14.68 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.353 -0.842 . . . . 0.0 110.613 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.7 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 36.2 m0 -82.66 -26.6 31.98 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.406 -0.809 . . . . 0.0 110.672 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' A' ' 10' ' ' ASP . 15.2 tptt 69.33 19.56 7.68 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.741 -0.599 . . . . 0.0 112.196 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.7 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.1 p90 -133.26 173.19 11.72 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.814 -1.179 . . . . 0.0 110.571 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.1 t -107.55 128.19 54.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.394 -0.816 . . . . 0.0 110.453 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.546 HG13 ' CD1' ' A' ' 28' ' ' TRP . 4.5 m -129.75 173.17 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.601 -0.687 . . . . 0.0 110.061 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -52.61 127.49 23.08 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.351 -0.843 . . . . 0.0 110.643 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.825 0 O-C-N 121.582 -0.699 . . . . 0.0 110.253 179.877 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.552 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.475 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -147.83 130.99 3.68 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.464 HD21 ' CE2' ' A' ' 31' ' ' TYR . 0.5 OUTLIER 59.55 95.34 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.86 -0.788 . . . . 0.0 111.205 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.9 mtt 57.67 43.82 21.64 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.484 0.659 . . . . 0.0 110.376 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.949 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -89.21 127.58 35.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.547 -0.721 . . . . 0.0 109.876 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -49.95 118.09 5.41 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.618 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 3.0 t -105.82 -66.68 0.97 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.613 -0.933 . . . . 0.0 109.608 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 t0 53.25 66.52 1.21 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.831 -0.543 . . . . 0.0 111.092 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.15 127.48 0.89 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -14.35 62.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.572 -0.958 . . . . 0.0 110.886 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 t -117.3 22.18 12.64 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.296 -0.878 . . . . 0.0 110.374 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.618 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 4.8 m -86.59 132.15 33.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -104.54 154.34 20.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.55 -0.719 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.462 ' CB ' ' HB2' ' A' ' 20' ' ' TYR . 34.0 m -87.44 -154.75 0.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.492 -0.755 . . . . 0.0 109.983 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.2 t -89.01 -70.76 0.63 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.211 -0.931 . . . . 0.0 110.615 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.4 p -158.24 113.5 2.65 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.449 -0.782 . . . . 0.0 110.339 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.36 24.38 36.89 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 89.1 m-85 -137.58 159.06 43.02 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.394 -1.062 . . . . 0.0 110.015 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.418 ' O ' HG22 ' A' ' 30' ' ' VAL . 19.5 t-20 -137.62 136.6 37.67 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.36 -0.837 . . . . 0.0 110.577 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 9.1 t -65.15 147.33 53.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.488 -0.758 . . . . 0.0 110.154 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.412 ' HB3' ' HD1' ' A' ' 26' ' ' TRP . 3.3 m -111.31 131.41 22.27 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.45 -0.781 . . . . 0.0 109.902 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.88 -26.36 11.25 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.887 1.467 . . . . 0.0 111.002 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.3 m -91.07 -25.87 19.43 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.453 -0.78 . . . . 0.0 110.925 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.684 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 72.6 m95 -102.65 -14.91 16.52 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.295 -0.878 . . . . 0.0 110.741 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.72 13.68 9.3 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.674 -0.641 . . . . 0.0 112.642 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.684 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -138.14 175.2 9.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.696 -1.252 . . . . 0.0 110.696 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.949 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -88.54 135.52 33.45 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.347 -0.845 . . . . 0.0 110.702 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 21' ' ' ASN . 35.4 m -123.47 -175.59 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.9 -0.5 . . . . 0.0 109.708 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CE2' HD21 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -69.91 149.16 48.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.354 -0.841 . . . . 0.0 110.4 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.534 -0.729 . . . . 0.0 110.115 179.832 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.586 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -156.56 139.36 6.47 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 5' ' ' LEU . 3.3 mm? 58.1 89.12 0.05 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.85 -0.794 . . . . 0.0 111.193 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.3 mmt 55.62 42.14 29.82 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.438 0.637 . . . . 0.0 110.192 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.586 ' HB2' ' N ' ' A' ' 4' ' ' GLY . . . -83.16 129.95 35.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.529 -0.732 . . . . 0.0 110.188 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.92 106.73 1.17 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 5.0 m -95.51 -50.0 5.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.502 -0.999 . . . . 0.0 110.206 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 t0 62.97 52.48 2.6 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.405 0.622 . . . . 0.0 109.993 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.6 125.23 0.91 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -17.44 62.29 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.448 -1.03 . . . . 0.0 110.817 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.36 25.18 11.75 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 110.607 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.409 HG21 ' HA ' ' A' ' 9' ' ' CYS . 3.3 m -80.24 132.59 35.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.279 -0.888 . . . . 0.0 109.758 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -81.72 139.24 35.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.462 -0.774 . . . . 0.0 110.212 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.435 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 29.2 m -109.26 -166.81 1.14 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.461 -0.774 . . . . 0.0 110.306 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -74.27 0.22 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.156 -0.965 . . . . 0.0 111.169 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.53 125.87 4.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.138 -0.976 . . . . 0.0 110.639 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.36 24.26 75.55 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.641 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 38.7 m-85 -129.49 137.81 51.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.42 -1.047 . . . . 0.0 109.999 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -125.56 130.64 52.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.465 -0.772 . . . . 0.0 110.331 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.435 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 76.9 m -68.24 149.76 49.1 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.578 -0.701 . . . . 0.0 110.314 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 55.7 m -107.77 137.38 19.73 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.447 -0.783 . . . . 0.0 110.055 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -75.26 -33.47 4.31 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.812 1.428 . . . . 0.0 111.065 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.1 m -88.78 -40.41 13.21 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.504 -0.747 . . . . 0.0 110.306 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.725 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 24.6 m0 -84.67 -23.31 29.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.563 -0.711 . . . . 0.0 110.407 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 5.5 tttt 70.6 10.19 7.06 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.854 -0.529 . . . . 0.0 112.368 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.725 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -127.45 167.29 16.45 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.62 -1.3 . . . . 0.0 110.937 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.6 t -92.97 143.57 26.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.445 -0.785 . . . . 0.0 110.694 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.53 HG13 ' CD1' ' A' ' 28' ' ' TRP . 26.3 m -139.58 163.91 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.528 -0.732 . . . . 0.0 109.818 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.14 137.5 58.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.423 -0.798 . . . . 0.0 110.412 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.89 0 O-C-N 121.666 -0.646 . . . . 0.0 110.596 -179.725 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.511 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 29' ' ' CYS . . . 167.22 -175.62 42.31 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 5' ' ' LEU . 1.7 mm? 52.51 72.55 0.4 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.737 -0.861 . . . . 0.0 110.647 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.456 ' HA ' ' CD1' ' A' ' 28' ' ' TRP . 6.2 ttm 60.87 42.0 13.71 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.609 -0.682 . . . . 0.0 110.533 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB3' ' CB ' ' A' ' 29' ' ' CYS . . . -82.85 100.51 10.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.446 -0.784 . . . . 0.0 109.793 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.73 109.05 1.6 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.9 p -114.71 -36.69 4.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.549 -0.971 . . . . 0.0 110.54 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.12 72.06 0.51 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.637 -0.664 . . . . 0.0 110.4 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.57 121.78 1.04 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -13.06 59.76 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.523 -0.986 . . . . 0.0 110.772 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.2 p -102.2 23.68 11.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 110.799 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.819 HG21 ' SG ' ' A' ' 22' ' ' CYS . 15.4 t -72.58 -169.79 0.59 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.144 -0.973 . . . . 0.0 109.991 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -133.64 107.41 7.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.166 -0.959 . . . . 0.0 110.53 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -98.62 -160.52 0.81 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.637 -0.664 . . . . 0.0 109.991 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -69.23 -77.12 0.08 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.078 -1.014 . . . . 0.0 110.569 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 p -164.7 -46.67 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.487 -0.758 . . . . 0.0 109.987 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.34 29.91 11.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 84.0 m-85 -129.2 125.94 38.09 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.912 . . . . 0.0 109.643 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -116.51 139.03 50.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -0.787 . . . . 0.0 110.319 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.819 ' SG ' HG21 ' A' ' 14' ' ' THR . 1.2 m -75.6 128.57 35.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.461 -0.774 . . . . 0.0 110.426 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.78 136.66 36.48 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.739 -0.601 . . . . 0.0 110.315 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.1 -27.74 11.55 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.923 1.486 . . . . 0.0 110.75 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.8 m -84.47 -29.56 25.95 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.433 -0.792 . . . . 0.0 110.627 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.673 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 78.3 m95 -100.53 -16.71 17.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.417 -0.802 . . . . 0.0 110.927 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.9 tptt 69.06 9.76 7.56 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.673 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -132.57 169.79 16.11 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.598 -1.314 . . . . 0.0 110.957 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.7 OUTLIER -89.32 140.62 29.31 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.632 0.729 . . . . 0.0 111.531 -178.67 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.508 HG13 ' CD1' ' A' ' 28' ' ' TRP . 3.1 m -140.31 178.24 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.92 149.74 11.15 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.256 -0.903 . . . . 0.0 110.518 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.907 0 O-C-N 121.527 -0.733 . . . . 0.0 110.667 -179.723 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.529 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.51 121.62 1.42 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.607 HD13 ' HE1' ' A' ' 20' ' ' TYR . 5.7 tp 66.88 101.08 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.858 -0.789 . . . . 0.0 111.055 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.65 26.09 15.83 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.871 -0.518 . . . . 0.0 111.022 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.758 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -91.07 135.98 33.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.99 127.46 44.88 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.517 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 1.4 t -120.58 -71.16 0.75 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.719 -0.871 . . . . 0.0 109.635 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 55.44 77.63 0.22 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.716 -0.615 . . . . 0.0 110.813 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.53 121.01 0.56 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -19.15 64.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.605 -0.938 . . . . 0.0 110.444 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -110.79 21.31 16.65 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.383 -0.823 . . . . 0.0 110.515 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.517 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 8.9 m -83.52 135.18 34.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.319 -0.863 . . . . 0.0 110.068 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.55 141.07 37.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.657 -0.652 . . . . 0.0 110.098 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 20' ' ' TYR . 72.8 m -81.34 -165.12 0.87 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.459 -0.776 . . . . 0.0 110.081 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -74.97 0.32 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.212 -0.93 . . . . 0.0 110.89 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.6 m -152.28 116.95 5.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.292 -0.88 . . . . 0.0 110.356 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.47 31.43 45.89 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.607 ' HE1' HD13 ' A' ' 5' ' ' LEU . 58.8 m-85 -138.08 158.15 44.9 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.469 -1.018 . . . . 0.0 110.103 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.443 ' O ' HG22 ' A' ' 30' ' ' VAL . 23.9 t-20 -139.52 138.25 36.16 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.0 110.274 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.3 t -69.74 126.95 31.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.353 -0.842 . . . . 0.0 110.775 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.72 131.73 42.61 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.633 -0.667 . . . . 0.0 109.821 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.84 -26.29 13.54 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.836 1.44 . . . . 0.0 111.304 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.9 m -83.07 -38.11 22.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.329 -0.857 . . . . 0.0 110.771 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.654 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 80.8 m95 -98.14 -9.54 25.62 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.384 -0.823 . . . . 0.0 111.012 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 3.1 mmmm 59.31 34.2 22.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.557 -0.714 . . . . 0.0 111.752 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.654 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -143.43 174.5 10.7 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.955 -1.091 . . . . 0.0 110.685 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.758 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -89.57 133.84 34.41 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.98 -1.075 . . . . 0.0 109.854 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.499 HG13 ' CD1' ' A' ' 28' ' ' TRP . 17.5 m -132.14 173.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.465 -0.772 . . . . 0.0 110.505 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -62.02 127.28 30.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.445 -0.785 . . . . 0.0 110.227 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.875 0 O-C-N 121.536 -0.727 . . . . 0.0 110.461 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.505 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.72 143.94 11.82 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER 62.21 93.07 0.05 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.917 -0.755 . . . . 0.0 111.02 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.9 mtt 58.46 32.58 22.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.706 -0.621 . . . . 0.0 110.99 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.95 131.53 35.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.38 -0.825 . . . . 0.0 109.553 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -50.74 116.45 4.32 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.505 ' SG ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -100.43 -60.1 1.59 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.621 -0.929 . . . . 0.0 109.494 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 2.3 m-20 46.58 77.74 0.08 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.191 0.519 . . . . 0.0 111.446 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.38 128.32 2.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -16.4 59.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.602 -0.94 . . . . 0.0 110.776 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 p -121.45 38.24 4.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.497 -0.752 . . . . 0.0 109.621 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.505 HG21 ' SG ' ' A' ' 9' ' ' CYS . 11.4 t -63.33 157.37 23.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.544 -0.722 . . . . 0.0 110.741 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.23 94.47 5.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.419 -0.801 . . . . 0.0 110.05 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.5 m -78.51 -162.45 0.36 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.611 -0.68 . . . . 0.0 110.375 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -90.65 -84.64 0.24 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.216 -0.927 . . . . 0.0 110.25 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.5 p -155.93 111.5 3.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.46 40.88 6.69 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.488 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 58.9 m-85 -132.92 156.86 46.48 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.32 -1.106 . . . . 0.0 110.038 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.14 132.96 34.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 110.543 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.6 126.67 29.09 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.503 -0.748 . . . . 0.0 110.05 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.5 m -77.0 137.92 65.51 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.499 -0.751 . . . . 0.0 110.424 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.33 -23.72 17.37 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.933 1.491 . . . . 0.0 111.198 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.2 m -101.12 -39.67 7.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.293 -0.879 . . . . 0.0 110.694 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.693 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 81.8 m95 -87.98 -19.57 27.05 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.337 -0.852 . . . . 0.0 111.207 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 67.86 14.71 9.48 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.597 -0.689 . . . . 0.0 112.302 179.492 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.693 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -121.39 166.35 14.21 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.747 -1.22 . . . . 0.0 110.323 178.323 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -89.39 124.13 34.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.116 -0.99 . . . . 0.0 110.78 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.504 HG13 ' CD1' ' A' ' 28' ' ' TRP . 18.4 m -119.74 170.86 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.796 -0.565 . . . . 0.0 109.681 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -54.4 125.7 20.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.291 -0.88 . . . . 0.0 110.342 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.587 -0.696 . . . . 0.0 109.98 179.795 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.55 ' N ' ' HG ' ' A' ' 17' ' ' CYS . . . . . . . . 0 N--CA 1.494 2.558 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.48 148.74 20.0 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.91 93.29 0.05 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.716 -0.873 . . . . 0.0 110.633 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 56.67 41.52 28.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.62 -0.675 . . . . 0.0 110.137 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -87.47 113.79 23.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.559 -0.713 . . . . 0.0 110.058 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.23 110.99 1.33 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.427 ' HA ' HG21 ' A' ' 14' ' ' THR . 55.5 m -95.55 -52.82 3.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.567 -0.96 . . . . 0.0 109.691 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.73 54.43 4.42 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.374 0.606 . . . . 0.0 110.483 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.34 127.21 0.87 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -15.75 62.07 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.644 -0.915 . . . . 0.0 110.898 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.55 30.34 6.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.237 -0.915 . . . . 0.0 110.254 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.427 HG21 ' HA ' ' A' ' 9' ' ' CYS . 24.4 m -90.67 143.11 27.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.75 173.96 6.08 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.43 -0.794 . . . . 0.0 110.131 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.3 m -133.52 -164.67 1.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.387 -0.821 . . . . 0.0 110.592 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.55 ' HG ' ' N ' ' A' ' 3' ' ' GLY . 90.4 m -75.26 -87.49 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.274 -0.891 . . . . 0.0 110.47 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -149.3 118.66 6.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.351 -0.843 . . . . 0.0 110.269 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.12 26.25 45.22 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.581 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 57.3 m-85 -133.29 150.12 51.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.383 -1.069 . . . . 0.0 109.911 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.15 140.37 37.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.452 -0.78 . . . . 0.0 110.541 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 76.6 m -73.48 142.75 46.8 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.441 -0.787 . . . . 0.0 109.97 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m -103.62 143.37 26.51 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.588 -0.695 . . . . 0.0 110.369 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.42 -33.04 4.47 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.012 1.533 . . . . 0.0 111.172 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.0 m -84.46 -39.69 18.62 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.45 -0.781 . . . . 0.0 110.79 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.698 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 17.9 m0 -88.61 -22.54 23.43 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.526 -0.734 . . . . 0.0 110.877 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 71.63 2.0 4.1 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.71 -0.619 . . . . 0.0 111.925 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.698 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -120.57 170.38 9.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.747 -1.221 . . . . 0.0 110.509 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 6.3 t -89.08 143.12 27.07 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.533 -0.729 . . . . 0.0 111.102 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.458 HG13 ' CD1' ' A' ' 28' ' ' TRP . 19.1 m -137.08 178.3 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.861 -0.524 . . . . 0.0 109.591 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -61.5 119.03 7.8 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 109.863 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.571 -0.705 . . . . 0.0 110.702 -179.477 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.483 ' N ' ' HG ' ' A' ' 17' ' ' CYS . . . . . . . . 0 N--CA 1.495 2.584 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.61 152.1 24.11 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.87 93.29 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.664 -0.904 . . . . 0.0 110.623 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 mtp 57.09 41.34 27.51 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.66 -0.65 . . . . 0.0 109.775 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -88.04 122.99 32.28 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.579 -0.701 . . . . 0.0 110.376 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.29 108.81 1.95 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 p -114.73 -40.48 3.55 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.567 -0.961 . . . . 0.0 110.866 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t70 56.92 69.28 0.76 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.647 -0.658 . . . . 0.0 110.447 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.45 115.7 1.3 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.22 -20.18 39.64 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.371 -1.076 . . . . 0.0 110.56 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.8 t -78.43 -19.98 52.04 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.485 -0.76 . . . . 0.0 110.537 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.2 m -56.7 133.12 53.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.469 -0.769 . . . . 0.0 110.089 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -85.31 152.9 22.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 110.505 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -118.82 -161.11 0.83 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.58 -0.7 . . . . 0.0 110.334 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.483 ' HG ' ' N ' ' A' ' 3' ' ' GLY . 82.0 m -71.94 -82.28 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.264 -0.897 . . . . 0.0 110.46 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.7 p -159.03 115.96 2.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.548 -0.72 . . . . 0.0 109.702 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.0 -4.54 78.25 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.41 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 78.5 m-85 -108.88 143.45 38.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.199 -1.177 . . . . 0.0 110.062 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -132.31 135.4 46.18 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.348 -0.845 . . . . 0.0 110.2 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 45.3 t -59.51 140.07 56.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.629 -0.669 . . . . 0.0 110.829 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.12 128.22 27.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.634 -0.666 . . . . 0.0 110.017 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.79 -20.83 19.5 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.908 1.478 . . . . 0.0 111.166 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.2 m -89.08 -34.83 16.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.234 -0.916 . . . . 0.0 110.751 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.7 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 86.3 m95 -102.04 -10.14 19.98 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.338 -0.851 . . . . 0.0 111.202 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 tptm 69.29 8.01 6.55 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.622 -0.674 . . . . 0.0 112.708 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.7 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -131.39 167.89 18.52 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.585 -1.322 . . . . 0.0 110.698 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 5.8 t -89.02 139.71 30.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.492 -0.755 . . . . 0.0 110.639 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.524 HG13 ' CD1' ' A' ' 28' ' ' TRP . 12.2 m -134.03 175.83 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.718 -0.614 . . . . 0.0 110.029 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.82 125.58 25.8 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.387 -0.82 . . . . 0.0 110.36 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.646 -0.659 . . . . 0.0 110.017 179.939 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.584 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.509 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.39 133.14 4.33 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.465 ' HA ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER 64.46 97.05 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.76 -0.847 . . . . 0.0 111.222 179.578 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 mpp? 54.02 34.71 20.37 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.656 -0.653 . . . . 0.0 110.291 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.584 ' HB1' ' HA3' ' A' ' 3' ' ' GLY . . . -90.22 127.51 36.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.525 -0.734 . . . . 0.0 110.5 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.11 112.18 3.98 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.602 ' HB2' HG21 ' A' ' 14' ' ' THR . 4.5 p -115.38 -45.34 2.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.519 -0.989 . . . . 0.0 110.328 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.438 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER 54.87 87.06 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.291 0.567 . . . . 0.0 110.427 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.15 115.34 0.77 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.452 ' HG2' ' HB3' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -62.37 -18.67 62.11 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.577 -0.955 . . . . 0.0 110.36 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.22 -17.87 26.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.365 -0.834 . . . . 0.0 110.537 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.602 HG21 ' HB2' ' A' ' 9' ' ' CYS . 27.7 m -58.76 120.93 9.87 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.263 -0.898 . . . . 0.0 109.978 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.413 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 39.8 t80 -94.61 20.58 8.34 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.527 -0.733 . . . . 0.0 110.852 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 20' ' ' TYR . 6.2 m 56.37 -149.51 0.46 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.027 -1.046 . . . . 0.0 110.045 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.04 -65.75 0.97 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.164 -0.96 . . . . 0.0 110.085 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 t -162.24 117.88 1.94 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.507 -0.746 . . . . 0.0 110.397 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.41 30.46 33.49 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.559 ' HB2' ' HB2' ' A' ' 16' ' ' CYS . 64.9 m-85 -136.92 168.27 19.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.419 -1.048 . . . . 0.0 110.137 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.88 124.05 16.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -0.78 . . . . 0.0 110.21 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.18 117.26 12.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.572 -0.705 . . . . 0.0 110.092 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 19.9 m -74.23 131.22 81.08 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.552 -0.718 . . . . 0.0 110.188 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.452 ' HB3' ' HG2' ' A' ' 12' ' ' LYS . 46.5 Cg_endo -73.28 -23.07 18.18 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.988 1.52 . . . . 0.0 111.093 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.3 m -96.24 -35.56 11.22 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.24 -0.913 . . . . 0.0 110.69 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.591 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 26.1 m0 -92.27 -19.08 22.55 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.348 -0.845 . . . . 0.0 110.876 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' CE ' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 70.76 7.21 6.14 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.591 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -118.68 163.44 16.83 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.755 -1.215 . . . . 0.0 110.665 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -96.42 124.0 40.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.599 -0.688 . . . . 0.0 110.895 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.587 HG13 ' CD1' ' A' ' 28' ' ' TRP . 2.1 m -121.29 170.39 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.588 -0.695 . . . . 0.0 110.14 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -52.67 146.41 10.29 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.432 -0.793 . . . . 0.0 110.627 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.359 -0.838 . . . . 0.0 110.233 -179.725 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.432 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 29' ' ' CYS . . . -160.66 175.92 37.33 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.414 HD23 ' CE1' ' A' ' 20' ' ' TYR . 0.2 OUTLIER 58.28 87.2 0.07 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.719 -0.871 . . . . 0.0 110.873 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 46.5 mmm 54.91 37.08 28.12 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.643 -0.661 . . . . 0.0 110.233 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -88.31 97.01 10.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.5 -0.75 . . . . 0.0 110.114 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.12 104.64 0.55 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 1.035 ' HB2' HG21 ' A' ' 14' ' ' THR . 21.8 p -110.23 -32.57 6.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.604 -0.939 . . . . 0.0 110.805 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 t70 65.0 99.03 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.696 -0.628 . . . . 0.0 110.603 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.36 117.53 1.54 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -66.07 -14.04 61.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.597 -0.943 . . . . 0.0 110.581 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.3 p -107.12 11.35 29.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.833 . . . . 0.0 110.792 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.035 HG21 ' HB2' ' A' ' 9' ' ' CYS . 19.9 m -74.03 141.42 45.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.139 -0.975 . . . . 0.0 110.012 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.84 163.34 15.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.455 -0.778 . . . . 0.0 110.351 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.0 m -129.89 -160.51 1.04 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.539 -0.726 . . . . 0.0 109.863 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.7 t -66.03 -66.36 0.56 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 t -171.4 -46.61 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.45 -0.781 . . . . 0.0 110.43 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.13 29.66 11.27 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.496 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 66.9 m-85 -130.94 158.9 39.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.468 -1.019 . . . . 0.0 110.155 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.47 129.35 18.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.369 -0.832 . . . . 0.0 110.398 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 2.3 m -67.1 127.23 31.81 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.507 -0.745 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 7.9 t -83.87 141.54 41.13 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.473 -0.767 . . . . 0.0 110.193 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.78 -24.96 15.04 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.891 1.469 . . . . 0.0 111.299 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.3 m -99.36 -31.68 11.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.161 -0.962 . . . . 0.0 110.962 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.706 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 36.6 m0 -87.97 -21.72 24.71 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.33 -0.856 . . . . 0.0 110.982 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 73.26 -2.08 2.85 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.707 -0.621 . . . . 0.0 112.042 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.706 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.9 p90 -122.46 165.56 16.16 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.609 -1.307 . . . . 0.0 110.67 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 5.0 t -89.32 133.92 34.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.517 -0.739 . . . . 0.0 111.106 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 33.1 m -126.27 -170.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.38 134.17 56.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.208 -0.932 . . . . 0.0 110.073 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.9 0 O-C-N 121.508 -0.745 . . . . 0.0 110.497 -179.733 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.636 ' N ' ' HG ' ' A' ' 17' ' ' CYS . . . . . . . . 0 N--CA 1.493 2.482 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.424 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -145.61 150.52 22.74 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER 58.34 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.697 -0.884 . . . . 0.0 110.789 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.2 mtm 59.42 37.8 23.02 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.658 -0.651 . . . . 0.0 110.405 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.476 ' HB1' ' HA3' ' A' ' 3' ' ' GLY . . . -90.19 112.34 23.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.452 -0.78 . . . . 0.0 110.01 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -50.62 107.71 0.41 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.979 ' HB2' HG21 ' A' ' 14' ' ' THR . 5.4 p -109.76 -42.17 4.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.691 -0.888 . . . . 0.0 110.334 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 55.0 72.42 0.47 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.78 -0.575 . . . . 0.0 111.032 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.32 126.6 2.7 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -11.38 57.11 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.587 -0.949 . . . . 0.0 110.435 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t -94.14 13.87 21.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.364 -0.835 . . . . 0.0 110.547 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.979 HG21 ' HB2' ' A' ' 9' ' ' CYS . 14.7 t -73.34 -173.75 1.45 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.184 -0.948 . . . . 0.0 110.166 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 96.78 4.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.018 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.2 m -77.64 -169.64 1.55 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.414 -0.804 . . . . 0.0 110.188 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.636 ' HG ' ' N ' ' A' ' 3' ' ' GLY . 88.9 m -79.32 -94.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.248 -0.907 . . . . 0.0 110.255 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 p -144.3 113.13 6.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.062 -1.024 . . . . 0.0 110.574 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.38 37.5 9.7 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 69.5 m-85 -132.18 148.32 52.46 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.361 -1.082 . . . . 0.0 110.055 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -124.1 128.11 48.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.498 -0.751 . . . . 0.0 110.485 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 42.3 t -69.39 121.1 16.27 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.608 -0.682 . . . . 0.0 109.971 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 58.4 m -76.23 129.64 79.79 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.521 -0.737 . . . . 0.0 110.199 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.45 -24.27 19.38 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.875 1.461 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -98.8 -36.2 9.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.302 -0.874 . . . . 0.0 110.492 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.724 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 50.6 m0 -85.18 -19.05 32.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.455 -0.778 . . . . 0.0 110.955 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 70.81 9.01 6.74 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.672 -0.643 . . . . 0.0 112.273 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.724 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -130.5 161.05 32.32 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.798 -1.188 . . . . 0.0 110.506 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.9 t -89.46 133.6 34.48 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.497 -0.752 . . . . 0.0 111.08 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.524 HG13 ' CD1' ' A' ' 28' ' ' TRP . 18.2 m -126.03 -177.55 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.74 -0.6 . . . . 0.0 109.518 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.42 ' HD2' HD21 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -62.45 135.75 57.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.212 -0.93 . . . . 0.0 110.209 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.489 -0.757 . . . . 0.0 110.632 -179.753 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.584 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.89 159.9 28.2 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' A' ' 5' ' ' LEU . 0.8 OUTLIER 55.36 85.67 0.06 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.749 -0.854 . . . . 0.0 111.104 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.3 mtp 58.55 37.37 25.47 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.682 -0.636 . . . . 0.0 110.661 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.99 125.72 33.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.43 108.05 0.81 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.945 ' HB2' HG21 ' A' ' 14' ' ' THR . 25.9 p -109.41 -41.35 4.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.551 -0.97 . . . . 0.0 110.583 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.1 t70 46.65 76.64 0.1 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.751 -0.593 . . . . 0.0 111.339 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.65 125.28 2.22 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -12.88 52.7 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.606 -0.938 . . . . 0.0 110.722 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.5 t -113.13 32.01 6.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.917 . . . . 0.0 110.244 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.945 HG21 ' HB2' ' A' ' 9' ' ' CYS . 15.0 t -72.58 -168.97 0.49 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.432 -0.793 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -127.04 92.38 3.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.489 -0.757 . . . . 0.0 110.429 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -82.17 -172.9 4.22 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.481 -0.762 . . . . 0.0 109.829 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 t -80.76 -75.49 0.27 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.07 -1.019 . . . . 0.0 110.751 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.0 p -162.78 125.23 2.71 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.281 -0.887 . . . . 0.0 110.141 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.28 28.34 64.19 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.497 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.3 m-85 -126.49 126.04 43.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.268 -1.136 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -105.47 132.3 51.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 110.187 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 4.8 t -85.24 130.12 34.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.567 -0.708 . . . . 0.0 110.162 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -92.39 136.58 25.35 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.525 -0.734 . . . . 0.0 109.968 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.32 -28.3 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.808 1.425 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 m -86.72 -34.68 19.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.383 -0.823 . . . . 0.0 110.213 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.671 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 46.9 m0 -88.22 -22.24 24.09 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.548 -0.72 . . . . 0.0 110.664 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 21.1 mmmt 66.96 15.36 10.13 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.85 -0.531 . . . . 0.0 112.032 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.671 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -131.66 166.97 20.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.804 -1.185 . . . . 0.0 110.803 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 3.8 t -104.9 133.08 50.31 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.431 -0.793 . . . . 0.0 110.639 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.546 HG13 ' CD1' ' A' ' 28' ' ' TRP . 4.3 m -136.02 171.96 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.627 -0.671 . . . . 0.0 109.967 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -49.86 142.62 8.67 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.36 -0.838 . . . . 0.0 110.728 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 -179.4 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.512 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.404 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -140.2 140.57 10.73 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 61.35 93.22 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.91 -0.759 . . . . 0.0 110.959 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.61 40.78 23.19 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.708 -0.62 . . . . 0.0 110.475 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.404 ' HB2' ' N ' ' A' ' 4' ' ' GLY . . . -88.1 130.6 34.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.425 -0.797 . . . . 0.0 109.916 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.3 110.84 1.72 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.697 ' SG ' HG21 ' A' ' 14' ' ' THR . 2.0 t -105.3 -72.3 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.655 -0.909 . . . . 0.0 109.553 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.4 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 6.0 t70 53.48 63.57 2.16 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.381 0.61 . . . . 0.0 110.822 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.48 126.2 0.93 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.56 -14.33 60.87 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.476 -1.014 . . . . 0.0 110.889 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.6 p -93.96 11.69 28.72 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.246 -0.909 . . . . 0.0 111.149 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.697 HG21 ' SG ' ' A' ' 9' ' ' CYS . 6.1 t -64.96 155.96 32.76 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.109 -0.994 . . . . 0.0 109.813 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -111.35 -18.92 12.79 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.311 -0.868 . . . . 0.0 111.257 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.6 m 55.62 -155.81 0.27 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.43 -0.794 . . . . 0.0 110.055 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.402 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 37.9 t -99.54 -104.47 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.131 -0.981 . . . . 0.0 109.412 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 t -131.7 106.0 7.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.989 -1.069 . . . . 0.0 109.753 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.37 53.53 2.61 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.477 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 75.0 m-85 -138.5 147.56 43.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.443 -1.033 . . . . 0.0 110.303 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -119.88 130.37 54.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.589 -0.694 . . . . 0.0 110.155 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.651 ' HB2' HG21 ' A' ' 14' ' ' THR . 37.9 t -74.94 138.29 42.23 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.544 -0.723 . . . . 0.0 110.158 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -100.9 133.33 21.14 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.729 . . . . 0.0 110.24 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.29 -42.14 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 124.007 1.53 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.7 m -80.89 -24.68 38.12 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.55 -0.719 . . . . 0.0 110.865 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.619 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 45.3 m95 -98.96 -19.33 17.36 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.338 -0.851 . . . . 0.0 110.881 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 69.22 8.46 6.82 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 178.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.619 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -131.45 163.37 28.09 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.627 -1.296 . . . . 0.0 111.099 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.7 t -91.41 138.01 31.91 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.49 -0.757 . . . . 0.0 110.575 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.53 173.84 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.515 -0.74 . . . . 0.0 109.698 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -58.04 133.01 55.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.326 -0.859 . . . . 0.0 110.169 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.574 -0.703 . . . . 0.0 110.501 -179.639 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.448 ' N ' ' HG ' ' A' ' 17' ' ' CYS . . . . . . . . 0 N--CA 1.497 2.733 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.44 159.35 30.06 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.84 90.55 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.696 -0.885 . . . . 0.0 110.622 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.13 34.31 23.24 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.657 -0.652 . . . . 0.0 110.405 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.5 133.93 34.87 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.466 -0.771 . . . . 0.0 109.795 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.31 114.45 5.86 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.472 ' SG ' HG21 ' A' ' 14' ' ' THR . 0.1 OUTLIER -97.01 -61.48 1.4 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.842 . . . . 0.0 109.677 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.432 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 1.1 t70 54.11 56.23 7.28 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.766 -0.584 . . . . 0.0 111.164 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.11 127.22 1.01 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -16.08 56.19 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.491 -1.005 . . . . 0.0 111.247 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.74 35.49 4.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.244 -0.91 . . . . 0.0 110.209 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.472 HG21 ' SG ' ' A' ' 9' ' ' CYS . 6.1 t -71.66 178.28 3.66 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.482 -0.761 . . . . 0.0 110.533 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -117.34 120.27 37.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.458 -0.776 . . . . 0.0 110.461 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m -115.16 -171.12 1.89 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.535 -0.728 . . . . 0.0 110.038 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.448 ' HG ' ' N ' ' A' ' 3' ' ' GLY . 99.8 m -81.37 -102.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.264 -0.897 . . . . 0.0 109.94 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.75 121.18 10.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.168 -0.958 . . . . 0.0 109.776 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 24.63 32.78 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 62.6 m-85 -128.51 126.38 40.31 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.356 -1.085 . . . . 0.0 109.539 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.41 143.24 43.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.4 -0.812 . . . . 0.0 110.713 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 19.4 t -78.77 126.4 30.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.687 -0.633 . . . . 0.0 110.155 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.13 137.33 42.98 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.469 -0.769 . . . . 0.0 110.147 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.57 -32.06 5.05 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.898 1.473 . . . . 0.0 110.964 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.6 m -86.44 -28.89 23.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.506 -0.746 . . . . 0.0 110.979 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.658 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 52.2 m95 -101.53 -22.89 14.4 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.388 -0.82 . . . . 0.0 111.061 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HG3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 67.94 28.24 6.95 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.647 -0.658 . . . . 0.0 112.374 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.658 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -135.77 171.27 14.71 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.772 -1.205 . . . . 0.0 110.412 178.055 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -97.53 125.11 42.05 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.088 -1.008 . . . . 0.0 110.145 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.552 HG13 ' CD1' ' A' ' 28' ' ' TRP . 15.6 m -124.72 163.44 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.543 -0.723 . . . . 0.0 110.241 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.83 131.1 49.85 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.537 -0.727 . . . . 0.0 110.399 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.653 -0.654 . . . . 0.0 110.362 -179.841 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.406 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.92 149.85 21.82 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.455 ' HA ' HD13 ' A' ' 5' ' ' LEU . 3.1 mm? 57.54 84.83 0.09 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.737 -0.861 . . . . 0.0 111.574 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 ttt 56.87 37.1 28.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.701 -0.624 . . . . 0.0 110.98 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.15 101.71 14.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.492 -0.755 . . . . 0.0 110.09 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 28' ' ' TRP . . . -54.63 110.3 1.58 Allowed Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.531 ' SG ' HG21 ' A' ' 14' ' ' THR . 23.4 p -105.89 -40.53 5.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.476 -1.014 . . . . 0.0 110.285 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.9 t70 54.64 95.54 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.326 0.584 . . . . 0.0 111.311 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.2 120.07 1.04 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -17.42 62.43 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.642 -0.917 . . . . 0.0 110.228 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 t -117.4 31.15 6.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.449 -0.782 . . . . 0.0 110.022 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.531 HG21 ' SG ' ' A' ' 9' ' ' CYS . 11.1 t -78.97 158.75 27.91 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.251 -0.906 . . . . 0.0 109.997 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.62 112.88 23.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.8 m -81.01 -165.78 0.99 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.442 -0.787 . . . . 0.0 110.109 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -79.58 -77.61 0.18 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.084 -1.01 . . . . 0.0 110.266 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.87 123.14 1.18 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.387 -0.82 . . . . 0.0 109.694 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.49 29.91 54.67 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.497 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.6 m-85 -126.77 150.59 49.03 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.366 -1.079 . . . . 0.0 110.212 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -126.05 130.51 51.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 110.315 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 1.3 m -86.97 129.55 34.83 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.386 -0.821 . . . . 0.0 110.119 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.96 144.58 30.29 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.515 -0.741 . . . . 0.0 110.239 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.62 -41.51 1.11 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.83 1.437 . . . . 0.0 111.121 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.4 m -76.94 -34.35 57.64 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.521 -0.737 . . . . 0.0 110.729 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.665 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 42.0 m0 -89.51 -28.58 19.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.405 -0.809 . . . . 0.0 110.683 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 1.3 tppt? 70.33 10.29 7.21 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.914 -0.491 . . . . 0.0 112.185 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.665 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -120.79 166.51 13.65 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.767 -1.208 . . . . 0.0 110.827 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 1.7 t -101.83 129.24 48.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.637 -0.664 . . . . 0.0 110.385 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 28' ' ' TRP . 4.4 m -124.18 175.36 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.56 -0.713 . . . . 0.0 109.961 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CD2' HD21 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -62.68 138.21 58.45 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.389 -0.819 . . . . 0.0 110.498 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.548 -0.72 . . . . 0.0 110.169 179.707 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.559 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -152.64 150.34 22.13 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.5 87.76 0.09 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.722 -0.869 . . . . 0.0 110.906 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.8 mtt 56.77 37.22 28.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.752 -0.592 . . . . 0.0 110.479 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.406 ' HB2' ' N ' ' A' ' 4' ' ' GLY . . . -86.37 114.69 23.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.443 -0.785 . . . . 0.0 109.698 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.63 98.21 0.06 OUTLIER Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.924 ' HB2' HG21 ' A' ' 14' ' ' THR . 9.1 p -87.21 -38.42 16.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.573 -0.957 . . . . 0.0 110.097 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.482 ' HA ' ' HD2' ' A' ' 27' ' ' LYS . 22.5 m-20 51.12 82.78 0.06 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.267 0.556 . . . . 0.0 111.433 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 131.93 124.21 2.54 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -10.62 40.36 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.644 -0.915 . . . . 0.0 110.734 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 m -106.6 26.88 9.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.231 -0.918 . . . . 0.0 110.248 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.924 HG21 ' HB2' ' A' ' 9' ' ' CYS . 14.1 t -77.36 -179.7 5.89 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.291 -0.88 . . . . 0.0 110.716 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.24 105.52 7.71 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.514 -0.742 . . . . 0.0 110.009 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.9 m -82.47 -171.27 3.38 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 110.484 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.68 -76.06 0.32 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.217 -0.927 . . . . 0.0 110.683 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.3 p -163.8 131.97 3.62 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.345 -0.847 . . . . 0.0 110.237 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.32 24.23 77.17 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.568 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 30.0 m-85 -125.15 142.92 51.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.395 -1.062 . . . . 0.0 109.785 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.649 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -122.0 117.8 27.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.801 . . . . 0.0 110.316 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 2.2 t -75.12 108.13 7.66 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.525 -0.735 . . . . 0.0 109.718 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.653 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -72.98 136.17 79.89 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 0.0 109.955 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.51 -28.79 14.16 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.95 1.5 . . . . 0.0 110.672 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -87.18 -35.08 18.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.39 -0.819 . . . . 0.0 110.255 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.674 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 47.3 m0 -87.38 -15.76 36.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.51 -0.744 . . . . 0.0 110.934 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 32.3 mmtm 61.68 15.84 7.26 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.723 -0.611 . . . . 0.0 112.344 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.674 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -132.55 167.29 20.27 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.838 -1.164 . . . . 0.0 110.6 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 3.6 t -107.86 127.94 54.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.632 -0.667 . . . . 0.0 110.218 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.582 HG13 ' CD1' ' A' ' 28' ' ' TRP . 3.6 m -131.89 165.48 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.537 -0.727 . . . . 0.0 110.584 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -45.79 142.29 2.58 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.654 -0.654 . . . . 0.0 110.883 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . . . . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 0.0 110.579 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.444 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.538 ' H ' ' HB2' ' A' ' 7' ' ' ALA . . . -179.32 140.77 4.5 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 61.17 93.93 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.851 -0.793 . . . . 0.0 111.061 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.2 mtp 55.91 42.61 28.61 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.679 -0.638 . . . . 0.0 109.979 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.783 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -86.18 115.7 23.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.608 -0.683 . . . . 0.0 110.049 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.9 110.16 2.24 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.537 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 7.4 p -113.67 -36.17 4.97 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.677 -0.896 . . . . 0.0 110.599 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.32 59.32 4.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.666 -0.647 . . . . 0.0 110.976 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.76 117.56 0.43 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -21.54 52.78 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.494 -1.003 . . . . 0.0 110.899 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -99.2 -12.41 20.46 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.434 -0.791 . . . . 0.0 110.806 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.537 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 54.1 m -56.67 132.97 53.46 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.348 -0.845 . . . . 0.0 110.506 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -94.26 175.41 6.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.576 -0.703 . . . . 0.0 110.347 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.9 m -124.68 -148.11 0.39 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.509 -0.744 . . . . 0.0 110.128 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 t -88.7 -71.51 0.59 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.084 -1.01 . . . . 0.0 110.782 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.9 p -161.45 119.83 2.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.411 -0.805 . . . . 0.0 110.342 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.43 26.03 48.76 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.69 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 74.9 m-85 -139.4 152.14 46.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.474 -1.015 . . . . 0.0 109.547 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.4 130.26 26.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.324 -0.86 . . . . 0.0 110.645 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 16.9 t -68.63 149.38 49.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.521 -0.737 . . . . 0.0 110.304 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.67 140.63 30.84 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.507 -0.746 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.29 -41.08 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.713 1.375 . . . . 0.0 111.185 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.0 m -72.63 -31.91 65.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.398 -0.814 . . . . 0.0 110.839 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.625 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 54.1 m95 -96.76 -20.43 18.23 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.399 -0.813 . . . . 0.0 110.475 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 5.5 tptt 70.37 8.81 6.77 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.673 -0.642 . . . . 0.0 112.25 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.625 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.7 p90 -136.77 169.0 18.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.723 -1.236 . . . . 0.0 110.757 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.783 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 11.4 t -89.17 145.6 25.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.557 -0.714 . . . . 0.0 110.922 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 27.8 m -132.69 -179.21 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -66.41 131.25 45.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.239 -0.913 . . . . 0.0 110.367 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.586 -0.696 . . . . 0.0 110.645 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.474 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.31 161.68 30.99 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 5' ' ' LEU . 1.7 mm? 55.4 84.28 0.08 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.74 -0.859 . . . . 0.0 111.109 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 56.25 40.48 29.94 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.62 -0.675 . . . . 0.0 110.46 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -89.49 107.4 19.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.511 -0.743 . . . . 0.0 110.455 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.45 108.79 1.97 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.871 ' SG ' HG21 ' A' ' 14' ' ' THR . 27.2 p -110.61 -32.3 6.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.583 -0.951 . . . . 0.0 110.92 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 t70 59.86 73.46 0.48 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.653 -0.654 . . . . 0.0 110.584 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 174.01 124.27 0.78 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.446 ' HG2' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -61.67 -19.01 61.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.727 -0.867 . . . . 0.0 111.007 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.446 ' N ' ' HG2' ' A' ' 12' ' ' LYS . 64.6 p -134.54 35.15 3.19 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.449 -0.782 . . . . 0.0 110.063 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.871 HG21 ' SG ' ' A' ' 9' ' ' CYS . 12.3 t -64.95 161.69 18.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.435 -0.791 . . . . 0.0 110.595 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -100.6 115.21 29.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.407 -0.808 . . . . 0.0 110.296 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.5 m -94.39 -163.99 1.12 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.627 -0.671 . . . . 0.0 109.911 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.74 -76.79 0.22 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.05 -1.031 . . . . 0.0 110.6 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 p -163.47 126.75 2.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.483 -0.76 . . . . 0.0 109.917 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.04 17.21 80.28 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.429 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 38.4 m-85 -124.67 126.82 46.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.183 -1.186 . . . . 0.0 109.977 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.71 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -113.73 135.84 53.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.665 -0.647 . . . . 0.0 109.787 179.609 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 14' ' ' THR . 0.8 OUTLIER -85.1 138.36 32.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.587 -0.696 . . . . 0.0 110.332 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 9.3 t -98.47 140.19 21.66 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.643 -0.661 . . . . 0.0 110.436 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.24 -28.78 15.0 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.818 1.43 . . . . 0.0 110.9 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -86.28 -27.81 24.16 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.366 -0.834 . . . . 0.0 110.756 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.621 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 21.2 m0 -99.01 -27.54 13.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.279 -0.888 . . . . 0.0 110.701 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.8 OUTLIER 75.01 -3.9 2.5 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.621 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -109.15 170.0 8.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.73 -1.231 . . . . 0.0 110.678 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 5.5 t -105.7 129.97 53.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.717 . . . . 0.0 110.032 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.548 HG13 ' CD1' ' A' ' 28' ' ' TRP . 3.3 m -135.73 174.33 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.682 -0.636 . . . . 0.0 109.929 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -54.71 128.53 33.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.452 -0.78 . . . . 0.0 110.724 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . . . . . . . . 0 N--CA 1.498 1.966 0 O-C-N 121.645 -0.659 . . . . 0.0 110.583 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.4 t -119.3 110.84 17.46 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.544 -0.974 . . . . 0.0 110.082 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 16' ' ' CYS . . . -134.74 135.25 7.82 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.1 158.74 27.78 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.8 83.82 0.1 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.78 -0.836 . . . . 0.0 111.094 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.1 mtp 56.29 34.89 24.88 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.663 -0.648 . . . . 0.0 110.68 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -83.02 145.17 29.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.433 -0.792 . . . . 0.0 109.905 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.3 121.0 24.11 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.648 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -110.61 -61.01 1.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.618 -0.931 . . . . 0.0 110.121 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 t70 59.41 77.85 0.29 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.406 0.622 . . . . 0.0 110.605 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.82 121.86 1.34 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -66.06 -13.45 60.02 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.491 -1.005 . . . . 0.0 110.925 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 p -110.84 2.94 18.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.29 -0.882 . . . . 0.0 111.13 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.648 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 1.9 m -66.83 138.2 57.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.116 -0.99 . . . . 0.0 110.172 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -100.09 138.86 36.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.51 -0.744 . . . . 0.0 110.269 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 3' ' ' GLY . 33.7 m -80.88 -157.23 0.15 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.684 -0.635 . . . . 0.0 109.833 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 t -78.93 -70.66 0.49 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.092 -1.005 . . . . 0.0 110.332 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.1 p -163.69 123.08 2.06 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.558 -0.714 . . . . 0.0 109.819 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.95 -3.97 86.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 49.0 m-85 -103.24 169.88 8.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -1.179 . . . . 0.0 110.115 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -148.23 129.68 14.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.959 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 14.6 t -73.03 132.67 43.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.49 -0.756 . . . . 0.0 110.614 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -95.67 128.8 36.52 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.573 -0.704 . . . . 0.0 109.461 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.27 -21.67 26.47 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.784 1.412 . . . . 0.0 111.003 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.6 m -87.7 -28.3 21.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.316 -0.865 . . . . 0.0 110.741 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.519 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 11.1 m0 -108.43 -12.74 14.98 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.437 -0.789 . . . . 0.0 111.243 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? 61.88 29.55 17.91 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.583 -0.698 . . . . 0.0 112.27 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.519 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -136.66 171.0 15.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.839 -1.163 . . . . 0.0 110.671 178.203 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -102.14 123.87 46.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.382 -0.824 . . . . 0.0 110.492 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.465 HG13 ' CD1' ' A' ' 28' ' ' TRP . 1.6 m -132.89 -179.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.547 -0.72 . . . . 0.0 109.85 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -55.17 143.53 27.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.356 -0.84 . . . . 0.0 110.334 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.41 141.13 29.04 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.38 -0.825 . . . . 0.0 110.419 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -149.65 86.59 5.37 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.501 -0.749 . . . . 0.0 110.085 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 C--N 1.311 -1.395 0 O-C-N 123.81 1.426 . . . . 0.0 110.898 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.428 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -139.19 100.38 4.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.421 -1.046 . . . . 0.0 110.394 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.5 134.25 11.89 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.83 155.71 26.44 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 58.5 91.42 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.794 -0.827 . . . . 0.0 111.0 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.4 mtt 55.64 35.39 25.15 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.733 -0.605 . . . . 0.0 110.591 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -86.24 93.92 9.18 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.499 -0.751 . . . . 0.0 109.698 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.14 106.66 0.77 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.962 ' HB2' HG21 ' A' ' 14' ' ' THR . 30.7 p -114.21 -37.2 4.47 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.595 -0.944 . . . . 0.0 110.772 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 t70 63.11 96.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.421 0.629 . . . . 0.0 110.791 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.02 117.67 0.6 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -63.17 -17.5 62.45 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.622 -0.928 . . . . 0.0 110.759 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 t -119.93 27.96 8.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.368 -0.832 . . . . 0.0 110.372 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.962 HG21 ' HB2' ' A' ' 9' ' ' CYS . 17.0 m -83.31 132.53 35.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.298 -0.876 . . . . 0.0 109.875 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -86.26 160.47 19.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.478 -0.764 . . . . 0.0 110.442 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.1 m -124.84 -164.83 1.31 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.535 -0.728 . . . . 0.0 110.498 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.428 ' HB2' ' CA ' ' A' ' 2' ' ' CYS . 23.7 t -74.0 -86.99 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.306 -0.871 . . . . 0.0 110.698 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.5 m -151.05 122.39 7.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.141 -0.974 . . . . 0.0 109.988 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.77 24.78 66.34 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.625 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 42.1 m-85 -130.67 140.11 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.454 -1.027 . . . . 0.0 109.831 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.73 128.6 39.24 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.434 -0.791 . . . . 0.0 110.627 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.4 m -71.12 120.26 16.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.666 -0.646 . . . . 0.0 110.008 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 5.5 t -82.44 140.08 44.85 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.401 -0.812 . . . . 0.0 110.255 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.38 -29.21 11.47 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.962 1.506 . . . . 0.0 110.854 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.0 m -86.05 -32.51 21.38 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.741 . . . . 0.0 110.464 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.707 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 34.5 m0 -93.31 -23.96 18.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.405 -0.809 . . . . 0.0 110.703 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER 72.35 1.78 4.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.851 -0.531 . . . . 0.0 111.973 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.707 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -121.96 168.07 12.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.919 -1.113 . . . . 0.0 109.999 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.625 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 4.4 t -94.71 144.09 25.9 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.454 -0.779 . . . . 0.0 110.839 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.469 HG13 ' CD1' ' A' ' 28' ' ' TRP . 0.8 OUTLIER -148.96 167.46 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -49.56 134.37 19.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.453 -0.779 . . . . 0.0 110.337 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.17 163.53 20.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.353 -0.842 . . . . 0.0 110.599 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.42 134.88 25.88 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.602 -0.686 . . . . 0.0 110.049 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 C--N 1.313 -1.311 0 O-C-N 123.842 1.443 . . . . 0.0 110.661 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.426 ' HB2' ' C ' ' A' ' 16' ' ' CYS . 29.0 p -90.19 173.72 8.0 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.513 -0.993 . . . . 0.0 110.692 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -134.8 146.5 18.52 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.89 149.38 21.39 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.55 95.63 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.917 -0.755 . . . . 0.0 110.635 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 15.1 mmt 58.04 38.28 26.65 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.729 -0.607 . . . . 0.0 110.471 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.84 140.74 29.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.609 -0.682 . . . . 0.0 109.871 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.4 116.28 8.88 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.442 ' SG ' HG21 ' A' ' 14' ' ' THR . 1.1 t -106.12 -70.42 0.79 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.691 -0.888 . . . . 0.0 109.316 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.464 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 7.2 t70 49.19 73.18 0.25 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.322 0.582 . . . . 0.0 110.729 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.63 120.85 1.87 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -62.51 -14.3 40.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.653 -0.91 . . . . 0.0 110.676 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.9 t -97.46 22.68 8.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.41 -0.806 . . . . 0.0 110.37 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.442 HG21 ' SG ' ' A' ' 9' ' ' CYS . 4.7 t -71.93 -179.05 2.56 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.225 -0.922 . . . . 0.0 110.244 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.76 94.95 3.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.308 -0.87 . . . . 0.0 110.326 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 20' ' ' TYR . 91.5 m -78.09 -179.49 6.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.403 -0.81 . . . . 0.0 109.929 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.0 m -83.02 -100.36 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.115 -0.99 . . . . 0.0 110.508 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.09 117.56 11.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.063 -1.023 . . . . 0.0 110.083 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.44 32.7 12.95 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.486 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 63.3 m-85 -130.09 142.9 50.56 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.218 -1.166 . . . . 0.0 110.601 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -123.13 133.94 54.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.578 -0.701 . . . . 0.0 110.091 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 8.5 t -82.12 130.67 35.15 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.555 -0.715 . . . . 0.0 110.396 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.523 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -92.29 140.49 24.34 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.339 -0.85 . . . . 0.0 110.009 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.75 -31.02 8.88 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.862 1.454 . . . . 0.0 111.178 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 m -88.93 -38.21 14.68 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.353 -0.842 . . . . 0.0 110.613 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.7 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 36.2 m0 -82.66 -26.6 31.98 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.406 -0.809 . . . . 0.0 110.672 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' A' ' 10' ' ' ASP . 15.2 tptt 69.33 19.56 7.68 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.741 -0.599 . . . . 0.0 112.196 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.7 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.1 p90 -133.26 173.19 11.72 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.814 -1.179 . . . . 0.0 110.571 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.1 t -107.55 128.19 54.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.394 -0.816 . . . . 0.0 110.453 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.546 HG13 ' CD1' ' A' ' 28' ' ' TRP . 4.5 m -129.75 173.17 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.601 -0.687 . . . . 0.0 110.061 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -52.61 127.49 23.08 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.351 -0.843 . . . . 0.0 110.643 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.02 -179.82 6.55 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.582 -0.699 . . . . 0.0 110.253 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -134.77 140.7 36.07 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.267 -0.896 . . . . 0.0 110.452 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 C--N 1.315 -1.229 0 O-C-N 123.825 1.434 . . . . 0.0 110.796 179.891 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.63 107.37 7.93 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.513 -0.992 . . . . 0.0 110.403 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.01 137.95 14.47 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.475 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -147.83 130.99 3.68 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.464 HD21 ' CE2' ' A' ' 31' ' ' TYR . 0.5 OUTLIER 59.55 95.34 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.86 -0.788 . . . . 0.0 111.205 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.9 mtt 57.67 43.82 21.64 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.484 0.659 . . . . 0.0 110.376 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.949 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -89.21 127.58 35.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.547 -0.721 . . . . 0.0 109.876 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -49.95 118.09 5.41 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.618 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 3.0 t -105.82 -66.68 0.97 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.613 -0.933 . . . . 0.0 109.608 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 t0 53.25 66.52 1.21 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.831 -0.543 . . . . 0.0 111.092 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.15 127.48 0.89 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -14.35 62.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.572 -0.958 . . . . 0.0 110.886 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 t -117.3 22.18 12.64 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.296 -0.878 . . . . 0.0 110.374 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.618 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 4.8 m -86.59 132.15 33.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -104.54 154.34 20.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.55 -0.719 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.462 ' CB ' ' HB2' ' A' ' 20' ' ' TYR . 34.0 m -87.44 -154.75 0.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.492 -0.755 . . . . 0.0 109.983 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.2 t -89.01 -70.76 0.63 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.211 -0.931 . . . . 0.0 110.615 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.4 p -158.24 113.5 2.65 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.449 -0.782 . . . . 0.0 110.339 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.36 24.38 36.89 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 89.1 m-85 -137.58 159.06 43.02 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.394 -1.062 . . . . 0.0 110.015 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.418 ' O ' HG22 ' A' ' 30' ' ' VAL . 19.5 t-20 -137.62 136.6 37.67 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.36 -0.837 . . . . 0.0 110.577 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 9.1 t -65.15 147.33 53.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.488 -0.758 . . . . 0.0 110.154 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.412 ' HB3' ' HD1' ' A' ' 26' ' ' TRP . 3.3 m -111.31 131.41 22.27 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.45 -0.781 . . . . 0.0 109.902 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.88 -26.36 11.25 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.887 1.467 . . . . 0.0 111.002 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.3 m -91.07 -25.87 19.43 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.453 -0.78 . . . . 0.0 110.925 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.684 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 72.6 m95 -102.65 -14.91 16.52 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.295 -0.878 . . . . 0.0 110.741 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.72 13.68 9.3 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.674 -0.641 . . . . 0.0 112.642 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.684 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -138.14 175.2 9.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.696 -1.252 . . . . 0.0 110.696 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.949 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -88.54 135.52 33.45 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.347 -0.845 . . . . 0.0 110.702 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 21' ' ' ASN . 35.4 m -123.47 -175.59 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.9 -0.5 . . . . 0.0 109.708 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CE2' HD21 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -69.91 149.16 48.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.354 -0.841 . . . . 0.0 110.4 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.0 113.56 10.17 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.534 -0.729 . . . . 0.0 110.115 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.488 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -66.4 -54.96 21.47 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.502 -0.749 . . . . 0.0 110.634 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 33' ' ' ARG . 45.2 Cg_endo . . . . . 0 N--CA 1.487 1.094 0 O-C-N 123.607 1.319 . . . . 0.0 110.733 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.0 t -114.22 76.95 1.02 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.503 -0.998 . . . . 0.0 110.185 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.96 132.71 11.03 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.586 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -156.56 139.36 6.47 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 5' ' ' LEU . 3.3 mm? 58.1 89.12 0.05 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.85 -0.794 . . . . 0.0 111.193 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.3 mmt 55.62 42.14 29.82 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.438 0.637 . . . . 0.0 110.192 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.586 ' HB2' ' N ' ' A' ' 4' ' ' GLY . . . -83.16 129.95 35.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.529 -0.732 . . . . 0.0 110.188 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.92 106.73 1.17 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 5.0 m -95.51 -50.0 5.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.502 -0.999 . . . . 0.0 110.206 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 t0 62.97 52.48 2.6 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.405 0.622 . . . . 0.0 109.993 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.6 125.23 0.91 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -17.44 62.29 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.448 -1.03 . . . . 0.0 110.817 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.36 25.18 11.75 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 110.607 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.409 HG21 ' HA ' ' A' ' 9' ' ' CYS . 3.3 m -80.24 132.59 35.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.279 -0.888 . . . . 0.0 109.758 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -81.72 139.24 35.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.462 -0.774 . . . . 0.0 110.212 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.435 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 29.2 m -109.26 -166.81 1.14 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.461 -0.774 . . . . 0.0 110.306 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -74.27 0.22 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.156 -0.965 . . . . 0.0 111.169 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.53 125.87 4.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.138 -0.976 . . . . 0.0 110.639 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.36 24.26 75.55 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.641 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 38.7 m-85 -129.49 137.81 51.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.42 -1.047 . . . . 0.0 109.999 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -125.56 130.64 52.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.465 -0.772 . . . . 0.0 110.331 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.435 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 76.9 m -68.24 149.76 49.1 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.578 -0.701 . . . . 0.0 110.314 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 55.7 m -107.77 137.38 19.73 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.447 -0.783 . . . . 0.0 110.055 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -75.26 -33.47 4.31 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.812 1.428 . . . . 0.0 111.065 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.1 m -88.78 -40.41 13.21 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.504 -0.747 . . . . 0.0 110.306 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.725 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 24.6 m0 -84.67 -23.31 29.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.563 -0.711 . . . . 0.0 110.407 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 5.5 tttt 70.6 10.19 7.06 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.854 -0.529 . . . . 0.0 112.368 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.725 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -127.45 167.29 16.45 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.62 -1.3 . . . . 0.0 110.937 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.6 t -92.97 143.57 26.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.445 -0.785 . . . . 0.0 110.694 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.53 HG13 ' CD1' ' A' ' 28' ' ' TRP . 26.3 m -139.58 163.91 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.528 -0.732 . . . . 0.0 109.818 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.14 137.5 58.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.423 -0.798 . . . . 0.0 110.412 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.97 147.18 35.03 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.666 -0.646 . . . . 0.0 110.596 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -132.68 66.17 76.01 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.55 -0.719 . . . . 0.0 110.576 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 C--N 1.314 -1.269 0 O-C-N 123.634 1.334 . . . . 0.0 110.785 179.813 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.2 m -103.87 103.29 13.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.422 -1.046 . . . . 0.0 110.229 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.32 147.3 20.69 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 29' ' ' CYS . . . 167.22 -175.62 42.31 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 5' ' ' LEU . 1.7 mm? 52.51 72.55 0.4 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.737 -0.861 . . . . 0.0 110.647 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.456 ' HA ' ' CD1' ' A' ' 28' ' ' TRP . 6.2 ttm 60.87 42.0 13.71 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.609 -0.682 . . . . 0.0 110.533 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB3' ' CB ' ' A' ' 29' ' ' CYS . . . -82.85 100.51 10.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.446 -0.784 . . . . 0.0 109.793 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.73 109.05 1.6 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.9 p -114.71 -36.69 4.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.549 -0.971 . . . . 0.0 110.54 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.12 72.06 0.51 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.637 -0.664 . . . . 0.0 110.4 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.57 121.78 1.04 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -13.06 59.76 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.523 -0.986 . . . . 0.0 110.772 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.2 p -102.2 23.68 11.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 110.799 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.819 HG21 ' SG ' ' A' ' 22' ' ' CYS . 15.4 t -72.58 -169.79 0.59 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.144 -0.973 . . . . 0.0 109.991 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -133.64 107.41 7.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.166 -0.959 . . . . 0.0 110.53 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -98.62 -160.52 0.81 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.637 -0.664 . . . . 0.0 109.991 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -69.23 -77.12 0.08 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.078 -1.014 . . . . 0.0 110.569 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 p -164.7 -46.67 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.487 -0.758 . . . . 0.0 109.987 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.34 29.91 11.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 84.0 m-85 -129.2 125.94 38.09 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.912 . . . . 0.0 109.643 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -116.51 139.03 50.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -0.787 . . . . 0.0 110.319 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.819 ' SG ' HG21 ' A' ' 14' ' ' THR . 1.2 m -75.6 128.57 35.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.461 -0.774 . . . . 0.0 110.426 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.78 136.66 36.48 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.739 -0.601 . . . . 0.0 110.315 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.1 -27.74 11.55 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.923 1.486 . . . . 0.0 110.75 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.8 m -84.47 -29.56 25.95 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.433 -0.792 . . . . 0.0 110.627 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.673 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 78.3 m95 -100.53 -16.71 17.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.417 -0.802 . . . . 0.0 110.927 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.9 tptt 69.06 9.76 7.56 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.673 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -132.57 169.79 16.11 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.598 -1.314 . . . . 0.0 110.957 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.7 OUTLIER -89.32 140.62 29.31 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.632 0.729 . . . . 0.0 111.531 -178.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.508 HG13 ' CD1' ' A' ' 28' ' ' TRP . 3.1 m -140.31 178.24 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.92 149.74 11.15 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.256 -0.903 . . . . 0.0 110.518 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.21 166.89 21.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.527 -0.733 . . . . 0.0 110.667 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -108.36 144.05 28.69 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.755 . . . . 0.0 110.41 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 C--N 1.314 -1.242 0 O-C-N 123.859 1.452 . . . . 0.0 110.803 179.919 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.9 p -127.02 177.97 6.29 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.66 -0.906 . . . . 0.0 110.309 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . -141.63 138.92 9.01 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.51 121.62 1.42 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.607 HD13 ' HE1' ' A' ' 20' ' ' TYR . 5.7 tp 66.88 101.08 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.858 -0.789 . . . . 0.0 111.055 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.65 26.09 15.83 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.871 -0.518 . . . . 0.0 111.022 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.758 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -91.07 135.98 33.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.99 127.46 44.88 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.517 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 1.4 t -120.58 -71.16 0.75 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.719 -0.871 . . . . 0.0 109.635 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 55.44 77.63 0.22 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.716 -0.615 . . . . 0.0 110.813 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.53 121.01 0.56 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -19.15 64.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.605 -0.938 . . . . 0.0 110.444 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -110.79 21.31 16.65 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.383 -0.823 . . . . 0.0 110.515 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.517 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 8.9 m -83.52 135.18 34.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.319 -0.863 . . . . 0.0 110.068 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.55 141.07 37.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.657 -0.652 . . . . 0.0 110.098 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 20' ' ' TYR . 72.8 m -81.34 -165.12 0.87 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.459 -0.776 . . . . 0.0 110.081 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -74.97 0.32 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.212 -0.93 . . . . 0.0 110.89 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.6 m -152.28 116.95 5.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.292 -0.88 . . . . 0.0 110.356 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.47 31.43 45.89 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.607 ' HE1' HD13 ' A' ' 5' ' ' LEU . 58.8 m-85 -138.08 158.15 44.9 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.469 -1.018 . . . . 0.0 110.103 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.443 ' O ' HG22 ' A' ' 30' ' ' VAL . 23.9 t-20 -139.52 138.25 36.16 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.0 110.274 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.3 t -69.74 126.95 31.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.353 -0.842 . . . . 0.0 110.775 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.72 131.73 42.61 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.633 -0.667 . . . . 0.0 109.821 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.84 -26.29 13.54 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.836 1.44 . . . . 0.0 111.304 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.9 m -83.07 -38.11 22.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.329 -0.857 . . . . 0.0 110.771 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.654 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 80.8 m95 -98.14 -9.54 25.62 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.384 -0.823 . . . . 0.0 111.012 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 3.1 mmmm 59.31 34.2 22.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.557 -0.714 . . . . 0.0 111.752 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.654 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -143.43 174.5 10.7 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.955 -1.091 . . . . 0.0 110.685 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.758 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -89.57 133.84 34.41 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.98 -1.075 . . . . 0.0 109.854 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.499 HG13 ' CD1' ' A' ' 28' ' ' TRP . 17.5 m -132.14 173.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.465 -0.772 . . . . 0.0 110.505 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -62.02 127.28 30.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.445 -0.785 . . . . 0.0 110.227 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 143.69 54.29 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.536 -0.727 . . . . 0.0 110.461 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -65.06 153.22 89.54 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.48 -0.762 . . . . 0.0 110.419 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.312 -1.386 0 O-C-N 124.037 1.546 . . . . 0.0 110.694 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.433 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -97.62 106.89 19.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.491 -1.005 . . . . 0.0 110.193 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.02 112.74 4.52 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.72 143.94 11.82 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER 62.21 93.07 0.05 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.917 -0.755 . . . . 0.0 111.02 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.9 mtt 58.46 32.58 22.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.706 -0.621 . . . . 0.0 110.99 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.95 131.53 35.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.38 -0.825 . . . . 0.0 109.553 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -50.74 116.45 4.32 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.505 ' SG ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -100.43 -60.1 1.59 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.621 -0.929 . . . . 0.0 109.494 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 2.3 m-20 46.58 77.74 0.08 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.191 0.519 . . . . 0.0 111.446 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.38 128.32 2.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -16.4 59.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.602 -0.94 . . . . 0.0 110.776 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 p -121.45 38.24 4.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.497 -0.752 . . . . 0.0 109.621 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.505 HG21 ' SG ' ' A' ' 9' ' ' CYS . 11.4 t -63.33 157.37 23.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.544 -0.722 . . . . 0.0 110.741 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.23 94.47 5.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.419 -0.801 . . . . 0.0 110.05 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.5 m -78.51 -162.45 0.36 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.611 -0.68 . . . . 0.0 110.375 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -90.65 -84.64 0.24 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.216 -0.927 . . . . 0.0 110.25 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.5 p -155.93 111.5 3.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.46 40.88 6.69 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.488 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 58.9 m-85 -132.92 156.86 46.48 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.32 -1.106 . . . . 0.0 110.038 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.14 132.96 34.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 110.543 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.6 126.67 29.09 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.503 -0.748 . . . . 0.0 110.05 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.5 m -77.0 137.92 65.51 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.499 -0.751 . . . . 0.0 110.424 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.33 -23.72 17.37 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.933 1.491 . . . . 0.0 111.198 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.2 m -101.12 -39.67 7.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.293 -0.879 . . . . 0.0 110.694 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.693 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 81.8 m95 -87.98 -19.57 27.05 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.337 -0.852 . . . . 0.0 111.207 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 67.86 14.71 9.48 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.597 -0.689 . . . . 0.0 112.302 179.492 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.693 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -121.39 166.35 14.21 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.747 -1.22 . . . . 0.0 110.323 178.323 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -89.39 124.13 34.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.116 -0.99 . . . . 0.0 110.78 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.504 HG13 ' CD1' ' A' ' 28' ' ' TRP . 18.4 m -119.74 170.86 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.796 -0.565 . . . . 0.0 109.681 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -54.4 125.7 20.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.291 -0.88 . . . . 0.0 110.342 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.79 123.84 28.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.587 -0.696 . . . . 0.0 109.98 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.37 132.29 89.75 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.501 -0.749 . . . . 0.0 110.2 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 C--N 1.314 -1.276 0 O-C-N 123.875 1.46 . . . . 0.0 110.653 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.425 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p -119.05 179.06 4.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.984 . . . . 0.0 110.261 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -134.98 151.46 20.45 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.48 148.74 20.0 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.91 93.29 0.05 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.716 -0.873 . . . . 0.0 110.633 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 56.67 41.52 28.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.62 -0.675 . . . . 0.0 110.137 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -87.47 113.79 23.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.559 -0.713 . . . . 0.0 110.058 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.23 110.99 1.33 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.427 ' HA ' HG21 ' A' ' 14' ' ' THR . 55.5 m -95.55 -52.82 3.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.567 -0.96 . . . . 0.0 109.691 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.73 54.43 4.42 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.374 0.606 . . . . 0.0 110.483 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.34 127.21 0.87 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -15.75 62.07 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.644 -0.915 . . . . 0.0 110.898 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.55 30.34 6.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.237 -0.915 . . . . 0.0 110.254 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.427 HG21 ' HA ' ' A' ' 9' ' ' CYS . 24.4 m -90.67 143.11 27.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.75 173.96 6.08 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.43 -0.794 . . . . 0.0 110.131 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.3 m -133.52 -164.67 1.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.387 -0.821 . . . . 0.0 110.592 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.4 m -75.26 -87.49 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.274 -0.891 . . . . 0.0 110.47 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -149.3 118.66 6.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.351 -0.843 . . . . 0.0 110.269 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.12 26.25 45.22 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.581 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 57.3 m-85 -133.29 150.12 51.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.383 -1.069 . . . . 0.0 109.911 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.15 140.37 37.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.452 -0.78 . . . . 0.0 110.541 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 76.6 m -73.48 142.75 46.8 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.441 -0.787 . . . . 0.0 109.97 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m -103.62 143.37 26.51 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.588 -0.695 . . . . 0.0 110.369 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.42 -33.04 4.47 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.012 1.533 . . . . 0.0 111.172 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.0 m -84.46 -39.69 18.62 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.45 -0.781 . . . . 0.0 110.79 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.698 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 17.9 m0 -88.61 -22.54 23.43 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.526 -0.734 . . . . 0.0 110.877 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 71.63 2.0 4.1 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.71 -0.619 . . . . 0.0 111.925 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.698 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -120.57 170.38 9.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.747 -1.221 . . . . 0.0 110.509 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 6.3 t -89.08 143.12 27.07 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.533 -0.729 . . . . 0.0 111.102 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.458 HG13 ' CD1' ' A' ' 28' ' ' TRP . 19.1 m -137.08 178.3 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.861 -0.524 . . . . 0.0 109.591 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -61.5 119.03 7.8 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 109.863 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.19 145.87 49.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.571 -0.705 . . . . 0.0 110.702 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.2 65.92 65.32 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.674 -0.641 . . . . 0.0 110.108 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.314 -1.265 0 O-C-N 123.696 1.366 . . . . 0.0 110.663 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.8 p -141.18 176.73 8.6 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.544 -0.974 . . . . 0.0 110.377 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -128.86 139.44 10.98 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.61 152.1 24.11 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.87 93.29 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.664 -0.904 . . . . 0.0 110.623 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 mtp 57.09 41.34 27.51 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.66 -0.65 . . . . 0.0 109.775 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -88.04 122.99 32.28 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.579 -0.701 . . . . 0.0 110.376 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.29 108.81 1.95 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 p -114.73 -40.48 3.55 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.567 -0.961 . . . . 0.0 110.866 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t70 56.92 69.28 0.76 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.647 -0.658 . . . . 0.0 110.447 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.45 115.7 1.3 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.22 -20.18 39.64 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.371 -1.076 . . . . 0.0 110.56 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.8 t -78.43 -19.98 52.04 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.485 -0.76 . . . . 0.0 110.537 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.2 m -56.7 133.12 53.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.469 -0.769 . . . . 0.0 110.089 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -85.31 152.9 22.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 110.505 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -118.82 -161.11 0.83 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.58 -0.7 . . . . 0.0 110.334 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.0 m -71.94 -82.28 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.264 -0.897 . . . . 0.0 110.46 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.7 p -159.03 115.96 2.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.548 -0.72 . . . . 0.0 109.702 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.0 -4.54 78.25 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.41 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 78.5 m-85 -108.88 143.45 38.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.199 -1.177 . . . . 0.0 110.062 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -132.31 135.4 46.18 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.348 -0.845 . . . . 0.0 110.2 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 45.3 t -59.51 140.07 56.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.629 -0.669 . . . . 0.0 110.829 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.12 128.22 27.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.634 -0.666 . . . . 0.0 110.017 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.79 -20.83 19.5 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.908 1.478 . . . . 0.0 111.166 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.2 m -89.08 -34.83 16.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.234 -0.916 . . . . 0.0 110.751 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.7 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 86.3 m95 -102.04 -10.14 19.98 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.338 -0.851 . . . . 0.0 111.202 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 tptm 69.29 8.01 6.55 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.622 -0.674 . . . . 0.0 112.708 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.7 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -131.39 167.89 18.52 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.585 -1.322 . . . . 0.0 110.698 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 5.8 t -89.02 139.71 30.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.492 -0.755 . . . . 0.0 110.639 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.524 HG13 ' CD1' ' A' ' 28' ' ' TRP . 12.2 m -134.03 175.83 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.718 -0.614 . . . . 0.0 110.029 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.82 125.58 25.8 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.387 -0.82 . . . . 0.0 110.36 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.05 69.15 1.29 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.646 -0.659 . . . . 0.0 110.017 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.32 146.23 77.51 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.388 -0.82 . . . . 0.0 110.386 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 C--N 1.312 -1.36 0 O-C-N 123.974 1.513 . . . . 0.0 110.625 -179.916 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.548 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 17' ' ' CYS . 15.3 p -124.06 -176.0 3.38 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.515 -0.991 . . . . 0.0 110.542 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.584 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . -156.03 155.07 26.02 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.39 133.14 4.33 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.465 ' HA ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER 64.46 97.05 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.76 -0.847 . . . . 0.0 111.222 179.578 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 mpp? 54.02 34.71 20.37 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.656 -0.653 . . . . 0.0 110.291 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.584 ' HB1' ' HA3' ' A' ' 3' ' ' GLY . . . -90.22 127.51 36.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.525 -0.734 . . . . 0.0 110.5 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.11 112.18 3.98 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.602 ' HB2' HG21 ' A' ' 14' ' ' THR . 4.5 p -115.38 -45.34 2.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.519 -0.989 . . . . 0.0 110.328 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.438 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER 54.87 87.06 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.291 0.567 . . . . 0.0 110.427 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.15 115.34 0.77 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.452 ' HG2' ' HB3' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -62.37 -18.67 62.11 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.577 -0.955 . . . . 0.0 110.36 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.22 -17.87 26.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.365 -0.834 . . . . 0.0 110.537 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.602 HG21 ' HB2' ' A' ' 9' ' ' CYS . 27.7 m -58.76 120.93 9.87 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.263 -0.898 . . . . 0.0 109.978 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CG ' ' O ' ' A' ' 15' ' ' PHE . 39.8 t80 -94.61 20.58 8.34 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.527 -0.733 . . . . 0.0 110.852 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 20' ' ' TYR . 6.2 m 56.37 -149.51 0.46 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.027 -1.046 . . . . 0.0 110.045 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -93.04 -65.75 0.97 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.164 -0.96 . . . . 0.0 110.085 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 t -162.24 117.88 1.94 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.507 -0.746 . . . . 0.0 110.397 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.41 30.46 33.49 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.559 ' HB2' ' HB2' ' A' ' 16' ' ' CYS . 64.9 m-85 -136.92 168.27 19.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.419 -1.048 . . . . 0.0 110.137 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.88 124.05 16.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -0.78 . . . . 0.0 110.21 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.18 117.26 12.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.572 -0.705 . . . . 0.0 110.092 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 19.9 m -74.23 131.22 81.08 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.552 -0.718 . . . . 0.0 110.188 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.452 ' HB3' ' HG2' ' A' ' 12' ' ' LYS . 46.5 Cg_endo -73.28 -23.07 18.18 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.988 1.52 . . . . 0.0 111.093 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.3 m -96.24 -35.56 11.22 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.24 -0.913 . . . . 0.0 110.69 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.591 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 26.1 m0 -92.27 -19.08 22.55 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.348 -0.845 . . . . 0.0 110.876 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' CE ' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 70.76 7.21 6.14 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.591 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -118.68 163.44 16.83 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.755 -1.215 . . . . 0.0 110.665 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -96.42 124.0 40.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.599 -0.688 . . . . 0.0 110.895 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.587 HG13 ' CD1' ' A' ' 28' ' ' TRP . 2.1 m -121.29 170.39 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.588 -0.695 . . . . 0.0 110.14 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -52.67 146.41 10.29 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.432 -0.793 . . . . 0.0 110.627 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.23 98.49 8.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.359 -0.838 . . . . 0.0 110.233 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -150.28 90.37 4.37 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.444 -0.785 . . . . 0.0 110.225 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.313 -1.329 0 O-C-N 123.861 1.453 . . . . 0.0 110.734 179.853 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 9.0 t -119.48 103.62 9.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.611 -0.934 . . . . 0.0 110.12 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.59 123.11 4.4 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 29' ' ' CYS . . . -160.66 175.92 37.33 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.414 HD23 ' CE1' ' A' ' 20' ' ' TYR . 0.2 OUTLIER 58.28 87.2 0.07 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.719 -0.871 . . . . 0.0 110.873 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 46.5 mmm 54.91 37.08 28.12 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.643 -0.661 . . . . 0.0 110.233 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -88.31 97.01 10.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.5 -0.75 . . . . 0.0 110.114 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.12 104.64 0.55 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 1.035 ' HB2' HG21 ' A' ' 14' ' ' THR . 21.8 p -110.23 -32.57 6.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.604 -0.939 . . . . 0.0 110.805 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 t70 65.0 99.03 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.696 -0.628 . . . . 0.0 110.603 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.36 117.53 1.54 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -66.07 -14.04 61.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.597 -0.943 . . . . 0.0 110.581 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.3 p -107.12 11.35 29.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.833 . . . . 0.0 110.792 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.035 HG21 ' HB2' ' A' ' 9' ' ' CYS . 19.9 m -74.03 141.42 45.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.139 -0.975 . . . . 0.0 110.012 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.84 163.34 15.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.455 -0.778 . . . . 0.0 110.351 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.0 m -129.89 -160.51 1.04 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.539 -0.726 . . . . 0.0 109.863 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 3.7 t -66.03 -66.36 0.56 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 t -171.4 -46.61 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.45 -0.781 . . . . 0.0 110.43 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.13 29.66 11.27 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.496 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 66.9 m-85 -130.94 158.9 39.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.468 -1.019 . . . . 0.0 110.155 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.47 129.35 18.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.369 -0.832 . . . . 0.0 110.398 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 2.3 m -67.1 127.23 31.81 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.507 -0.745 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 7.9 t -83.87 141.54 41.13 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.473 -0.767 . . . . 0.0 110.193 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.78 -24.96 15.04 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.891 1.469 . . . . 0.0 111.299 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.3 m -99.36 -31.68 11.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.161 -0.962 . . . . 0.0 110.962 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.706 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 36.6 m0 -87.97 -21.72 24.71 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.33 -0.856 . . . . 0.0 110.982 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 73.26 -2.08 2.85 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.707 -0.621 . . . . 0.0 112.042 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.706 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.9 p90 -122.46 165.56 16.16 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.609 -1.307 . . . . 0.0 110.67 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 5.0 t -89.32 133.92 34.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.517 -0.739 . . . . 0.0 111.106 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 33.1 m -126.27 -170.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.38 134.17 56.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.208 -0.932 . . . . 0.0 110.073 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.87 129.65 42.88 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.508 -0.745 . . . . 0.0 110.497 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -126.36 113.07 23.42 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.569 -0.707 . . . . 0.0 110.195 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 C--N 1.314 -1.27 0 O-C-N 123.775 1.408 . . . . 0.0 110.67 179.855 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.2 p -126.18 177.05 6.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.49 -1.006 . . . . 0.0 110.549 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.476 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . -135.94 138.87 10.25 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.424 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -145.61 150.52 22.74 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER 58.34 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.697 -0.884 . . . . 0.0 110.789 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.2 mtm 59.42 37.8 23.02 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.658 -0.651 . . . . 0.0 110.405 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.476 ' HB1' ' HA3' ' A' ' 3' ' ' GLY . . . -90.19 112.34 23.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.452 -0.78 . . . . 0.0 110.01 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -50.62 107.71 0.41 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.979 ' HB2' HG21 ' A' ' 14' ' ' THR . 5.4 p -109.76 -42.17 4.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.691 -0.888 . . . . 0.0 110.334 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 55.0 72.42 0.47 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.78 -0.575 . . . . 0.0 111.032 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.32 126.6 2.7 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -11.38 57.11 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.587 -0.949 . . . . 0.0 110.435 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t -94.14 13.87 21.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.364 -0.835 . . . . 0.0 110.547 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.979 HG21 ' HB2' ' A' ' 9' ' ' CYS . 14.7 t -73.34 -173.75 1.45 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.184 -0.948 . . . . 0.0 110.166 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 96.78 4.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.018 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.2 m -77.64 -169.64 1.55 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.414 -0.804 . . . . 0.0 110.188 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -79.32 -94.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.248 -0.907 . . . . 0.0 110.255 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 p -144.3 113.13 6.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.062 -1.024 . . . . 0.0 110.574 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.38 37.5 9.7 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 69.5 m-85 -132.18 148.32 52.46 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.361 -1.082 . . . . 0.0 110.055 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -124.1 128.11 48.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.498 -0.751 . . . . 0.0 110.485 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 42.3 t -69.39 121.1 16.27 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.608 -0.682 . . . . 0.0 109.971 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 58.4 m -76.23 129.64 79.79 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.521 -0.737 . . . . 0.0 110.199 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.45 -24.27 19.38 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.875 1.461 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -98.8 -36.2 9.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.302 -0.874 . . . . 0.0 110.492 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.724 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 50.6 m0 -85.18 -19.05 32.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.455 -0.778 . . . . 0.0 110.955 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 70.81 9.01 6.74 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.672 -0.643 . . . . 0.0 112.273 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.724 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -130.5 161.05 32.32 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.798 -1.188 . . . . 0.0 110.506 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.9 t -89.46 133.6 34.48 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.497 -0.752 . . . . 0.0 111.08 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.524 HG13 ' CD1' ' A' ' 28' ' ' TRP . 18.2 m -126.03 -177.55 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.74 -0.6 . . . . 0.0 109.518 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.42 ' HD2' HD21 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -62.45 135.75 57.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.212 -0.93 . . . . 0.0 110.209 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.04 -179.05 3.51 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.489 -0.757 . . . . 0.0 110.632 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 58.47 86.51 0.16 Allowed Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.718 -0.614 . . . . 0.0 110.641 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--N 1.312 -1.379 0 O-C-N 123.909 1.479 . . . . 0.0 110.678 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.479 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.9 t -110.88 90.02 3.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.501 -1.0 . . . . 0.0 110.301 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.15 121.96 5.47 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.89 159.9 28.2 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' A' ' 5' ' ' LEU . 0.8 OUTLIER 55.36 85.67 0.06 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.749 -0.854 . . . . 0.0 111.104 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.3 mtp 58.55 37.37 25.47 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.682 -0.636 . . . . 0.0 110.661 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.99 125.72 33.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.43 108.05 0.81 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.945 ' HB2' HG21 ' A' ' 14' ' ' THR . 25.9 p -109.41 -41.35 4.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.551 -0.97 . . . . 0.0 110.583 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.1 t70 46.65 76.64 0.1 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.751 -0.593 . . . . 0.0 111.339 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.65 125.28 2.22 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -12.88 52.7 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.606 -0.938 . . . . 0.0 110.722 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.5 t -113.13 32.01 6.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.917 . . . . 0.0 110.244 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.945 HG21 ' HB2' ' A' ' 9' ' ' CYS . 15.0 t -72.58 -168.97 0.49 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.432 -0.793 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -127.04 92.38 3.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.489 -0.757 . . . . 0.0 110.429 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -82.17 -172.9 4.22 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.481 -0.762 . . . . 0.0 109.829 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 t -80.76 -75.49 0.27 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.07 -1.019 . . . . 0.0 110.751 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.0 p -162.78 125.23 2.71 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.281 -0.887 . . . . 0.0 110.141 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.28 28.34 64.19 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.497 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.3 m-85 -126.49 126.04 43.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.268 -1.136 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -105.47 132.3 51.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 110.187 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 4.8 t -85.24 130.12 34.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.567 -0.708 . . . . 0.0 110.162 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -92.39 136.58 25.35 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.525 -0.734 . . . . 0.0 109.968 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.32 -28.3 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.808 1.425 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 m -86.72 -34.68 19.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.383 -0.823 . . . . 0.0 110.213 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.671 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 46.9 m0 -88.22 -22.24 24.09 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.548 -0.72 . . . . 0.0 110.664 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 21.1 mmmt 66.96 15.36 10.13 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.85 -0.531 . . . . 0.0 112.032 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.671 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -131.66 166.97 20.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.804 -1.185 . . . . 0.0 110.803 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 3.8 t -104.9 133.08 50.31 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.431 -0.793 . . . . 0.0 110.639 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.546 HG13 ' CD1' ' A' ' 28' ' ' TRP . 4.3 m -136.02 171.96 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.627 -0.671 . . . . 0.0 109.967 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -49.86 142.62 8.67 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.36 -0.838 . . . . 0.0 110.728 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.05 177.84 4.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -129.09 68.87 80.54 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.474 -0.766 . . . . 0.0 110.19 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.315 -1.228 0 O-C-N 123.659 1.347 . . . . 0.0 110.534 -179.918 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.92 100.47 9.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.616 -0.932 . . . . 0.0 109.801 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.86 108.01 3.48 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.404 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -140.2 140.57 10.73 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 61.35 93.22 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.91 -0.759 . . . . 0.0 110.959 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.61 40.78 23.19 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.708 -0.62 . . . . 0.0 110.475 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.404 ' HB2' ' N ' ' A' ' 4' ' ' GLY . . . -88.1 130.6 34.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.425 -0.797 . . . . 0.0 109.916 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.3 110.84 1.72 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.697 ' SG ' HG21 ' A' ' 14' ' ' THR . 2.0 t -105.3 -72.3 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.655 -0.909 . . . . 0.0 109.553 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.4 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 6.0 t70 53.48 63.57 2.16 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.381 0.61 . . . . 0.0 110.822 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.48 126.2 0.93 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.56 -14.33 60.87 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.476 -1.014 . . . . 0.0 110.889 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.6 p -93.96 11.69 28.72 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.246 -0.909 . . . . 0.0 111.149 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.697 HG21 ' SG ' ' A' ' 9' ' ' CYS . 6.1 t -64.96 155.96 32.76 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.109 -0.994 . . . . 0.0 109.813 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -111.35 -18.92 12.79 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.311 -0.868 . . . . 0.0 111.257 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.6 m 55.62 -155.81 0.27 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.43 -0.794 . . . . 0.0 110.055 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.402 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 37.9 t -99.54 -104.47 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.131 -0.981 . . . . 0.0 109.412 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 t -131.7 106.0 7.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.989 -1.069 . . . . 0.0 109.753 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.37 53.53 2.61 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.477 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 75.0 m-85 -138.5 147.56 43.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.443 -1.033 . . . . 0.0 110.303 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -119.88 130.37 54.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.589 -0.694 . . . . 0.0 110.155 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.651 ' HB2' HG21 ' A' ' 14' ' ' THR . 37.9 t -74.94 138.29 42.23 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.544 -0.723 . . . . 0.0 110.158 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -100.9 133.33 21.14 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.729 . . . . 0.0 110.24 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.29 -42.14 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 124.007 1.53 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.7 m -80.89 -24.68 38.12 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.55 -0.719 . . . . 0.0 110.865 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.619 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 45.3 m95 -98.96 -19.33 17.36 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.338 -0.851 . . . . 0.0 110.881 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 69.22 8.46 6.82 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 178.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.619 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -131.45 163.37 28.09 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.627 -1.296 . . . . 0.0 111.099 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.7 t -91.41 138.01 31.91 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.49 -0.757 . . . . 0.0 110.575 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.53 173.84 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.515 -0.74 . . . . 0.0 109.698 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -58.04 133.01 55.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.326 -0.859 . . . . 0.0 110.169 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.47 131.41 48.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.574 -0.703 . . . . 0.0 110.501 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -120.77 118.8 30.43 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.527 -0.733 . . . . 0.0 110.304 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 C--N 1.315 -1.224 0 O-C-N 123.797 1.419 . . . . 0.0 111.307 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 28.2 p -127.06 177.84 6.38 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.569 -0.959 . . . . 0.0 110.679 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.29 147.09 16.43 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.44 159.35 30.06 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.84 90.55 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.696 -0.885 . . . . 0.0 110.622 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.13 34.31 23.24 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.657 -0.652 . . . . 0.0 110.405 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.5 133.93 34.87 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.466 -0.771 . . . . 0.0 109.795 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.31 114.45 5.86 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.472 ' SG ' HG21 ' A' ' 14' ' ' THR . 0.1 OUTLIER -97.01 -61.48 1.4 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.842 . . . . 0.0 109.677 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.432 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 1.1 t70 54.11 56.23 7.28 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.766 -0.584 . . . . 0.0 111.164 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.11 127.22 1.01 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -16.08 56.19 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.491 -1.005 . . . . 0.0 111.247 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.74 35.49 4.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.244 -0.91 . . . . 0.0 110.209 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.472 HG21 ' SG ' ' A' ' 9' ' ' CYS . 6.1 t -71.66 178.28 3.66 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.482 -0.761 . . . . 0.0 110.533 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -117.34 120.27 37.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.458 -0.776 . . . . 0.0 110.461 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m -115.16 -171.12 1.89 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.535 -0.728 . . . . 0.0 110.038 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.8 m -81.37 -102.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.264 -0.897 . . . . 0.0 109.94 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.75 121.18 10.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.168 -0.958 . . . . 0.0 109.776 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 24.63 32.78 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 62.6 m-85 -128.51 126.38 40.31 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.356 -1.085 . . . . 0.0 109.539 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.41 143.24 43.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.4 -0.812 . . . . 0.0 110.713 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 19.4 t -78.77 126.4 30.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.687 -0.633 . . . . 0.0 110.155 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.13 137.33 42.98 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.469 -0.769 . . . . 0.0 110.147 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.57 -32.06 5.05 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.898 1.473 . . . . 0.0 110.964 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.6 m -86.44 -28.89 23.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.506 -0.746 . . . . 0.0 110.979 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.658 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 52.2 m95 -101.53 -22.89 14.4 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.388 -0.82 . . . . 0.0 111.061 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HG3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 67.94 28.24 6.95 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.647 -0.658 . . . . 0.0 112.374 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.658 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -135.77 171.27 14.71 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.772 -1.205 . . . . 0.0 110.412 178.055 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -97.53 125.11 42.05 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.088 -1.008 . . . . 0.0 110.145 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.552 HG13 ' CD1' ' A' ' 28' ' ' TRP . 15.6 m -124.72 163.44 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.543 -0.723 . . . . 0.0 110.241 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.83 131.1 49.85 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.537 -0.727 . . . . 0.0 110.399 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.99 154.49 20.53 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.653 -0.654 . . . . 0.0 110.362 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -124.72 123.96 25.62 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.38 -0.825 . . . . 0.0 110.352 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--N 1.313 -1.3 0 O-C-N 123.923 1.486 . . . . 0.0 110.809 179.871 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.528 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -108.07 97.48 7.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.602 -0.94 . . . . 0.0 109.92 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.05 111.97 4.19 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.92 149.85 21.82 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.455 ' HA ' HD13 ' A' ' 5' ' ' LEU . 3.1 mm? 57.54 84.83 0.09 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.737 -0.861 . . . . 0.0 111.574 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 ttt 56.87 37.1 28.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.701 -0.624 . . . . 0.0 110.98 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.15 101.71 14.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.492 -0.755 . . . . 0.0 110.09 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 28' ' ' TRP . . . -54.63 110.3 1.58 Allowed Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.531 ' SG ' HG21 ' A' ' 14' ' ' THR . 23.4 p -105.89 -40.53 5.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.476 -1.014 . . . . 0.0 110.285 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.9 t70 54.64 95.54 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.326 0.584 . . . . 0.0 111.311 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.2 120.07 1.04 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -17.42 62.43 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.642 -0.917 . . . . 0.0 110.228 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 t -117.4 31.15 6.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.449 -0.782 . . . . 0.0 110.022 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.531 HG21 ' SG ' ' A' ' 9' ' ' CYS . 11.1 t -78.97 158.75 27.91 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.251 -0.906 . . . . 0.0 109.997 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.62 112.88 23.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.8 m -81.01 -165.78 0.99 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.442 -0.787 . . . . 0.0 110.109 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -79.58 -77.61 0.18 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.084 -1.01 . . . . 0.0 110.266 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.87 123.14 1.18 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.387 -0.82 . . . . 0.0 109.694 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.49 29.91 54.67 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.497 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.6 m-85 -126.77 150.59 49.03 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.366 -1.079 . . . . 0.0 110.212 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -126.05 130.51 51.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 110.315 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 1.3 m -86.97 129.55 34.83 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.386 -0.821 . . . . 0.0 110.119 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.96 144.58 30.29 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.515 -0.741 . . . . 0.0 110.239 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.62 -41.51 1.11 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.83 1.437 . . . . 0.0 111.121 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.4 m -76.94 -34.35 57.64 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.521 -0.737 . . . . 0.0 110.729 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.665 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 42.0 m0 -89.51 -28.58 19.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.405 -0.809 . . . . 0.0 110.683 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 1.3 tppt? 70.33 10.29 7.21 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.914 -0.491 . . . . 0.0 112.185 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.665 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -120.79 166.51 13.65 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.767 -1.208 . . . . 0.0 110.827 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 1.7 t -101.83 129.24 48.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.637 -0.664 . . . . 0.0 110.385 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 28' ' ' TRP . 4.4 m -124.18 175.36 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.56 -0.713 . . . . 0.0 109.961 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CD2' HD21 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -62.68 138.21 58.45 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.389 -0.819 . . . . 0.0 110.498 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.63 -168.01 0.78 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.548 -0.72 . . . . 0.0 110.169 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -117.63 67.87 5.67 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.459 -0.775 . . . . 0.0 110.474 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 N--CA 1.488 1.16 0 O-C-N 123.585 1.308 . . . . 0.0 110.841 179.799 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.4 p -106.68 176.28 5.22 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.559 -0.965 . . . . 0.0 110.33 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.39 137.09 9.19 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -152.64 150.34 22.13 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.5 87.76 0.09 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.722 -0.869 . . . . 0.0 110.906 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.8 mtt 56.77 37.22 28.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.752 -0.592 . . . . 0.0 110.479 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.406 ' HB2' ' N ' ' A' ' 4' ' ' GLY . . . -86.37 114.69 23.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.443 -0.785 . . . . 0.0 109.698 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.63 98.21 0.06 OUTLIER Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.924 ' HB2' HG21 ' A' ' 14' ' ' THR . 9.1 p -87.21 -38.42 16.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.573 -0.957 . . . . 0.0 110.097 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.482 ' HA ' ' HD2' ' A' ' 27' ' ' LYS . 22.5 m-20 51.12 82.78 0.06 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.267 0.556 . . . . 0.0 111.433 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 131.93 124.21 2.54 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -10.62 40.36 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.644 -0.915 . . . . 0.0 110.734 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 m -106.6 26.88 9.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.231 -0.918 . . . . 0.0 110.248 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.924 HG21 ' HB2' ' A' ' 9' ' ' CYS . 14.1 t -77.36 -179.7 5.89 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.291 -0.88 . . . . 0.0 110.716 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.24 105.52 7.71 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.514 -0.742 . . . . 0.0 110.009 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.9 m -82.47 -171.27 3.38 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 110.484 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.68 -76.06 0.32 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.217 -0.927 . . . . 0.0 110.683 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.3 p -163.8 131.97 3.62 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.345 -0.847 . . . . 0.0 110.237 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.32 24.23 77.17 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.568 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 30.0 m-85 -125.15 142.92 51.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.395 -1.062 . . . . 0.0 109.785 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.649 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -122.0 117.8 27.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.801 . . . . 0.0 110.316 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 2.2 t -75.12 108.13 7.66 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.525 -0.735 . . . . 0.0 109.718 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.653 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -72.98 136.17 79.89 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 0.0 109.955 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.51 -28.79 14.16 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.95 1.5 . . . . 0.0 110.672 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -87.18 -35.08 18.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.39 -0.819 . . . . 0.0 110.255 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.674 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 47.3 m0 -87.38 -15.76 36.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.51 -0.744 . . . . 0.0 110.934 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 32.3 mmtm 61.68 15.84 7.26 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.723 -0.611 . . . . 0.0 112.344 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.674 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -132.55 167.29 20.27 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.838 -1.164 . . . . 0.0 110.6 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 3.6 t -107.86 127.94 54.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.632 -0.667 . . . . 0.0 110.218 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.582 HG13 ' CD1' ' A' ' 28' ' ' TRP . 3.6 m -131.89 165.48 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.537 -0.727 . . . . 0.0 110.584 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -45.79 142.29 2.58 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.654 -0.654 . . . . 0.0 110.883 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . . . -126.02 144.02 50.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 0.0 110.579 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.93 131.19 27.12 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.555 -0.715 . . . . 0.0 110.056 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.314 -1.288 0 O-C-N 123.837 1.44 . . . . 0.0 110.645 -179.918 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.464 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.0 t -97.52 92.84 6.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.541 -0.976 . . . . 0.0 109.938 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -116.53 163.82 12.4 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.538 ' H ' ' HB2' ' A' ' 7' ' ' ALA . . . -179.32 140.77 4.5 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 61.17 93.93 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.851 -0.793 . . . . 0.0 111.061 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.2 mtp 55.91 42.61 28.61 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.679 -0.638 . . . . 0.0 109.979 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.783 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -86.18 115.7 23.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.608 -0.683 . . . . 0.0 110.049 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.9 110.16 2.24 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.537 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 7.4 p -113.67 -36.17 4.97 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.677 -0.896 . . . . 0.0 110.599 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.32 59.32 4.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.666 -0.647 . . . . 0.0 110.976 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.76 117.56 0.43 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -21.54 52.78 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.494 -1.003 . . . . 0.0 110.899 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -99.2 -12.41 20.46 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.434 -0.791 . . . . 0.0 110.806 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.537 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 54.1 m -56.67 132.97 53.46 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.348 -0.845 . . . . 0.0 110.506 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -94.26 175.41 6.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.576 -0.703 . . . . 0.0 110.347 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.9 m -124.68 -148.11 0.39 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.509 -0.744 . . . . 0.0 110.128 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 t -88.7 -71.51 0.59 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.084 -1.01 . . . . 0.0 110.782 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.9 p -161.45 119.83 2.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.411 -0.805 . . . . 0.0 110.342 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.43 26.03 48.76 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.69 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 74.9 m-85 -139.4 152.14 46.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.474 -1.015 . . . . 0.0 109.547 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.4 130.26 26.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.324 -0.86 . . . . 0.0 110.645 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 16.9 t -68.63 149.38 49.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.521 -0.737 . . . . 0.0 110.304 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.67 140.63 30.84 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.507 -0.746 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.29 -41.08 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.713 1.375 . . . . 0.0 111.185 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.0 m -72.63 -31.91 65.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.398 -0.814 . . . . 0.0 110.839 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.625 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 54.1 m95 -96.76 -20.43 18.23 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.399 -0.813 . . . . 0.0 110.475 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 5.5 tptt 70.37 8.81 6.77 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.673 -0.642 . . . . 0.0 112.25 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.625 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.7 p90 -136.77 169.0 18.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.723 -1.236 . . . . 0.0 110.757 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.783 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 11.4 t -89.17 145.6 25.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.557 -0.714 . . . . 0.0 110.922 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 27.8 m -132.69 -179.21 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -66.41 131.25 45.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.239 -0.913 . . . . 0.0 110.367 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.35 149.71 49.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.586 -0.696 . . . . 0.0 110.645 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -140.25 159.61 63.11 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.52 -0.737 . . . . 0.0 110.654 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 C--N 1.313 -1.307 0 O-C-N 123.937 1.493 . . . . 0.0 110.654 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.56 137.52 51.46 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.537 -0.978 . . . . 0.0 110.257 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.59 125.27 1.89 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.31 161.68 30.99 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 5' ' ' LEU . 1.7 mm? 55.4 84.28 0.08 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.74 -0.859 . . . . 0.0 111.109 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 56.25 40.48 29.94 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.62 -0.675 . . . . 0.0 110.46 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -89.49 107.4 19.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.511 -0.743 . . . . 0.0 110.455 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.45 108.79 1.97 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.871 ' SG ' HG21 ' A' ' 14' ' ' THR . 27.2 p -110.61 -32.3 6.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.583 -0.951 . . . . 0.0 110.92 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 t70 59.86 73.46 0.48 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.653 -0.654 . . . . 0.0 110.584 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 174.01 124.27 0.78 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.446 ' HG2' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -61.67 -19.01 61.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.727 -0.867 . . . . 0.0 111.007 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.446 ' N ' ' HG2' ' A' ' 12' ' ' LYS . 64.6 p -134.54 35.15 3.19 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.449 -0.782 . . . . 0.0 110.063 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.871 HG21 ' SG ' ' A' ' 9' ' ' CYS . 12.3 t -64.95 161.69 18.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.435 -0.791 . . . . 0.0 110.595 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -100.6 115.21 29.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.407 -0.808 . . . . 0.0 110.296 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.5 m -94.39 -163.99 1.12 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.627 -0.671 . . . . 0.0 109.911 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.74 -76.79 0.22 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.05 -1.031 . . . . 0.0 110.6 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 p -163.47 126.75 2.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.483 -0.76 . . . . 0.0 109.917 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.04 17.21 80.28 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.429 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 38.4 m-85 -124.67 126.82 46.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.183 -1.186 . . . . 0.0 109.977 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.71 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -113.73 135.84 53.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.665 -0.647 . . . . 0.0 109.787 179.609 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 14' ' ' THR . 0.8 OUTLIER -85.1 138.36 32.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.587 -0.696 . . . . 0.0 110.332 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 9.3 t -98.47 140.19 21.66 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.643 -0.661 . . . . 0.0 110.436 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.24 -28.78 15.0 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.818 1.43 . . . . 0.0 110.9 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -86.28 -27.81 24.16 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.366 -0.834 . . . . 0.0 110.756 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.621 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 21.2 m0 -99.01 -27.54 13.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.279 -0.888 . . . . 0.0 110.701 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.8 OUTLIER 75.01 -3.9 2.5 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.621 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -109.15 170.0 8.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.73 -1.231 . . . . 0.0 110.678 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 5.5 t -105.7 129.97 53.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.717 . . . . 0.0 110.032 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.548 HG13 ' CD1' ' A' ' 28' ' ' TRP . 3.3 m -135.73 174.33 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.682 -0.636 . . . . 0.0 109.929 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -54.71 128.53 33.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.452 -0.78 . . . . 0.0 110.724 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . . . -85.46 167.63 15.31 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.645 -0.659 . . . . 0.0 110.583 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -140.33 140.35 22.95 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.499 -0.75 . . . . 0.0 110.306 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 O-C-N 123.718 1.378 . . . . 0.0 110.811 -179.87 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 16' ' ' CYS . . . . . . . . 0 N--CA 1.493 2.492 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.1 158.74 27.78 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.8 83.82 0.1 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.78 -0.836 . . . . 0.0 111.094 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.1 mtp 56.29 34.89 24.88 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.663 -0.648 . . . . 0.0 110.68 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -83.02 145.17 29.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.433 -0.792 . . . . 0.0 109.905 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.3 121.0 24.11 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.648 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -110.61 -61.01 1.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.618 -0.931 . . . . 0.0 110.121 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 t70 59.41 77.85 0.29 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.406 0.622 . . . . 0.0 110.605 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.82 121.86 1.34 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -66.06 -13.45 60.02 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.491 -1.005 . . . . 0.0 110.925 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 p -110.84 2.94 18.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.29 -0.882 . . . . 0.0 111.13 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.648 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 1.9 m -66.83 138.2 57.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.116 -0.99 . . . . 0.0 110.172 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -100.09 138.86 36.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.51 -0.744 . . . . 0.0 110.269 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 3' ' ' GLY . 33.7 m -80.88 -157.23 0.15 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.684 -0.635 . . . . 0.0 109.833 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 t -78.93 -70.66 0.49 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.092 -1.005 . . . . 0.0 110.332 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.1 p -163.69 123.08 2.06 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.558 -0.714 . . . . 0.0 109.819 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.95 -3.97 86.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 49.0 m-85 -103.24 169.88 8.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -1.179 . . . . 0.0 110.115 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -148.23 129.68 14.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.959 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 14.6 t -73.03 132.67 43.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.49 -0.756 . . . . 0.0 110.614 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -95.67 128.8 36.52 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.573 -0.704 . . . . 0.0 109.461 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.27 -21.67 26.47 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.784 1.412 . . . . 0.0 111.003 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.6 m -87.7 -28.3 21.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.316 -0.865 . . . . 0.0 110.741 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.519 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 11.1 m0 -108.43 -12.74 14.98 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.437 -0.789 . . . . 0.0 111.243 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? 61.88 29.55 17.91 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.583 -0.698 . . . . 0.0 112.27 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.519 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -136.66 171.0 15.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.839 -1.163 . . . . 0.0 110.671 178.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -102.14 123.87 46.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.382 -0.824 . . . . 0.0 110.492 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.465 HG13 ' CD1' ' A' ' 28' ' ' TRP . 1.6 m -132.89 -179.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.547 -0.72 . . . . 0.0 109.85 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -55.17 143.53 27.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.356 -0.84 . . . . 0.0 110.334 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.38 -0.825 . . . . 0.0 110.419 -179.546 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.566 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.83 155.71 26.44 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 58.5 91.42 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.794 -0.827 . . . . 0.0 111.0 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.4 mtt 55.64 35.39 25.15 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.733 -0.605 . . . . 0.0 110.591 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -86.24 93.92 9.18 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.499 -0.751 . . . . 0.0 109.698 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.14 106.66 0.77 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.962 ' HB2' HG21 ' A' ' 14' ' ' THR . 30.7 p -114.21 -37.2 4.47 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.595 -0.944 . . . . 0.0 110.772 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 t70 63.11 96.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.421 0.629 . . . . 0.0 110.791 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.02 117.67 0.6 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -63.17 -17.5 62.45 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.622 -0.928 . . . . 0.0 110.759 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 t -119.93 27.96 8.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.368 -0.832 . . . . 0.0 110.372 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.962 HG21 ' HB2' ' A' ' 9' ' ' CYS . 17.0 m -83.31 132.53 35.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.298 -0.876 . . . . 0.0 109.875 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -86.26 160.47 19.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.478 -0.764 . . . . 0.0 110.442 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.1 m -124.84 -164.83 1.31 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.535 -0.728 . . . . 0.0 110.498 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.7 t -74.0 -86.99 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.306 -0.871 . . . . 0.0 110.698 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.5 m -151.05 122.39 7.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.141 -0.974 . . . . 0.0 109.988 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.77 24.78 66.34 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.625 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 42.1 m-85 -130.67 140.11 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.454 -1.027 . . . . 0.0 109.831 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.73 128.6 39.24 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.434 -0.791 . . . . 0.0 110.627 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.4 m -71.12 120.26 16.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.666 -0.646 . . . . 0.0 110.008 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 5.5 t -82.44 140.08 44.85 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.401 -0.812 . . . . 0.0 110.255 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.38 -29.21 11.47 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.962 1.506 . . . . 0.0 110.854 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.0 m -86.05 -32.51 21.38 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.741 . . . . 0.0 110.464 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.707 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 34.5 m0 -93.31 -23.96 18.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.405 -0.809 . . . . 0.0 110.703 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER 72.35 1.78 4.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.851 -0.531 . . . . 0.0 111.973 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.707 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -121.96 168.07 12.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.919 -1.113 . . . . 0.0 109.999 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.625 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 4.4 t -94.71 144.09 25.9 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.454 -0.779 . . . . 0.0 110.839 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.469 HG13 ' CD1' ' A' ' 28' ' ' TRP . 0.8 OUTLIER -148.96 167.46 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -49.56 134.37 19.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.453 -0.779 . . . . 0.0 110.337 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.864 0 O-C-N 121.353 -0.842 . . . . 0.0 110.599 -179.309 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.6 ' N ' ' HG ' ' A' ' 17' ' ' CYS . . . . . . . . 0 N--CA 1.494 2.533 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.89 149.38 21.39 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.55 95.63 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.917 -0.755 . . . . 0.0 110.635 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 15.1 mmt 58.04 38.28 26.65 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.729 -0.607 . . . . 0.0 110.471 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.84 140.74 29.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.609 -0.682 . . . . 0.0 109.871 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.4 116.28 8.88 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.442 ' SG ' HG21 ' A' ' 14' ' ' THR . 1.1 t -106.12 -70.42 0.79 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.691 -0.888 . . . . 0.0 109.316 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.464 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 7.2 t70 49.19 73.18 0.25 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.322 0.582 . . . . 0.0 110.729 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.63 120.85 1.87 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -62.51 -14.3 40.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.653 -0.91 . . . . 0.0 110.676 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.9 t -97.46 22.68 8.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.41 -0.806 . . . . 0.0 110.37 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.442 HG21 ' SG ' ' A' ' 9' ' ' CYS . 4.7 t -71.93 -179.05 2.56 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.225 -0.922 . . . . 0.0 110.244 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.76 94.95 3.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.308 -0.87 . . . . 0.0 110.326 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 20' ' ' TYR . 91.5 m -78.09 -179.49 6.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.403 -0.81 . . . . 0.0 109.929 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.6 ' HG ' ' N ' ' A' ' 3' ' ' GLY . 70.0 m -83.02 -100.36 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.115 -0.99 . . . . 0.0 110.508 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.09 117.56 11.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.063 -1.023 . . . . 0.0 110.083 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.44 32.7 12.95 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.486 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 63.3 m-85 -130.09 142.9 50.56 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.218 -1.166 . . . . 0.0 110.601 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -123.13 133.94 54.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.578 -0.701 . . . . 0.0 110.091 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 8.5 t -82.12 130.67 35.15 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.555 -0.715 . . . . 0.0 110.396 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.523 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -92.29 140.49 24.34 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.339 -0.85 . . . . 0.0 110.009 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.75 -31.02 8.88 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.862 1.454 . . . . 0.0 111.178 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 m -88.93 -38.21 14.68 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.353 -0.842 . . . . 0.0 110.613 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.7 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 36.2 m0 -82.66 -26.6 31.98 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.406 -0.809 . . . . 0.0 110.672 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' A' ' 10' ' ' ASP . 15.2 tptt 69.33 19.56 7.68 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.741 -0.599 . . . . 0.0 112.196 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.7 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.1 p90 -133.26 173.19 11.72 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.814 -1.179 . . . . 0.0 110.571 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.1 t -107.55 128.19 54.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.394 -0.816 . . . . 0.0 110.453 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.546 HG13 ' CD1' ' A' ' 28' ' ' TRP . 4.5 m -129.75 173.17 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.601 -0.687 . . . . 0.0 110.061 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -52.61 127.49 23.08 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.351 -0.843 . . . . 0.0 110.643 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.825 0 O-C-N 121.582 -0.699 . . . . 0.0 110.253 179.877 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.552 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.475 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -147.83 130.99 3.68 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.464 HD21 ' CE2' ' A' ' 31' ' ' TYR . 0.5 OUTLIER 59.55 95.34 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.86 -0.788 . . . . 0.0 111.205 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.9 mtt 57.67 43.82 21.64 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.484 0.659 . . . . 0.0 110.376 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.949 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -89.21 127.58 35.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.547 -0.721 . . . . 0.0 109.876 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -49.95 118.09 5.41 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.618 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 3.0 t -105.82 -66.68 0.97 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.613 -0.933 . . . . 0.0 109.608 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 t0 53.25 66.52 1.21 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.831 -0.543 . . . . 0.0 111.092 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.15 127.48 0.89 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -14.35 62.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.572 -0.958 . . . . 0.0 110.886 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 t -117.3 22.18 12.64 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.296 -0.878 . . . . 0.0 110.374 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.618 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 4.8 m -86.59 132.15 33.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -104.54 154.34 20.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.55 -0.719 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.462 ' CB ' ' HB2' ' A' ' 20' ' ' TYR . 34.0 m -87.44 -154.75 0.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.492 -0.755 . . . . 0.0 109.983 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.2 t -89.01 -70.76 0.63 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.211 -0.931 . . . . 0.0 110.615 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.4 p -158.24 113.5 2.65 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.449 -0.782 . . . . 0.0 110.339 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.36 24.38 36.89 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 89.1 m-85 -137.58 159.06 43.02 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.394 -1.062 . . . . 0.0 110.015 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.418 ' O ' HG22 ' A' ' 30' ' ' VAL . 19.5 t-20 -137.62 136.6 37.67 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.36 -0.837 . . . . 0.0 110.577 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 9.1 t -65.15 147.33 53.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.488 -0.758 . . . . 0.0 110.154 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.412 ' HB3' ' HD1' ' A' ' 26' ' ' TRP . 3.3 m -111.31 131.41 22.27 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.45 -0.781 . . . . 0.0 109.902 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.88 -26.36 11.25 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.887 1.467 . . . . 0.0 111.002 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.3 m -91.07 -25.87 19.43 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.453 -0.78 . . . . 0.0 110.925 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.684 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 72.6 m95 -102.65 -14.91 16.52 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.295 -0.878 . . . . 0.0 110.741 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.72 13.68 9.3 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.674 -0.641 . . . . 0.0 112.642 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.684 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -138.14 175.2 9.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.696 -1.252 . . . . 0.0 110.696 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.949 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -88.54 135.52 33.45 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.347 -0.845 . . . . 0.0 110.702 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 21' ' ' ASN . 35.4 m -123.47 -175.59 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.9 -0.5 . . . . 0.0 109.708 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CE2' HD21 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -69.91 149.16 48.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.354 -0.841 . . . . 0.0 110.4 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.534 -0.729 . . . . 0.0 110.115 179.832 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.586 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -156.56 139.36 6.47 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 5' ' ' LEU . 3.3 mm? 58.1 89.12 0.05 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.85 -0.794 . . . . 0.0 111.193 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.3 mmt 55.62 42.14 29.82 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.438 0.637 . . . . 0.0 110.192 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.586 ' HB2' ' N ' ' A' ' 4' ' ' GLY . . . -83.16 129.95 35.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.529 -0.732 . . . . 0.0 110.188 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.92 106.73 1.17 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 5.0 m -95.51 -50.0 5.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.502 -0.999 . . . . 0.0 110.206 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 t0 62.97 52.48 2.6 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.405 0.622 . . . . 0.0 109.993 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.6 125.23 0.91 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -17.44 62.29 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.448 -1.03 . . . . 0.0 110.817 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.36 25.18 11.75 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 110.607 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.409 HG21 ' HA ' ' A' ' 9' ' ' CYS . 3.3 m -80.24 132.59 35.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.279 -0.888 . . . . 0.0 109.758 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -81.72 139.24 35.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.462 -0.774 . . . . 0.0 110.212 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.435 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 29.2 m -109.26 -166.81 1.14 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.461 -0.774 . . . . 0.0 110.306 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -74.27 0.22 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.156 -0.965 . . . . 0.0 111.169 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.53 125.87 4.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.138 -0.976 . . . . 0.0 110.639 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.36 24.26 75.55 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.641 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 38.7 m-85 -129.49 137.81 51.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.42 -1.047 . . . . 0.0 109.999 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -125.56 130.64 52.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.465 -0.772 . . . . 0.0 110.331 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.435 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 76.9 m -68.24 149.76 49.1 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.578 -0.701 . . . . 0.0 110.314 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 55.7 m -107.77 137.38 19.73 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.447 -0.783 . . . . 0.0 110.055 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -75.26 -33.47 4.31 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.812 1.428 . . . . 0.0 111.065 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.1 m -88.78 -40.41 13.21 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.504 -0.747 . . . . 0.0 110.306 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.725 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 24.6 m0 -84.67 -23.31 29.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.563 -0.711 . . . . 0.0 110.407 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 5.5 tttt 70.6 10.19 7.06 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.854 -0.529 . . . . 0.0 112.368 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.725 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -127.45 167.29 16.45 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.62 -1.3 . . . . 0.0 110.937 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.6 t -92.97 143.57 26.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.445 -0.785 . . . . 0.0 110.694 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.53 HG13 ' CD1' ' A' ' 28' ' ' TRP . 26.3 m -139.58 163.91 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.528 -0.732 . . . . 0.0 109.818 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.14 137.5 58.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.423 -0.798 . . . . 0.0 110.412 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.89 0 O-C-N 121.666 -0.646 . . . . 0.0 110.596 -179.725 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.511 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 29' ' ' CYS . . . 167.22 -175.62 42.31 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 5' ' ' LEU . 1.7 mm? 52.51 72.55 0.4 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.737 -0.861 . . . . 0.0 110.647 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.456 ' HA ' ' CD1' ' A' ' 28' ' ' TRP . 6.2 ttm 60.87 42.0 13.71 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.609 -0.682 . . . . 0.0 110.533 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB3' ' CB ' ' A' ' 29' ' ' CYS . . . -82.85 100.51 10.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.446 -0.784 . . . . 0.0 109.793 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.73 109.05 1.6 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.9 p -114.71 -36.69 4.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.549 -0.971 . . . . 0.0 110.54 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.12 72.06 0.51 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.637 -0.664 . . . . 0.0 110.4 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.57 121.78 1.04 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -13.06 59.76 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.523 -0.986 . . . . 0.0 110.772 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.2 p -102.2 23.68 11.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 110.799 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.819 HG21 ' SG ' ' A' ' 22' ' ' CYS . 15.4 t -72.58 -169.79 0.59 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.144 -0.973 . . . . 0.0 109.991 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -133.64 107.41 7.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.166 -0.959 . . . . 0.0 110.53 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -98.62 -160.52 0.81 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.637 -0.664 . . . . 0.0 109.991 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -69.23 -77.12 0.08 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.078 -1.014 . . . . 0.0 110.569 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 p -164.7 -46.67 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.487 -0.758 . . . . 0.0 109.987 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.34 29.91 11.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 84.0 m-85 -129.2 125.94 38.09 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.912 . . . . 0.0 109.643 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -116.51 139.03 50.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -0.787 . . . . 0.0 110.319 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.819 ' SG ' HG21 ' A' ' 14' ' ' THR . 1.2 m -75.6 128.57 35.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.461 -0.774 . . . . 0.0 110.426 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.78 136.66 36.48 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.739 -0.601 . . . . 0.0 110.315 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.1 -27.74 11.55 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.923 1.486 . . . . 0.0 110.75 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.8 m -84.47 -29.56 25.95 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.433 -0.792 . . . . 0.0 110.627 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.673 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 78.3 m95 -100.53 -16.71 17.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.417 -0.802 . . . . 0.0 110.927 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.9 tptt 69.06 9.76 7.56 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.673 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -132.57 169.79 16.11 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.598 -1.314 . . . . 0.0 110.957 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.7 OUTLIER -89.32 140.62 29.31 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.632 0.729 . . . . 0.0 111.531 -178.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.508 HG13 ' CD1' ' A' ' 28' ' ' TRP . 3.1 m -140.31 178.24 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.92 149.74 11.15 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.256 -0.903 . . . . 0.0 110.518 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.907 0 O-C-N 121.527 -0.733 . . . . 0.0 110.667 -179.723 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.529 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.51 121.62 1.42 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.607 HD13 ' HE1' ' A' ' 20' ' ' TYR . 5.7 tp 66.88 101.08 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.858 -0.789 . . . . 0.0 111.055 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.65 26.09 15.83 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.871 -0.518 . . . . 0.0 111.022 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.758 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -91.07 135.98 33.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.99 127.46 44.88 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.517 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 1.4 t -120.58 -71.16 0.75 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.719 -0.871 . . . . 0.0 109.635 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 55.44 77.63 0.22 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.716 -0.615 . . . . 0.0 110.813 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.53 121.01 0.56 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -19.15 64.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.605 -0.938 . . . . 0.0 110.444 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -110.79 21.31 16.65 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.383 -0.823 . . . . 0.0 110.515 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.517 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 8.9 m -83.52 135.18 34.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.319 -0.863 . . . . 0.0 110.068 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.55 141.07 37.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.657 -0.652 . . . . 0.0 110.098 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 20' ' ' TYR . 72.8 m -81.34 -165.12 0.87 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.459 -0.776 . . . . 0.0 110.081 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -74.97 0.32 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.212 -0.93 . . . . 0.0 110.89 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.6 m -152.28 116.95 5.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.292 -0.88 . . . . 0.0 110.356 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.47 31.43 45.89 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.607 ' HE1' HD13 ' A' ' 5' ' ' LEU . 58.8 m-85 -138.08 158.15 44.9 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.469 -1.018 . . . . 0.0 110.103 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.443 ' O ' HG22 ' A' ' 30' ' ' VAL . 23.9 t-20 -139.52 138.25 36.16 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.0 110.274 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.3 t -69.74 126.95 31.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.353 -0.842 . . . . 0.0 110.775 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.72 131.73 42.61 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.633 -0.667 . . . . 0.0 109.821 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.84 -26.29 13.54 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.836 1.44 . . . . 0.0 111.304 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.9 m -83.07 -38.11 22.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.329 -0.857 . . . . 0.0 110.771 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.654 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 80.8 m95 -98.14 -9.54 25.62 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.384 -0.823 . . . . 0.0 111.012 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 3.1 mmmm 59.31 34.2 22.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.557 -0.714 . . . . 0.0 111.752 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.654 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -143.43 174.5 10.7 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.955 -1.091 . . . . 0.0 110.685 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.758 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -89.57 133.84 34.41 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.98 -1.075 . . . . 0.0 109.854 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.499 HG13 ' CD1' ' A' ' 28' ' ' TRP . 17.5 m -132.14 173.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.465 -0.772 . . . . 0.0 110.505 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -62.02 127.28 30.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.445 -0.785 . . . . 0.0 110.227 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.875 0 O-C-N 121.536 -0.727 . . . . 0.0 110.461 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.505 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.72 143.94 11.82 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER 62.21 93.07 0.05 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.917 -0.755 . . . . 0.0 111.02 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.9 mtt 58.46 32.58 22.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.706 -0.621 . . . . 0.0 110.99 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.95 131.53 35.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.38 -0.825 . . . . 0.0 109.553 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -50.74 116.45 4.32 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.505 ' SG ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -100.43 -60.1 1.59 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.621 -0.929 . . . . 0.0 109.494 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 2.3 m-20 46.58 77.74 0.08 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.191 0.519 . . . . 0.0 111.446 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.38 128.32 2.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -16.4 59.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.602 -0.94 . . . . 0.0 110.776 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 p -121.45 38.24 4.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.497 -0.752 . . . . 0.0 109.621 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.505 HG21 ' SG ' ' A' ' 9' ' ' CYS . 11.4 t -63.33 157.37 23.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.544 -0.722 . . . . 0.0 110.741 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.23 94.47 5.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.419 -0.801 . . . . 0.0 110.05 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.5 m -78.51 -162.45 0.36 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.611 -0.68 . . . . 0.0 110.375 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -90.65 -84.64 0.24 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.216 -0.927 . . . . 0.0 110.25 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.5 p -155.93 111.5 3.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.46 40.88 6.69 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.488 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 58.9 m-85 -132.92 156.86 46.48 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.32 -1.106 . . . . 0.0 110.038 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.14 132.96 34.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 110.543 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.6 126.67 29.09 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.503 -0.748 . . . . 0.0 110.05 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.5 m -77.0 137.92 65.51 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.499 -0.751 . . . . 0.0 110.424 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.33 -23.72 17.37 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.933 1.491 . . . . 0.0 111.198 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.2 m -101.12 -39.67 7.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.293 -0.879 . . . . 0.0 110.694 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.693 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 81.8 m95 -87.98 -19.57 27.05 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.337 -0.852 . . . . 0.0 111.207 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 67.86 14.71 9.48 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.597 -0.689 . . . . 0.0 112.302 179.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.693 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -121.39 166.35 14.21 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.747 -1.22 . . . . 0.0 110.323 178.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -89.39 124.13 34.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.116 -0.99 . . . . 0.0 110.78 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.504 HG13 ' CD1' ' A' ' 28' ' ' TRP . 18.4 m -119.74 170.86 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.796 -0.565 . . . . 0.0 109.681 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -54.4 125.7 20.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.291 -0.88 . . . . 0.0 110.342 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.587 -0.696 . . . . 0.0 109.98 179.795 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.55 ' N ' ' HG ' ' A' ' 17' ' ' CYS . . . . . . . . 0 N--CA 1.494 2.558 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.48 148.74 20.0 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.91 93.29 0.05 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.716 -0.873 . . . . 0.0 110.633 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 56.67 41.52 28.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.62 -0.675 . . . . 0.0 110.137 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -87.47 113.79 23.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.559 -0.713 . . . . 0.0 110.058 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.23 110.99 1.33 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.427 ' HA ' HG21 ' A' ' 14' ' ' THR . 55.5 m -95.55 -52.82 3.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.567 -0.96 . . . . 0.0 109.691 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.73 54.43 4.42 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.374 0.606 . . . . 0.0 110.483 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.34 127.21 0.87 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -15.75 62.07 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.644 -0.915 . . . . 0.0 110.898 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.55 30.34 6.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.237 -0.915 . . . . 0.0 110.254 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.427 HG21 ' HA ' ' A' ' 9' ' ' CYS . 24.4 m -90.67 143.11 27.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.75 173.96 6.08 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.43 -0.794 . . . . 0.0 110.131 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.3 m -133.52 -164.67 1.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.387 -0.821 . . . . 0.0 110.592 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.55 ' HG ' ' N ' ' A' ' 3' ' ' GLY . 90.4 m -75.26 -87.49 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.274 -0.891 . . . . 0.0 110.47 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -149.3 118.66 6.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.351 -0.843 . . . . 0.0 110.269 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.12 26.25 45.22 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.581 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 57.3 m-85 -133.29 150.12 51.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.383 -1.069 . . . . 0.0 109.911 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.15 140.37 37.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.452 -0.78 . . . . 0.0 110.541 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 76.6 m -73.48 142.75 46.8 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.441 -0.787 . . . . 0.0 109.97 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m -103.62 143.37 26.51 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.588 -0.695 . . . . 0.0 110.369 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.42 -33.04 4.47 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.012 1.533 . . . . 0.0 111.172 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.0 m -84.46 -39.69 18.62 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.45 -0.781 . . . . 0.0 110.79 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.698 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 17.9 m0 -88.61 -22.54 23.43 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.526 -0.734 . . . . 0.0 110.877 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 71.63 2.0 4.1 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.71 -0.619 . . . . 0.0 111.925 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.698 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -120.57 170.38 9.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.747 -1.221 . . . . 0.0 110.509 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 6.3 t -89.08 143.12 27.07 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.533 -0.729 . . . . 0.0 111.102 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.458 HG13 ' CD1' ' A' ' 28' ' ' TRP . 19.1 m -137.08 178.3 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.861 -0.524 . . . . 0.0 109.591 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -61.5 119.03 7.8 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 109.863 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.571 -0.705 . . . . 0.0 110.702 -179.477 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.483 ' N ' ' HG ' ' A' ' 17' ' ' CYS . . . . . . . . 0 N--CA 1.495 2.584 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.61 152.1 24.11 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.87 93.29 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.664 -0.904 . . . . 0.0 110.623 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 mtp 57.09 41.34 27.51 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.66 -0.65 . . . . 0.0 109.775 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -88.04 122.99 32.28 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.579 -0.701 . . . . 0.0 110.376 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.29 108.81 1.95 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 p -114.73 -40.48 3.55 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.567 -0.961 . . . . 0.0 110.866 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t70 56.92 69.28 0.76 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.647 -0.658 . . . . 0.0 110.447 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.45 115.7 1.3 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.22 -20.18 39.64 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.371 -1.076 . . . . 0.0 110.56 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.8 t -78.43 -19.98 52.04 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.485 -0.76 . . . . 0.0 110.537 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.2 m -56.7 133.12 53.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.469 -0.769 . . . . 0.0 110.089 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -85.31 152.9 22.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 110.505 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -118.82 -161.11 0.83 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.58 -0.7 . . . . 0.0 110.334 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.483 ' HG ' ' N ' ' A' ' 3' ' ' GLY . 82.0 m -71.94 -82.28 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.264 -0.897 . . . . 0.0 110.46 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.7 p -159.03 115.96 2.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.548 -0.72 . . . . 0.0 109.702 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.0 -4.54 78.25 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.41 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 78.5 m-85 -108.88 143.45 38.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.199 -1.177 . . . . 0.0 110.062 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -132.31 135.4 46.18 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.348 -0.845 . . . . 0.0 110.2 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 45.3 t -59.51 140.07 56.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.629 -0.669 . . . . 0.0 110.829 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.12 128.22 27.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.634 -0.666 . . . . 0.0 110.017 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.79 -20.83 19.5 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.908 1.478 . . . . 0.0 111.166 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.2 m -89.08 -34.83 16.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.234 -0.916 . . . . 0.0 110.751 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.7 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 86.3 m95 -102.04 -10.14 19.98 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.338 -0.851 . . . . 0.0 111.202 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 tptm 69.29 8.01 6.55 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.622 -0.674 . . . . 0.0 112.708 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.7 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -131.39 167.89 18.52 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.585 -1.322 . . . . 0.0 110.698 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 5.8 t -89.02 139.71 30.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.492 -0.755 . . . . 0.0 110.639 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.524 HG13 ' CD1' ' A' ' 28' ' ' TRP . 12.2 m -134.03 175.83 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.718 -0.614 . . . . 0.0 110.029 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.82 125.58 25.8 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.387 -0.82 . . . . 0.0 110.36 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.646 -0.659 . . . . 0.0 110.017 179.939 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.584 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.509 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.39 133.14 4.33 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER 64.46 97.05 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.76 -0.847 . . . . 0.0 111.222 179.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 mpp? 54.02 34.71 20.37 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.656 -0.653 . . . . 0.0 110.291 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.584 ' HB1' ' HA3' ' A' ' 3' ' ' GLY . . . -90.22 127.51 36.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.525 -0.734 . . . . 0.0 110.5 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.11 112.18 3.98 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.602 ' HB2' HG21 ' A' ' 14' ' ' THR . 4.5 p -115.38 -45.34 2.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.519 -0.989 . . . . 0.0 110.328 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.438 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER 54.87 87.06 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.291 0.567 . . . . 0.0 110.427 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.15 115.34 0.77 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.452 ' HG2' ' HB3' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -62.37 -18.67 62.11 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.577 -0.955 . . . . 0.0 110.36 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.22 -17.87 26.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.365 -0.834 . . . . 0.0 110.537 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.602 HG21 ' HB2' ' A' ' 9' ' ' CYS . 27.7 m -58.76 120.93 9.87 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.263 -0.898 . . . . 0.0 109.978 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.413 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 39.8 t80 -94.61 20.58 8.34 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.527 -0.733 . . . . 0.0 110.852 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 20' ' ' TYR . 6.2 m 56.37 -149.51 0.46 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.027 -1.046 . . . . 0.0 110.045 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.04 -65.75 0.97 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.164 -0.96 . . . . 0.0 110.085 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 t -162.24 117.88 1.94 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.507 -0.746 . . . . 0.0 110.397 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.41 30.46 33.49 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.559 ' HB2' ' HB2' ' A' ' 16' ' ' CYS . 64.9 m-85 -136.92 168.27 19.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.419 -1.048 . . . . 0.0 110.137 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.88 124.05 16.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -0.78 . . . . 0.0 110.21 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.18 117.26 12.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.572 -0.705 . . . . 0.0 110.092 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 19.9 m -74.23 131.22 81.08 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.552 -0.718 . . . . 0.0 110.188 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.452 ' HB3' ' HG2' ' A' ' 12' ' ' LYS . 46.5 Cg_endo -73.28 -23.07 18.18 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.988 1.52 . . . . 0.0 111.093 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.3 m -96.24 -35.56 11.22 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.24 -0.913 . . . . 0.0 110.69 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.591 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 26.1 m0 -92.27 -19.08 22.55 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.348 -0.845 . . . . 0.0 110.876 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' CE ' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 70.76 7.21 6.14 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.591 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -118.68 163.44 16.83 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.755 -1.215 . . . . 0.0 110.665 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -96.42 124.0 40.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.599 -0.688 . . . . 0.0 110.895 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.587 HG13 ' CD1' ' A' ' 28' ' ' TRP . 2.1 m -121.29 170.39 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.588 -0.695 . . . . 0.0 110.14 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -52.67 146.41 10.29 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.432 -0.793 . . . . 0.0 110.627 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.359 -0.838 . . . . 0.0 110.233 -179.725 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.432 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 29' ' ' CYS . . . -160.66 175.92 37.33 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.414 HD23 ' CE1' ' A' ' 20' ' ' TYR . 0.2 OUTLIER 58.28 87.2 0.07 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.719 -0.871 . . . . 0.0 110.873 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 46.5 mmm 54.91 37.08 28.12 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.643 -0.661 . . . . 0.0 110.233 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -88.31 97.01 10.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.5 -0.75 . . . . 0.0 110.114 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.12 104.64 0.55 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 1.035 ' HB2' HG21 ' A' ' 14' ' ' THR . 21.8 p -110.23 -32.57 6.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.604 -0.939 . . . . 0.0 110.805 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 t70 65.0 99.03 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.696 -0.628 . . . . 0.0 110.603 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.36 117.53 1.54 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -66.07 -14.04 61.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.597 -0.943 . . . . 0.0 110.581 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.3 p -107.12 11.35 29.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.833 . . . . 0.0 110.792 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.035 HG21 ' HB2' ' A' ' 9' ' ' CYS . 19.9 m -74.03 141.42 45.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.139 -0.975 . . . . 0.0 110.012 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.84 163.34 15.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.455 -0.778 . . . . 0.0 110.351 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.0 m -129.89 -160.51 1.04 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.539 -0.726 . . . . 0.0 109.863 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.7 t -66.03 -66.36 0.56 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 t -171.4 -46.61 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.45 -0.781 . . . . 0.0 110.43 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.13 29.66 11.27 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.496 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 66.9 m-85 -130.94 158.9 39.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.468 -1.019 . . . . 0.0 110.155 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.47 129.35 18.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.369 -0.832 . . . . 0.0 110.398 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 2.3 m -67.1 127.23 31.81 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.507 -0.745 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 7.9 t -83.87 141.54 41.13 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.473 -0.767 . . . . 0.0 110.193 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.78 -24.96 15.04 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.891 1.469 . . . . 0.0 111.299 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.3 m -99.36 -31.68 11.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.161 -0.962 . . . . 0.0 110.962 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.706 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 36.6 m0 -87.97 -21.72 24.71 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.33 -0.856 . . . . 0.0 110.982 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 73.26 -2.08 2.85 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.707 -0.621 . . . . 0.0 112.042 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.706 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.9 p90 -122.46 165.56 16.16 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.609 -1.307 . . . . 0.0 110.67 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 5.0 t -89.32 133.92 34.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.517 -0.739 . . . . 0.0 111.106 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 33.1 m -126.27 -170.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.38 134.17 56.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.208 -0.932 . . . . 0.0 110.073 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.9 0 O-C-N 121.508 -0.745 . . . . 0.0 110.497 -179.733 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.636 ' N ' ' HG ' ' A' ' 17' ' ' CYS . . . . . . . . 0 N--CA 1.493 2.482 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.424 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -145.61 150.52 22.74 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER 58.34 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.697 -0.884 . . . . 0.0 110.789 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.2 mtm 59.42 37.8 23.02 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.658 -0.651 . . . . 0.0 110.405 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.476 ' HB1' ' HA3' ' A' ' 3' ' ' GLY . . . -90.19 112.34 23.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.452 -0.78 . . . . 0.0 110.01 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -50.62 107.71 0.41 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.979 ' HB2' HG21 ' A' ' 14' ' ' THR . 5.4 p -109.76 -42.17 4.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.691 -0.888 . . . . 0.0 110.334 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 55.0 72.42 0.47 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.78 -0.575 . . . . 0.0 111.032 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.32 126.6 2.7 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -11.38 57.11 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.587 -0.949 . . . . 0.0 110.435 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t -94.14 13.87 21.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.364 -0.835 . . . . 0.0 110.547 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.979 HG21 ' HB2' ' A' ' 9' ' ' CYS . 14.7 t -73.34 -173.75 1.45 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.184 -0.948 . . . . 0.0 110.166 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 96.78 4.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.018 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.2 m -77.64 -169.64 1.55 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.414 -0.804 . . . . 0.0 110.188 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.636 ' HG ' ' N ' ' A' ' 3' ' ' GLY . 88.9 m -79.32 -94.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.248 -0.907 . . . . 0.0 110.255 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 p -144.3 113.13 6.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.062 -1.024 . . . . 0.0 110.574 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.38 37.5 9.7 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 69.5 m-85 -132.18 148.32 52.46 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.361 -1.082 . . . . 0.0 110.055 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -124.1 128.11 48.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.498 -0.751 . . . . 0.0 110.485 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 42.3 t -69.39 121.1 16.27 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.608 -0.682 . . . . 0.0 109.971 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 58.4 m -76.23 129.64 79.79 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.521 -0.737 . . . . 0.0 110.199 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.45 -24.27 19.38 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.875 1.461 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -98.8 -36.2 9.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.302 -0.874 . . . . 0.0 110.492 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.724 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 50.6 m0 -85.18 -19.05 32.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.455 -0.778 . . . . 0.0 110.955 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 70.81 9.01 6.74 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.672 -0.643 . . . . 0.0 112.273 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.724 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -130.5 161.05 32.32 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.798 -1.188 . . . . 0.0 110.506 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.9 t -89.46 133.6 34.48 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.497 -0.752 . . . . 0.0 111.08 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.524 HG13 ' CD1' ' A' ' 28' ' ' TRP . 18.2 m -126.03 -177.55 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.74 -0.6 . . . . 0.0 109.518 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.42 ' HD2' HD21 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -62.45 135.75 57.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.212 -0.93 . . . . 0.0 110.209 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.489 -0.757 . . . . 0.0 110.632 -179.753 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.584 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.89 159.9 28.2 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER 55.36 85.67 0.06 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.749 -0.854 . . . . 0.0 111.104 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.3 mtp 58.55 37.37 25.47 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.682 -0.636 . . . . 0.0 110.661 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.99 125.72 33.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.43 108.05 0.81 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.945 ' HB2' HG21 ' A' ' 14' ' ' THR . 25.9 p -109.41 -41.35 4.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.551 -0.97 . . . . 0.0 110.583 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.1 t70 46.65 76.64 0.1 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.751 -0.593 . . . . 0.0 111.339 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.65 125.28 2.22 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -12.88 52.7 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.606 -0.938 . . . . 0.0 110.722 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.5 t -113.13 32.01 6.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.917 . . . . 0.0 110.244 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.945 HG21 ' HB2' ' A' ' 9' ' ' CYS . 15.0 t -72.58 -168.97 0.49 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.432 -0.793 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -127.04 92.38 3.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.489 -0.757 . . . . 0.0 110.429 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -82.17 -172.9 4.22 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.481 -0.762 . . . . 0.0 109.829 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 t -80.76 -75.49 0.27 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.07 -1.019 . . . . 0.0 110.751 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.0 p -162.78 125.23 2.71 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.281 -0.887 . . . . 0.0 110.141 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.28 28.34 64.19 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.497 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.3 m-85 -126.49 126.04 43.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.268 -1.136 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -105.47 132.3 51.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 110.187 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 4.8 t -85.24 130.12 34.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.567 -0.708 . . . . 0.0 110.162 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -92.39 136.58 25.35 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.525 -0.734 . . . . 0.0 109.968 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.32 -28.3 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.808 1.425 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 m -86.72 -34.68 19.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.383 -0.823 . . . . 0.0 110.213 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.671 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 46.9 m0 -88.22 -22.24 24.09 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.548 -0.72 . . . . 0.0 110.664 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 21.1 mmmt 66.96 15.36 10.13 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.85 -0.531 . . . . 0.0 112.032 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.671 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -131.66 166.97 20.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.804 -1.185 . . . . 0.0 110.803 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 3.8 t -104.9 133.08 50.31 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.431 -0.793 . . . . 0.0 110.639 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.546 HG13 ' CD1' ' A' ' 28' ' ' TRP . 4.3 m -136.02 171.96 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.627 -0.671 . . . . 0.0 109.967 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -49.86 142.62 8.67 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.36 -0.838 . . . . 0.0 110.728 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 -179.4 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.512 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.404 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -140.2 140.57 10.73 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 61.35 93.22 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.91 -0.759 . . . . 0.0 110.959 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.61 40.78 23.19 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.708 -0.62 . . . . 0.0 110.475 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.404 ' HB2' ' N ' ' A' ' 4' ' ' GLY . . . -88.1 130.6 34.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.425 -0.797 . . . . 0.0 109.916 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.3 110.84 1.72 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.697 ' SG ' HG21 ' A' ' 14' ' ' THR . 2.0 t -105.3 -72.3 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.655 -0.909 . . . . 0.0 109.553 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.4 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 6.0 t70 53.48 63.57 2.16 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.381 0.61 . . . . 0.0 110.822 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.48 126.2 0.93 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.56 -14.33 60.87 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.476 -1.014 . . . . 0.0 110.889 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.6 p -93.96 11.69 28.72 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.246 -0.909 . . . . 0.0 111.149 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.697 HG21 ' SG ' ' A' ' 9' ' ' CYS . 6.1 t -64.96 155.96 32.76 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.109 -0.994 . . . . 0.0 109.813 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -111.35 -18.92 12.79 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.311 -0.868 . . . . 0.0 111.257 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.6 m 55.62 -155.81 0.27 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.43 -0.794 . . . . 0.0 110.055 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.402 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 37.9 t -99.54 -104.47 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.131 -0.981 . . . . 0.0 109.412 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 t -131.7 106.0 7.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.989 -1.069 . . . . 0.0 109.753 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.37 53.53 2.61 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.477 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 75.0 m-85 -138.5 147.56 43.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.443 -1.033 . . . . 0.0 110.303 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -119.88 130.37 54.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.589 -0.694 . . . . 0.0 110.155 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.651 ' HB2' HG21 ' A' ' 14' ' ' THR . 37.9 t -74.94 138.29 42.23 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.544 -0.723 . . . . 0.0 110.158 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -100.9 133.33 21.14 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.729 . . . . 0.0 110.24 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.29 -42.14 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 124.007 1.53 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.7 m -80.89 -24.68 38.12 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.55 -0.719 . . . . 0.0 110.865 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.619 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 45.3 m95 -98.96 -19.33 17.36 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.338 -0.851 . . . . 0.0 110.881 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 69.22 8.46 6.82 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 178.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.619 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -131.45 163.37 28.09 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.627 -1.296 . . . . 0.0 111.099 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.7 t -91.41 138.01 31.91 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.49 -0.757 . . . . 0.0 110.575 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.53 173.84 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.515 -0.74 . . . . 0.0 109.698 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -58.04 133.01 55.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.326 -0.859 . . . . 0.0 110.169 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.574 -0.703 . . . . 0.0 110.501 -179.639 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.448 ' N ' ' HG ' ' A' ' 17' ' ' CYS . . . . . . . . 0 N--CA 1.497 2.733 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.44 159.35 30.06 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.84 90.55 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.696 -0.885 . . . . 0.0 110.622 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.13 34.31 23.24 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.657 -0.652 . . . . 0.0 110.405 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.5 133.93 34.87 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.466 -0.771 . . . . 0.0 109.795 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.31 114.45 5.86 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.472 ' SG ' HG21 ' A' ' 14' ' ' THR . 0.1 OUTLIER -97.01 -61.48 1.4 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.842 . . . . 0.0 109.677 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.432 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 1.1 t70 54.11 56.23 7.28 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.766 -0.584 . . . . 0.0 111.164 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.11 127.22 1.01 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -16.08 56.19 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.491 -1.005 . . . . 0.0 111.247 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.74 35.49 4.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.244 -0.91 . . . . 0.0 110.209 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.472 HG21 ' SG ' ' A' ' 9' ' ' CYS . 6.1 t -71.66 178.28 3.66 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.482 -0.761 . . . . 0.0 110.533 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -117.34 120.27 37.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.458 -0.776 . . . . 0.0 110.461 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m -115.16 -171.12 1.89 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.535 -0.728 . . . . 0.0 110.038 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.448 ' HG ' ' N ' ' A' ' 3' ' ' GLY . 99.8 m -81.37 -102.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.264 -0.897 . . . . 0.0 109.94 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.75 121.18 10.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.168 -0.958 . . . . 0.0 109.776 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 24.63 32.78 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 62.6 m-85 -128.51 126.38 40.31 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.356 -1.085 . . . . 0.0 109.539 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.41 143.24 43.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.4 -0.812 . . . . 0.0 110.713 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 19.4 t -78.77 126.4 30.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.687 -0.633 . . . . 0.0 110.155 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.13 137.33 42.98 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.469 -0.769 . . . . 0.0 110.147 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.57 -32.06 5.05 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.898 1.473 . . . . 0.0 110.964 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.6 m -86.44 -28.89 23.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.506 -0.746 . . . . 0.0 110.979 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.658 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 52.2 m95 -101.53 -22.89 14.4 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.388 -0.82 . . . . 0.0 111.061 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HG3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 67.94 28.24 6.95 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.647 -0.658 . . . . 0.0 112.374 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.658 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -135.77 171.27 14.71 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.772 -1.205 . . . . 0.0 110.412 178.055 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -97.53 125.11 42.05 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.088 -1.008 . . . . 0.0 110.145 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.552 HG13 ' CD1' ' A' ' 28' ' ' TRP . 15.6 m -124.72 163.44 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.543 -0.723 . . . . 0.0 110.241 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.83 131.1 49.85 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.537 -0.727 . . . . 0.0 110.399 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.653 -0.654 . . . . 0.0 110.362 -179.841 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.406 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.92 149.85 21.82 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.455 ' HA ' HD13 ' A' ' 5' ' ' LEU . 3.1 mm? 57.54 84.83 0.09 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.737 -0.861 . . . . 0.0 111.574 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 ttt 56.87 37.1 28.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.701 -0.624 . . . . 0.0 110.98 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.15 101.71 14.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.492 -0.755 . . . . 0.0 110.09 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 28' ' ' TRP . . . -54.63 110.3 1.58 Allowed Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.531 ' SG ' HG21 ' A' ' 14' ' ' THR . 23.4 p -105.89 -40.53 5.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.476 -1.014 . . . . 0.0 110.285 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.9 t70 54.64 95.54 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.326 0.584 . . . . 0.0 111.311 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.2 120.07 1.04 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -17.42 62.43 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.642 -0.917 . . . . 0.0 110.228 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 t -117.4 31.15 6.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.449 -0.782 . . . . 0.0 110.022 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.531 HG21 ' SG ' ' A' ' 9' ' ' CYS . 11.1 t -78.97 158.75 27.91 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.251 -0.906 . . . . 0.0 109.997 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.62 112.88 23.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.8 m -81.01 -165.78 0.99 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.442 -0.787 . . . . 0.0 110.109 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -79.58 -77.61 0.18 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.084 -1.01 . . . . 0.0 110.266 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.87 123.14 1.18 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.387 -0.82 . . . . 0.0 109.694 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.49 29.91 54.67 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.497 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.6 m-85 -126.77 150.59 49.03 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.366 -1.079 . . . . 0.0 110.212 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -126.05 130.51 51.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 110.315 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 1.3 m -86.97 129.55 34.83 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.386 -0.821 . . . . 0.0 110.119 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.96 144.58 30.29 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.515 -0.741 . . . . 0.0 110.239 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.62 -41.51 1.11 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.83 1.437 . . . . 0.0 111.121 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.4 m -76.94 -34.35 57.64 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.521 -0.737 . . . . 0.0 110.729 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.665 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 42.0 m0 -89.51 -28.58 19.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.405 -0.809 . . . . 0.0 110.683 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 1.3 tppt? 70.33 10.29 7.21 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.914 -0.491 . . . . 0.0 112.185 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.665 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -120.79 166.51 13.65 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.767 -1.208 . . . . 0.0 110.827 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 1.7 t -101.83 129.24 48.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.637 -0.664 . . . . 0.0 110.385 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 28' ' ' TRP . 4.4 m -124.18 175.36 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.56 -0.713 . . . . 0.0 109.961 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CD2' HD21 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -62.68 138.21 58.45 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.389 -0.819 . . . . 0.0 110.498 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.548 -0.72 . . . . 0.0 110.169 179.707 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.559 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -152.64 150.34 22.13 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.5 87.76 0.09 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.722 -0.869 . . . . 0.0 110.906 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.8 mtt 56.77 37.22 28.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.752 -0.592 . . . . 0.0 110.479 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.406 ' HB2' ' N ' ' A' ' 4' ' ' GLY . . . -86.37 114.69 23.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.443 -0.785 . . . . 0.0 109.698 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.63 98.21 0.06 OUTLIER Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.924 ' HB2' HG21 ' A' ' 14' ' ' THR . 9.1 p -87.21 -38.42 16.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.573 -0.957 . . . . 0.0 110.097 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.482 ' HA ' ' HD2' ' A' ' 27' ' ' LYS . 22.5 m-20 51.12 82.78 0.06 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.267 0.556 . . . . 0.0 111.433 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 131.93 124.21 2.54 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -10.62 40.36 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.644 -0.915 . . . . 0.0 110.734 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 m -106.6 26.88 9.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.231 -0.918 . . . . 0.0 110.248 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.924 HG21 ' HB2' ' A' ' 9' ' ' CYS . 14.1 t -77.36 -179.7 5.89 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.291 -0.88 . . . . 0.0 110.716 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.24 105.52 7.71 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.514 -0.742 . . . . 0.0 110.009 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.9 m -82.47 -171.27 3.38 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 110.484 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.68 -76.06 0.32 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.217 -0.927 . . . . 0.0 110.683 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.3 p -163.8 131.97 3.62 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.345 -0.847 . . . . 0.0 110.237 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.32 24.23 77.17 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.568 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 30.0 m-85 -125.15 142.92 51.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.395 -1.062 . . . . 0.0 109.785 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.649 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -122.0 117.8 27.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.801 . . . . 0.0 110.316 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 2.2 t -75.12 108.13 7.66 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.525 -0.735 . . . . 0.0 109.718 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.653 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -72.98 136.17 79.89 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 0.0 109.955 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.51 -28.79 14.16 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.95 1.5 . . . . 0.0 110.672 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -87.18 -35.08 18.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.39 -0.819 . . . . 0.0 110.255 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.674 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 47.3 m0 -87.38 -15.76 36.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.51 -0.744 . . . . 0.0 110.934 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 32.3 mmtm 61.68 15.84 7.26 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.723 -0.611 . . . . 0.0 112.344 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.674 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -132.55 167.29 20.27 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.838 -1.164 . . . . 0.0 110.6 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 3.6 t -107.86 127.94 54.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.632 -0.667 . . . . 0.0 110.218 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.582 HG13 ' CD1' ' A' ' 28' ' ' TRP . 3.6 m -131.89 165.48 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.537 -0.727 . . . . 0.0 110.584 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -45.79 142.29 2.58 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.654 -0.654 . . . . 0.0 110.883 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . . . . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 0.0 110.579 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.444 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.538 ' H ' ' HB2' ' A' ' 7' ' ' ALA . . . -179.32 140.77 4.5 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 61.17 93.93 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.851 -0.793 . . . . 0.0 111.061 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.2 mtp 55.91 42.61 28.61 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.679 -0.638 . . . . 0.0 109.979 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.783 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -86.18 115.7 23.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.608 -0.683 . . . . 0.0 110.049 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.9 110.16 2.24 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.537 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 7.4 p -113.67 -36.17 4.97 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.677 -0.896 . . . . 0.0 110.599 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.32 59.32 4.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.666 -0.647 . . . . 0.0 110.976 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.76 117.56 0.43 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -21.54 52.78 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.494 -1.003 . . . . 0.0 110.899 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -99.2 -12.41 20.46 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.434 -0.791 . . . . 0.0 110.806 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.537 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 54.1 m -56.67 132.97 53.46 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.348 -0.845 . . . . 0.0 110.506 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -94.26 175.41 6.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.576 -0.703 . . . . 0.0 110.347 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.9 m -124.68 -148.11 0.39 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.509 -0.744 . . . . 0.0 110.128 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 t -88.7 -71.51 0.59 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.084 -1.01 . . . . 0.0 110.782 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.9 p -161.45 119.83 2.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.411 -0.805 . . . . 0.0 110.342 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.43 26.03 48.76 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.69 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 74.9 m-85 -139.4 152.14 46.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.474 -1.015 . . . . 0.0 109.547 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.4 130.26 26.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.324 -0.86 . . . . 0.0 110.645 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 16.9 t -68.63 149.38 49.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.521 -0.737 . . . . 0.0 110.304 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.67 140.63 30.84 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.507 -0.746 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.29 -41.08 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.713 1.375 . . . . 0.0 111.185 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.0 m -72.63 -31.91 65.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.398 -0.814 . . . . 0.0 110.839 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.625 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 54.1 m95 -96.76 -20.43 18.23 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.399 -0.813 . . . . 0.0 110.475 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 5.5 tptt 70.37 8.81 6.77 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.673 -0.642 . . . . 0.0 112.25 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.625 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.7 p90 -136.77 169.0 18.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.723 -1.236 . . . . 0.0 110.757 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.783 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 11.4 t -89.17 145.6 25.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.557 -0.714 . . . . 0.0 110.922 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 27.8 m -132.69 -179.21 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -66.41 131.25 45.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.239 -0.913 . . . . 0.0 110.367 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.586 -0.696 . . . . 0.0 110.645 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.474 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.31 161.68 30.99 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 5' ' ' LEU . 1.7 mm? 55.4 84.28 0.08 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.74 -0.859 . . . . 0.0 111.109 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 56.25 40.48 29.94 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.62 -0.675 . . . . 0.0 110.46 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -89.49 107.4 19.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.511 -0.743 . . . . 0.0 110.455 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.45 108.79 1.97 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.871 ' SG ' HG21 ' A' ' 14' ' ' THR . 27.2 p -110.61 -32.3 6.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.583 -0.951 . . . . 0.0 110.92 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 t70 59.86 73.46 0.48 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.653 -0.654 . . . . 0.0 110.584 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 174.01 124.27 0.78 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.446 ' HG2' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -61.67 -19.01 61.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.727 -0.867 . . . . 0.0 111.007 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.446 ' N ' ' HG2' ' A' ' 12' ' ' LYS . 64.6 p -134.54 35.15 3.19 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.449 -0.782 . . . . 0.0 110.063 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.871 HG21 ' SG ' ' A' ' 9' ' ' CYS . 12.3 t -64.95 161.69 18.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.435 -0.791 . . . . 0.0 110.595 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -100.6 115.21 29.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.407 -0.808 . . . . 0.0 110.296 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.5 m -94.39 -163.99 1.12 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.627 -0.671 . . . . 0.0 109.911 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.74 -76.79 0.22 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.05 -1.031 . . . . 0.0 110.6 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 p -163.47 126.75 2.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.483 -0.76 . . . . 0.0 109.917 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.04 17.21 80.28 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.429 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 38.4 m-85 -124.67 126.82 46.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.183 -1.186 . . . . 0.0 109.977 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.71 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -113.73 135.84 53.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.665 -0.647 . . . . 0.0 109.787 179.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 14' ' ' THR . 0.8 OUTLIER -85.1 138.36 32.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.587 -0.696 . . . . 0.0 110.332 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 9.3 t -98.47 140.19 21.66 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.643 -0.661 . . . . 0.0 110.436 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.24 -28.78 15.0 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.818 1.43 . . . . 0.0 110.9 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -86.28 -27.81 24.16 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.366 -0.834 . . . . 0.0 110.756 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.621 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 21.2 m0 -99.01 -27.54 13.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.279 -0.888 . . . . 0.0 110.701 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.8 OUTLIER 75.01 -3.9 2.5 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.621 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -109.15 170.0 8.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.73 -1.231 . . . . 0.0 110.678 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 5.5 t -105.7 129.97 53.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.717 . . . . 0.0 110.032 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.548 HG13 ' CD1' ' A' ' 28' ' ' TRP . 3.3 m -135.73 174.33 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.682 -0.636 . . . . 0.0 109.929 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -54.71 128.53 33.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.452 -0.78 . . . . 0.0 110.724 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . . . . . . . . 0 N--CA 1.498 1.966 0 O-C-N 121.645 -0.659 . . . . 0.0 110.583 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.4 t -119.3 110.84 17.46 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.544 -0.974 . . . . 0.0 110.082 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 16' ' ' CYS . . . -134.74 135.25 7.82 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.1 158.74 27.78 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.8 83.82 0.1 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.78 -0.836 . . . . 0.0 111.094 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.1 mtp 56.29 34.89 24.88 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.663 -0.648 . . . . 0.0 110.68 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -83.02 145.17 29.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.433 -0.792 . . . . 0.0 109.905 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.3 121.0 24.11 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.648 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -110.61 -61.01 1.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.618 -0.931 . . . . 0.0 110.121 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 t70 59.41 77.85 0.29 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.406 0.622 . . . . 0.0 110.605 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.82 121.86 1.34 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -66.06 -13.45 60.02 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.491 -1.005 . . . . 0.0 110.925 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 p -110.84 2.94 18.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.29 -0.882 . . . . 0.0 111.13 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.648 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 1.9 m -66.83 138.2 57.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.116 -0.99 . . . . 0.0 110.172 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -100.09 138.86 36.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.51 -0.744 . . . . 0.0 110.269 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 3' ' ' GLY . 33.7 m -80.88 -157.23 0.15 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.684 -0.635 . . . . 0.0 109.833 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 t -78.93 -70.66 0.49 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.092 -1.005 . . . . 0.0 110.332 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.1 p -163.69 123.08 2.06 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.558 -0.714 . . . . 0.0 109.819 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.95 -3.97 86.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 49.0 m-85 -103.24 169.88 8.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -1.179 . . . . 0.0 110.115 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -148.23 129.68 14.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.465 -0.772 . . . . 0.0 109.959 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 14.6 t -73.03 132.67 43.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.49 -0.756 . . . . 0.0 110.614 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -95.67 128.8 36.52 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.573 -0.704 . . . . 0.0 109.461 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.27 -21.67 26.47 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.784 1.412 . . . . 0.0 111.003 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.6 m -87.7 -28.3 21.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.316 -0.865 . . . . 0.0 110.741 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.519 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 11.1 m0 -108.43 -12.74 14.98 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.437 -0.789 . . . . 0.0 111.243 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? 61.88 29.55 17.91 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.583 -0.698 . . . . 0.0 112.27 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.519 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -136.66 171.0 15.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.839 -1.163 . . . . 0.0 110.671 178.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -102.14 123.87 46.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.382 -0.824 . . . . 0.0 110.492 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.465 HG13 ' CD1' ' A' ' 28' ' ' TRP . 1.6 m -132.89 -179.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.547 -0.72 . . . . 0.0 109.85 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -55.17 143.53 27.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.356 -0.84 . . . . 0.0 110.334 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.41 141.13 29.04 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.38 -0.825 . . . . 0.0 110.419 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -149.65 86.59 5.37 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.501 -0.749 . . . . 0.0 110.085 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 C--N 1.311 -1.395 0 O-C-N 123.81 1.426 . . . . 0.0 110.898 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.428 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -139.19 100.38 4.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.421 -1.046 . . . . 0.0 110.394 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -112.5 134.25 11.89 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.83 155.71 26.44 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 58.5 91.42 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.794 -0.827 . . . . 0.0 111.0 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.4 mtt 55.64 35.39 25.15 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.733 -0.605 . . . . 0.0 110.591 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -86.24 93.92 9.18 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.499 -0.751 . . . . 0.0 109.698 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.14 106.66 0.77 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.962 ' HB2' HG21 ' A' ' 14' ' ' THR . 30.7 p -114.21 -37.2 4.47 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.595 -0.944 . . . . 0.0 110.772 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 t70 63.11 96.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.421 0.629 . . . . 0.0 110.791 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.02 117.67 0.6 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -63.17 -17.5 62.45 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.622 -0.928 . . . . 0.0 110.759 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 t -119.93 27.96 8.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.368 -0.832 . . . . 0.0 110.372 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.962 HG21 ' HB2' ' A' ' 9' ' ' CYS . 17.0 m -83.31 132.53 35.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.298 -0.876 . . . . 0.0 109.875 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -86.26 160.47 19.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.478 -0.764 . . . . 0.0 110.442 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.1 m -124.84 -164.83 1.31 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.535 -0.728 . . . . 0.0 110.498 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.428 ' HB2' ' CA ' ' A' ' 2' ' ' CYS . 23.7 t -74.0 -86.99 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.306 -0.871 . . . . 0.0 110.698 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.5 m -151.05 122.39 7.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.141 -0.974 . . . . 0.0 109.988 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.77 24.78 66.34 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.625 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 42.1 m-85 -130.67 140.11 50.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.454 -1.027 . . . . 0.0 109.831 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.73 128.6 39.24 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.434 -0.791 . . . . 0.0 110.627 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.4 m -71.12 120.26 16.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.666 -0.646 . . . . 0.0 110.008 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 5.5 t -82.44 140.08 44.85 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.401 -0.812 . . . . 0.0 110.255 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.38 -29.21 11.47 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.962 1.506 . . . . 0.0 110.854 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.0 m -86.05 -32.51 21.38 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.741 . . . . 0.0 110.464 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.707 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 34.5 m0 -93.31 -23.96 18.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.405 -0.809 . . . . 0.0 110.703 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER 72.35 1.78 4.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.851 -0.531 . . . . 0.0 111.973 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.707 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -121.96 168.07 12.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.919 -1.113 . . . . 0.0 109.999 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.625 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 4.4 t -94.71 144.09 25.9 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.454 -0.779 . . . . 0.0 110.839 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.469 HG13 ' CD1' ' A' ' 28' ' ' TRP . 0.8 OUTLIER -148.96 167.46 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -49.56 134.37 19.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.453 -0.779 . . . . 0.0 110.337 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.17 163.53 20.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.353 -0.842 . . . . 0.0 110.599 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.42 134.88 25.88 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.602 -0.686 . . . . 0.0 110.049 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 C--N 1.313 -1.311 0 O-C-N 123.842 1.443 . . . . 0.0 110.661 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.426 ' HB2' ' C ' ' A' ' 16' ' ' CYS . 29.0 p -90.19 173.72 8.0 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.513 -0.993 . . . . 0.0 110.692 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -134.8 146.5 18.52 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.89 149.38 21.39 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.55 95.63 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.917 -0.755 . . . . 0.0 110.635 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 15.1 mmt 58.04 38.28 26.65 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.729 -0.607 . . . . 0.0 110.471 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.84 140.74 29.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.609 -0.682 . . . . 0.0 109.871 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.4 116.28 8.88 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.442 ' SG ' HG21 ' A' ' 14' ' ' THR . 1.1 t -106.12 -70.42 0.79 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.691 -0.888 . . . . 0.0 109.316 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.464 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 7.2 t70 49.19 73.18 0.25 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.322 0.582 . . . . 0.0 110.729 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.63 120.85 1.87 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -62.51 -14.3 40.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.653 -0.91 . . . . 0.0 110.676 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.9 t -97.46 22.68 8.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.41 -0.806 . . . . 0.0 110.37 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.442 HG21 ' SG ' ' A' ' 9' ' ' CYS . 4.7 t -71.93 -179.05 2.56 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.225 -0.922 . . . . 0.0 110.244 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.76 94.95 3.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.308 -0.87 . . . . 0.0 110.326 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 20' ' ' TYR . 91.5 m -78.09 -179.49 6.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.403 -0.81 . . . . 0.0 109.929 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.0 m -83.02 -100.36 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.115 -0.99 . . . . 0.0 110.508 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.09 117.56 11.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.063 -1.023 . . . . 0.0 110.083 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.44 32.7 12.95 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.486 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 63.3 m-85 -130.09 142.9 50.56 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.218 -1.166 . . . . 0.0 110.601 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -123.13 133.94 54.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.578 -0.701 . . . . 0.0 110.091 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 8.5 t -82.12 130.67 35.15 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.555 -0.715 . . . . 0.0 110.396 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.523 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -92.29 140.49 24.34 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.339 -0.85 . . . . 0.0 110.009 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.75 -31.02 8.88 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.862 1.454 . . . . 0.0 111.178 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 m -88.93 -38.21 14.68 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.353 -0.842 . . . . 0.0 110.613 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.7 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 36.2 m0 -82.66 -26.6 31.98 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.406 -0.809 . . . . 0.0 110.672 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' A' ' 10' ' ' ASP . 15.2 tptt 69.33 19.56 7.68 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.741 -0.599 . . . . 0.0 112.196 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.7 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.1 p90 -133.26 173.19 11.72 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.814 -1.179 . . . . 0.0 110.571 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.1 t -107.55 128.19 54.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.394 -0.816 . . . . 0.0 110.453 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.546 HG13 ' CD1' ' A' ' 28' ' ' TRP . 4.5 m -129.75 173.17 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.601 -0.687 . . . . 0.0 110.061 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -52.61 127.49 23.08 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.351 -0.843 . . . . 0.0 110.643 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.02 -179.82 6.55 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.582 -0.699 . . . . 0.0 110.253 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -134.77 140.7 36.07 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.267 -0.896 . . . . 0.0 110.452 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 C--N 1.315 -1.229 0 O-C-N 123.825 1.434 . . . . 0.0 110.796 179.891 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.63 107.37 7.93 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.513 -0.992 . . . . 0.0 110.403 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.01 137.95 14.47 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.475 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -147.83 130.99 3.68 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.464 HD21 ' CE2' ' A' ' 31' ' ' TYR . 0.5 OUTLIER 59.55 95.34 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.86 -0.788 . . . . 0.0 111.205 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.9 mtt 57.67 43.82 21.64 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.484 0.659 . . . . 0.0 110.376 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.949 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -89.21 127.58 35.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.547 -0.721 . . . . 0.0 109.876 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -49.95 118.09 5.41 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.618 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 3.0 t -105.82 -66.68 0.97 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.613 -0.933 . . . . 0.0 109.608 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 t0 53.25 66.52 1.21 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.831 -0.543 . . . . 0.0 111.092 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.15 127.48 0.89 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -14.35 62.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.572 -0.958 . . . . 0.0 110.886 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 t -117.3 22.18 12.64 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.296 -0.878 . . . . 0.0 110.374 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.618 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 4.8 m -86.59 132.15 33.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -104.54 154.34 20.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.55 -0.719 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.462 ' CB ' ' HB2' ' A' ' 20' ' ' TYR . 34.0 m -87.44 -154.75 0.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.492 -0.755 . . . . 0.0 109.983 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.2 t -89.01 -70.76 0.63 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.211 -0.931 . . . . 0.0 110.615 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.4 p -158.24 113.5 2.65 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.449 -0.782 . . . . 0.0 110.339 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.36 24.38 36.89 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB2' ' CB ' ' A' ' 16' ' ' CYS . 89.1 m-85 -137.58 159.06 43.02 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.394 -1.062 . . . . 0.0 110.015 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.418 ' O ' HG22 ' A' ' 30' ' ' VAL . 19.5 t-20 -137.62 136.6 37.67 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.36 -0.837 . . . . 0.0 110.577 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 9.1 t -65.15 147.33 53.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.488 -0.758 . . . . 0.0 110.154 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.412 ' HB3' ' HD1' ' A' ' 26' ' ' TRP . 3.3 m -111.31 131.41 22.27 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.45 -0.781 . . . . 0.0 109.902 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.88 -26.36 11.25 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.887 1.467 . . . . 0.0 111.002 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.3 m -91.07 -25.87 19.43 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.453 -0.78 . . . . 0.0 110.925 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.684 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 72.6 m95 -102.65 -14.91 16.52 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.295 -0.878 . . . . 0.0 110.741 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.72 13.68 9.3 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.674 -0.641 . . . . 0.0 112.642 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.684 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -138.14 175.2 9.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.696 -1.252 . . . . 0.0 110.696 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.949 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -88.54 135.52 33.45 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.347 -0.845 . . . . 0.0 110.702 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 21' ' ' ASN . 35.4 m -123.47 -175.59 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.9 -0.5 . . . . 0.0 109.708 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CE2' HD21 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -69.91 149.16 48.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.354 -0.841 . . . . 0.0 110.4 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.0 113.56 10.17 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.534 -0.729 . . . . 0.0 110.115 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.488 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -66.4 -54.96 21.47 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.502 -0.749 . . . . 0.0 110.634 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 33' ' ' ARG . 45.2 Cg_endo . . . . . 0 N--CA 1.487 1.094 0 O-C-N 123.607 1.319 . . . . 0.0 110.733 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.0 t -114.22 76.95 1.02 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.503 -0.998 . . . . 0.0 110.185 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.96 132.71 11.03 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.586 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -156.56 139.36 6.47 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 5' ' ' LEU . 3.3 mm? 58.1 89.12 0.05 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.85 -0.794 . . . . 0.0 111.193 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.3 mmt 55.62 42.14 29.82 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.438 0.637 . . . . 0.0 110.192 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.586 ' HB2' ' N ' ' A' ' 4' ' ' GLY . . . -83.16 129.95 35.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.529 -0.732 . . . . 0.0 110.188 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.92 106.73 1.17 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 5.0 m -95.51 -50.0 5.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.502 -0.999 . . . . 0.0 110.206 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 t0 62.97 52.48 2.6 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.405 0.622 . . . . 0.0 109.993 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.6 125.23 0.91 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -17.44 62.29 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.448 -1.03 . . . . 0.0 110.817 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.36 25.18 11.75 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 110.607 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.409 HG21 ' HA ' ' A' ' 9' ' ' CYS . 3.3 m -80.24 132.59 35.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.279 -0.888 . . . . 0.0 109.758 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -81.72 139.24 35.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.462 -0.774 . . . . 0.0 110.212 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.435 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 29.2 m -109.26 -166.81 1.14 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.461 -0.774 . . . . 0.0 110.306 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -74.27 0.22 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.156 -0.965 . . . . 0.0 111.169 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.53 125.87 4.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.138 -0.976 . . . . 0.0 110.639 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.36 24.26 75.55 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.641 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 38.7 m-85 -129.49 137.81 51.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.42 -1.047 . . . . 0.0 109.999 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -125.56 130.64 52.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.465 -0.772 . . . . 0.0 110.331 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.435 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 76.9 m -68.24 149.76 49.1 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.578 -0.701 . . . . 0.0 110.314 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 55.7 m -107.77 137.38 19.73 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.447 -0.783 . . . . 0.0 110.055 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -75.26 -33.47 4.31 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.812 1.428 . . . . 0.0 111.065 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.1 m -88.78 -40.41 13.21 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.504 -0.747 . . . . 0.0 110.306 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.725 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 24.6 m0 -84.67 -23.31 29.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.563 -0.711 . . . . 0.0 110.407 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 5.5 tttt 70.6 10.19 7.06 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.854 -0.529 . . . . 0.0 112.368 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.725 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -127.45 167.29 16.45 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.62 -1.3 . . . . 0.0 110.937 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 2.6 t -92.97 143.57 26.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.445 -0.785 . . . . 0.0 110.694 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.53 HG13 ' CD1' ' A' ' 28' ' ' TRP . 26.3 m -139.58 163.91 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.528 -0.732 . . . . 0.0 109.818 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.14 137.5 58.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.423 -0.798 . . . . 0.0 110.412 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.97 147.18 35.03 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.666 -0.646 . . . . 0.0 110.596 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -132.68 66.17 76.01 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.55 -0.719 . . . . 0.0 110.576 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 C--N 1.314 -1.269 0 O-C-N 123.634 1.334 . . . . 0.0 110.785 179.813 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.2 m -103.87 103.29 13.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.422 -1.046 . . . . 0.0 110.229 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.32 147.3 20.69 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 29' ' ' CYS . . . 167.22 -175.62 42.31 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 5' ' ' LEU . 1.7 mm? 52.51 72.55 0.4 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.737 -0.861 . . . . 0.0 110.647 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.456 ' HA ' ' CD1' ' A' ' 28' ' ' TRP . 6.2 ttm 60.87 42.0 13.71 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.609 -0.682 . . . . 0.0 110.533 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB3' ' CB ' ' A' ' 29' ' ' CYS . . . -82.85 100.51 10.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.446 -0.784 . . . . 0.0 109.793 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.73 109.05 1.6 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.9 p -114.71 -36.69 4.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.549 -0.971 . . . . 0.0 110.54 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.12 72.06 0.51 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.637 -0.664 . . . . 0.0 110.4 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.57 121.78 1.04 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -13.06 59.76 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.523 -0.986 . . . . 0.0 110.772 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.2 p -102.2 23.68 11.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 110.799 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.819 HG21 ' SG ' ' A' ' 22' ' ' CYS . 15.4 t -72.58 -169.79 0.59 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.144 -0.973 . . . . 0.0 109.991 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -133.64 107.41 7.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.166 -0.959 . . . . 0.0 110.53 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -98.62 -160.52 0.81 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.637 -0.664 . . . . 0.0 109.991 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -69.23 -77.12 0.08 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.078 -1.014 . . . . 0.0 110.569 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 p -164.7 -46.67 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.487 -0.758 . . . . 0.0 109.987 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.34 29.91 11.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 84.0 m-85 -129.2 125.94 38.09 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.912 . . . . 0.0 109.643 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -116.51 139.03 50.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -0.787 . . . . 0.0 110.319 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.819 ' SG ' HG21 ' A' ' 14' ' ' THR . 1.2 m -75.6 128.57 35.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.461 -0.774 . . . . 0.0 110.426 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.78 136.66 36.48 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.739 -0.601 . . . . 0.0 110.315 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.1 -27.74 11.55 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.923 1.486 . . . . 0.0 110.75 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.8 m -84.47 -29.56 25.95 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.433 -0.792 . . . . 0.0 110.627 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.673 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 78.3 m95 -100.53 -16.71 17.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.417 -0.802 . . . . 0.0 110.927 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.9 tptt 69.06 9.76 7.56 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.673 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -132.57 169.79 16.11 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.598 -1.314 . . . . 0.0 110.957 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.7 OUTLIER -89.32 140.62 29.31 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.632 0.729 . . . . 0.0 111.531 -178.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.508 HG13 ' CD1' ' A' ' 28' ' ' TRP . 3.1 m -140.31 178.24 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.92 149.74 11.15 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.256 -0.903 . . . . 0.0 110.518 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.21 166.89 21.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.527 -0.733 . . . . 0.0 110.667 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -108.36 144.05 28.69 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.755 . . . . 0.0 110.41 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 C--N 1.314 -1.242 0 O-C-N 123.859 1.452 . . . . 0.0 110.803 179.919 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.9 p -127.02 177.97 6.29 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.66 -0.906 . . . . 0.0 110.309 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . -141.63 138.92 9.01 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.51 121.62 1.42 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.607 HD13 ' HE1' ' A' ' 20' ' ' TYR . 5.7 tp 66.88 101.08 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.858 -0.789 . . . . 0.0 111.055 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.65 26.09 15.83 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.871 -0.518 . . . . 0.0 111.022 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.758 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . . . -91.07 135.98 33.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.99 127.46 44.88 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.517 ' SG ' ' HB ' ' A' ' 14' ' ' THR . 1.4 t -120.58 -71.16 0.75 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.719 -0.871 . . . . 0.0 109.635 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 55.44 77.63 0.22 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.716 -0.615 . . . . 0.0 110.813 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.53 121.01 0.56 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -19.15 64.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.605 -0.938 . . . . 0.0 110.444 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -110.79 21.31 16.65 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.383 -0.823 . . . . 0.0 110.515 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.517 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 8.9 m -83.52 135.18 34.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.319 -0.863 . . . . 0.0 110.068 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.55 141.07 37.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.657 -0.652 . . . . 0.0 110.098 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 20' ' ' TYR . 72.8 m -81.34 -165.12 0.87 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.459 -0.776 . . . . 0.0 110.081 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -74.97 0.32 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.212 -0.93 . . . . 0.0 110.89 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.6 m -152.28 116.95 5.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.292 -0.88 . . . . 0.0 110.356 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.47 31.43 45.89 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.607 ' HE1' HD13 ' A' ' 5' ' ' LEU . 58.8 m-85 -138.08 158.15 44.9 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.469 -1.018 . . . . 0.0 110.103 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.443 ' O ' HG22 ' A' ' 30' ' ' VAL . 23.9 t-20 -139.52 138.25 36.16 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.0 110.274 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.3 t -69.74 126.95 31.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.353 -0.842 . . . . 0.0 110.775 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.72 131.73 42.61 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.633 -0.667 . . . . 0.0 109.821 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.84 -26.29 13.54 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.836 1.44 . . . . 0.0 111.304 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.9 m -83.07 -38.11 22.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.329 -0.857 . . . . 0.0 110.771 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.654 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 80.8 m95 -98.14 -9.54 25.62 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.384 -0.823 . . . . 0.0 111.012 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 3.1 mmmm 59.31 34.2 22.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.557 -0.714 . . . . 0.0 111.752 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.654 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -143.43 174.5 10.7 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.955 -1.091 . . . . 0.0 110.685 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.758 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -89.57 133.84 34.41 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.98 -1.075 . . . . 0.0 109.854 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.499 HG13 ' CD1' ' A' ' 28' ' ' TRP . 17.5 m -132.14 173.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.465 -0.772 . . . . 0.0 110.505 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -62.02 127.28 30.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.445 -0.785 . . . . 0.0 110.227 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 143.69 54.29 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.536 -0.727 . . . . 0.0 110.461 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -65.06 153.22 89.54 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.48 -0.762 . . . . 0.0 110.419 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.312 -1.386 0 O-C-N 124.037 1.546 . . . . 0.0 110.694 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.433 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -97.62 106.89 19.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.491 -1.005 . . . . 0.0 110.193 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.02 112.74 4.52 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.72 143.94 11.82 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER 62.21 93.07 0.05 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.917 -0.755 . . . . 0.0 111.02 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.9 mtt 58.46 32.58 22.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.706 -0.621 . . . . 0.0 110.99 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.95 131.53 35.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.38 -0.825 . . . . 0.0 109.553 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -50.74 116.45 4.32 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.505 ' SG ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -100.43 -60.1 1.59 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.621 -0.929 . . . . 0.0 109.494 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 2.3 m-20 46.58 77.74 0.08 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.191 0.519 . . . . 0.0 111.446 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.38 128.32 2.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -16.4 59.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.602 -0.94 . . . . 0.0 110.776 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 p -121.45 38.24 4.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.497 -0.752 . . . . 0.0 109.621 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.505 HG21 ' SG ' ' A' ' 9' ' ' CYS . 11.4 t -63.33 157.37 23.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.544 -0.722 . . . . 0.0 110.741 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.23 94.47 5.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.419 -0.801 . . . . 0.0 110.05 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.5 m -78.51 -162.45 0.36 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.611 -0.68 . . . . 0.0 110.375 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -90.65 -84.64 0.24 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.216 -0.927 . . . . 0.0 110.25 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.5 p -155.93 111.5 3.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.46 40.88 6.69 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.488 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 58.9 m-85 -132.92 156.86 46.48 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.32 -1.106 . . . . 0.0 110.038 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.14 132.96 34.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 110.543 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.6 126.67 29.09 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.503 -0.748 . . . . 0.0 110.05 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.5 m -77.0 137.92 65.51 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.499 -0.751 . . . . 0.0 110.424 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.33 -23.72 17.37 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.933 1.491 . . . . 0.0 111.198 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.2 m -101.12 -39.67 7.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.293 -0.879 . . . . 0.0 110.694 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.693 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 81.8 m95 -87.98 -19.57 27.05 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.337 -0.852 . . . . 0.0 111.207 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 67.86 14.71 9.48 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.597 -0.689 . . . . 0.0 112.302 179.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.693 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -121.39 166.35 14.21 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.747 -1.22 . . . . 0.0 110.323 178.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -89.39 124.13 34.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.116 -0.99 . . . . 0.0 110.78 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.504 HG13 ' CD1' ' A' ' 28' ' ' TRP . 18.4 m -119.74 170.86 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.796 -0.565 . . . . 0.0 109.681 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -54.4 125.7 20.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.291 -0.88 . . . . 0.0 110.342 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.79 123.84 28.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.587 -0.696 . . . . 0.0 109.98 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.37 132.29 89.75 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.501 -0.749 . . . . 0.0 110.2 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 C--N 1.314 -1.276 0 O-C-N 123.875 1.46 . . . . 0.0 110.653 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.425 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p -119.05 179.06 4.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.984 . . . . 0.0 110.261 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -134.98 151.46 20.45 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.48 148.74 20.0 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.91 93.29 0.05 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.716 -0.873 . . . . 0.0 110.633 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 56.67 41.52 28.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.62 -0.675 . . . . 0.0 110.137 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -87.47 113.79 23.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.559 -0.713 . . . . 0.0 110.058 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.23 110.99 1.33 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.427 ' HA ' HG21 ' A' ' 14' ' ' THR . 55.5 m -95.55 -52.82 3.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.567 -0.96 . . . . 0.0 109.691 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.73 54.43 4.42 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.374 0.606 . . . . 0.0 110.483 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.34 127.21 0.87 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -15.75 62.07 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.644 -0.915 . . . . 0.0 110.898 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.55 30.34 6.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.237 -0.915 . . . . 0.0 110.254 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.427 HG21 ' HA ' ' A' ' 9' ' ' CYS . 24.4 m -90.67 143.11 27.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.75 173.96 6.08 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.43 -0.794 . . . . 0.0 110.131 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.3 m -133.52 -164.67 1.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.387 -0.821 . . . . 0.0 110.592 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.4 m -75.26 -87.49 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.274 -0.891 . . . . 0.0 110.47 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 t -149.3 118.66 6.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.351 -0.843 . . . . 0.0 110.269 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.12 26.25 45.22 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.581 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 57.3 m-85 -133.29 150.12 51.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.383 -1.069 . . . . 0.0 109.911 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.15 140.37 37.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.452 -0.78 . . . . 0.0 110.541 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 76.6 m -73.48 142.75 46.8 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.441 -0.787 . . . . 0.0 109.97 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m -103.62 143.37 26.51 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.588 -0.695 . . . . 0.0 110.369 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.42 -33.04 4.47 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.012 1.533 . . . . 0.0 111.172 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.0 m -84.46 -39.69 18.62 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.45 -0.781 . . . . 0.0 110.79 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.698 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 17.9 m0 -88.61 -22.54 23.43 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.526 -0.734 . . . . 0.0 110.877 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 71.63 2.0 4.1 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.71 -0.619 . . . . 0.0 111.925 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.698 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -120.57 170.38 9.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.747 -1.221 . . . . 0.0 110.509 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 6.3 t -89.08 143.12 27.07 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.533 -0.729 . . . . 0.0 111.102 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.458 HG13 ' CD1' ' A' ' 28' ' ' TRP . 19.1 m -137.08 178.3 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.861 -0.524 . . . . 0.0 109.591 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -61.5 119.03 7.8 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 109.863 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.19 145.87 49.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.571 -0.705 . . . . 0.0 110.702 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.2 65.92 65.32 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.674 -0.641 . . . . 0.0 110.108 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.314 -1.265 0 O-C-N 123.696 1.366 . . . . 0.0 110.663 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.8 p -141.18 176.73 8.6 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.544 -0.974 . . . . 0.0 110.377 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -128.86 139.44 10.98 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.61 152.1 24.11 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.87 93.29 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.664 -0.904 . . . . 0.0 110.623 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 mtp 57.09 41.34 27.51 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.66 -0.65 . . . . 0.0 109.775 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -88.04 122.99 32.28 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.579 -0.701 . . . . 0.0 110.376 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.29 108.81 1.95 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 p -114.73 -40.48 3.55 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.567 -0.961 . . . . 0.0 110.866 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 t70 56.92 69.28 0.76 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.647 -0.658 . . . . 0.0 110.447 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.45 115.7 1.3 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.22 -20.18 39.64 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.371 -1.076 . . . . 0.0 110.56 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.8 t -78.43 -19.98 52.04 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.485 -0.76 . . . . 0.0 110.537 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.2 m -56.7 133.12 53.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.469 -0.769 . . . . 0.0 110.089 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -85.31 152.9 22.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 110.505 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -118.82 -161.11 0.83 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.58 -0.7 . . . . 0.0 110.334 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.0 m -71.94 -82.28 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.264 -0.897 . . . . 0.0 110.46 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.7 p -159.03 115.96 2.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.548 -0.72 . . . . 0.0 109.702 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.0 -4.54 78.25 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.41 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 78.5 m-85 -108.88 143.45 38.07 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.199 -1.177 . . . . 0.0 110.062 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -132.31 135.4 46.18 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.348 -0.845 . . . . 0.0 110.2 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 45.3 t -59.51 140.07 56.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.629 -0.669 . . . . 0.0 110.829 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.12 128.22 27.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.634 -0.666 . . . . 0.0 110.017 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.79 -20.83 19.5 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.908 1.478 . . . . 0.0 111.166 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.2 m -89.08 -34.83 16.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.234 -0.916 . . . . 0.0 110.751 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.7 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 86.3 m95 -102.04 -10.14 19.98 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.338 -0.851 . . . . 0.0 111.202 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 tptm 69.29 8.01 6.55 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.622 -0.674 . . . . 0.0 112.708 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.7 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -131.39 167.89 18.52 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.585 -1.322 . . . . 0.0 110.698 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 5.8 t -89.02 139.71 30.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.492 -0.755 . . . . 0.0 110.639 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.524 HG13 ' CD1' ' A' ' 28' ' ' TRP . 12.2 m -134.03 175.83 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.718 -0.614 . . . . 0.0 110.029 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.82 125.58 25.8 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.387 -0.82 . . . . 0.0 110.36 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.05 69.15 1.29 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.646 -0.659 . . . . 0.0 110.017 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.32 146.23 77.51 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.388 -0.82 . . . . 0.0 110.386 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 C--N 1.312 -1.36 0 O-C-N 123.974 1.513 . . . . 0.0 110.625 -179.916 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.548 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 17' ' ' CYS . 15.3 p -124.06 -176.0 3.38 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.515 -0.991 . . . . 0.0 110.542 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.584 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . -156.03 155.07 26.02 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.39 133.14 4.33 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.465 ' HA ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER 64.46 97.05 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.76 -0.847 . . . . 0.0 111.222 179.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 mpp? 54.02 34.71 20.37 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.656 -0.653 . . . . 0.0 110.291 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.584 ' HB1' ' HA3' ' A' ' 3' ' ' GLY . . . -90.22 127.51 36.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.525 -0.734 . . . . 0.0 110.5 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.11 112.18 3.98 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.602 ' HB2' HG21 ' A' ' 14' ' ' THR . 4.5 p -115.38 -45.34 2.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.519 -0.989 . . . . 0.0 110.328 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.438 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER 54.87 87.06 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.291 0.567 . . . . 0.0 110.427 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.15 115.34 0.77 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.452 ' HG2' ' HB3' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -62.37 -18.67 62.11 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.577 -0.955 . . . . 0.0 110.36 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.22 -17.87 26.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.365 -0.834 . . . . 0.0 110.537 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.602 HG21 ' HB2' ' A' ' 9' ' ' CYS . 27.7 m -58.76 120.93 9.87 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.263 -0.898 . . . . 0.0 109.978 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CG ' ' O ' ' A' ' 15' ' ' PHE . 39.8 t80 -94.61 20.58 8.34 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.527 -0.733 . . . . 0.0 110.852 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 20' ' ' TYR . 6.2 m 56.37 -149.51 0.46 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.027 -1.046 . . . . 0.0 110.045 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -93.04 -65.75 0.97 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.164 -0.96 . . . . 0.0 110.085 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 t -162.24 117.88 1.94 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.507 -0.746 . . . . 0.0 110.397 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.41 30.46 33.49 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.559 ' HB2' ' HB2' ' A' ' 16' ' ' CYS . 64.9 m-85 -136.92 168.27 19.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.419 -1.048 . . . . 0.0 110.137 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.88 124.05 16.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -0.78 . . . . 0.0 110.21 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.18 117.26 12.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.572 -0.705 . . . . 0.0 110.092 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 19.9 m -74.23 131.22 81.08 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.552 -0.718 . . . . 0.0 110.188 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.452 ' HB3' ' HG2' ' A' ' 12' ' ' LYS . 46.5 Cg_endo -73.28 -23.07 18.18 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.988 1.52 . . . . 0.0 111.093 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.3 m -96.24 -35.56 11.22 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.24 -0.913 . . . . 0.0 110.69 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.591 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 26.1 m0 -92.27 -19.08 22.55 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.348 -0.845 . . . . 0.0 110.876 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' CE ' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 70.76 7.21 6.14 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.591 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.3 p90 -118.68 163.44 16.83 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.755 -1.215 . . . . 0.0 110.665 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m -96.42 124.0 40.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.599 -0.688 . . . . 0.0 110.895 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.587 HG13 ' CD1' ' A' ' 28' ' ' TRP . 2.1 m -121.29 170.39 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.588 -0.695 . . . . 0.0 110.14 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -52.67 146.41 10.29 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.432 -0.793 . . . . 0.0 110.627 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.23 98.49 8.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.359 -0.838 . . . . 0.0 110.233 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -150.28 90.37 4.37 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.444 -0.785 . . . . 0.0 110.225 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.313 -1.329 0 O-C-N 123.861 1.453 . . . . 0.0 110.734 179.853 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 9.0 t -119.48 103.62 9.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.611 -0.934 . . . . 0.0 110.12 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.59 123.11 4.4 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 29' ' ' CYS . . . -160.66 175.92 37.33 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.414 HD23 ' CE1' ' A' ' 20' ' ' TYR . 0.2 OUTLIER 58.28 87.2 0.07 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.719 -0.871 . . . . 0.0 110.873 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 46.5 mmm 54.91 37.08 28.12 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.643 -0.661 . . . . 0.0 110.233 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -88.31 97.01 10.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.5 -0.75 . . . . 0.0 110.114 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.12 104.64 0.55 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 1.035 ' HB2' HG21 ' A' ' 14' ' ' THR . 21.8 p -110.23 -32.57 6.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.604 -0.939 . . . . 0.0 110.805 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 t70 65.0 99.03 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.696 -0.628 . . . . 0.0 110.603 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.36 117.53 1.54 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -66.07 -14.04 61.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.597 -0.943 . . . . 0.0 110.581 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.3 p -107.12 11.35 29.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.833 . . . . 0.0 110.792 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.035 HG21 ' HB2' ' A' ' 9' ' ' CYS . 19.9 m -74.03 141.42 45.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.139 -0.975 . . . . 0.0 110.012 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.84 163.34 15.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.455 -0.778 . . . . 0.0 110.351 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.0 m -129.89 -160.51 1.04 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.539 -0.726 . . . . 0.0 109.863 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 3.7 t -66.03 -66.36 0.56 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 t -171.4 -46.61 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.45 -0.781 . . . . 0.0 110.43 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.13 29.66 11.27 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.496 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 66.9 m-85 -130.94 158.9 39.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.468 -1.019 . . . . 0.0 110.155 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.47 129.35 18.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.369 -0.832 . . . . 0.0 110.398 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 2.3 m -67.1 127.23 31.81 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.507 -0.745 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 7.9 t -83.87 141.54 41.13 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.473 -0.767 . . . . 0.0 110.193 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.78 -24.96 15.04 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.891 1.469 . . . . 0.0 111.299 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.3 m -99.36 -31.68 11.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.161 -0.962 . . . . 0.0 110.962 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.706 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 36.6 m0 -87.97 -21.72 24.71 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.33 -0.856 . . . . 0.0 110.982 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 73.26 -2.08 2.85 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.707 -0.621 . . . . 0.0 112.042 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.706 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.9 p90 -122.46 165.56 16.16 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.609 -1.307 . . . . 0.0 110.67 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 5.0 t -89.32 133.92 34.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.517 -0.739 . . . . 0.0 111.106 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 33.1 m -126.27 -170.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.38 134.17 56.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.208 -0.932 . . . . 0.0 110.073 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.87 129.65 42.88 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.508 -0.745 . . . . 0.0 110.497 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -126.36 113.07 23.42 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.569 -0.707 . . . . 0.0 110.195 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 C--N 1.314 -1.27 0 O-C-N 123.775 1.408 . . . . 0.0 110.67 179.855 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.2 p -126.18 177.05 6.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.49 -1.006 . . . . 0.0 110.549 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.476 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . -135.94 138.87 10.25 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.424 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -145.61 150.52 22.74 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER 58.34 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.697 -0.884 . . . . 0.0 110.789 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.2 mtm 59.42 37.8 23.02 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.658 -0.651 . . . . 0.0 110.405 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.476 ' HB1' ' HA3' ' A' ' 3' ' ' GLY . . . -90.19 112.34 23.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.452 -0.78 . . . . 0.0 110.01 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -50.62 107.71 0.41 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.979 ' HB2' HG21 ' A' ' 14' ' ' THR . 5.4 p -109.76 -42.17 4.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.691 -0.888 . . . . 0.0 110.334 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 55.0 72.42 0.47 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.78 -0.575 . . . . 0.0 111.032 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.32 126.6 2.7 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -11.38 57.11 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.587 -0.949 . . . . 0.0 110.435 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t -94.14 13.87 21.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.364 -0.835 . . . . 0.0 110.547 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.979 HG21 ' HB2' ' A' ' 9' ' ' CYS . 14.7 t -73.34 -173.75 1.45 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.184 -0.948 . . . . 0.0 110.166 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 96.78 4.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.018 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.2 m -77.64 -169.64 1.55 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.414 -0.804 . . . . 0.0 110.188 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -79.32 -94.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.248 -0.907 . . . . 0.0 110.255 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 p -144.3 113.13 6.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.062 -1.024 . . . . 0.0 110.574 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.38 37.5 9.7 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 69.5 m-85 -132.18 148.32 52.46 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.361 -1.082 . . . . 0.0 110.055 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -124.1 128.11 48.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.498 -0.751 . . . . 0.0 110.485 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 42.3 t -69.39 121.1 16.27 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.608 -0.682 . . . . 0.0 109.971 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 58.4 m -76.23 129.64 79.79 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.521 -0.737 . . . . 0.0 110.199 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.45 -24.27 19.38 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.875 1.461 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -98.8 -36.2 9.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.302 -0.874 . . . . 0.0 110.492 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.724 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 50.6 m0 -85.18 -19.05 32.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.455 -0.778 . . . . 0.0 110.955 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER 70.81 9.01 6.74 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.672 -0.643 . . . . 0.0 112.273 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.724 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.6 p90 -130.5 161.05 32.32 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.798 -1.188 . . . . 0.0 110.506 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.9 t -89.46 133.6 34.48 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.497 -0.752 . . . . 0.0 111.08 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.524 HG13 ' CD1' ' A' ' 28' ' ' TRP . 18.2 m -126.03 -177.55 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.74 -0.6 . . . . 0.0 109.518 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.42 ' HD2' HD21 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -62.45 135.75 57.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.212 -0.93 . . . . 0.0 110.209 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.04 -179.05 3.51 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.489 -0.757 . . . . 0.0 110.632 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 58.47 86.51 0.16 Allowed Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.718 -0.614 . . . . 0.0 110.641 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--N 1.312 -1.379 0 O-C-N 123.909 1.479 . . . . 0.0 110.678 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.479 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.9 t -110.88 90.02 3.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.501 -1.0 . . . . 0.0 110.301 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.15 121.96 5.47 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.89 159.9 28.2 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER 55.36 85.67 0.06 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.749 -0.854 . . . . 0.0 111.104 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.3 mtp 58.55 37.37 25.47 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.682 -0.636 . . . . 0.0 110.661 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.99 125.72 33.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.43 108.05 0.81 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.945 ' HB2' HG21 ' A' ' 14' ' ' THR . 25.9 p -109.41 -41.35 4.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.551 -0.97 . . . . 0.0 110.583 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.1 t70 46.65 76.64 0.1 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.751 -0.593 . . . . 0.0 111.339 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.65 125.28 2.22 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -12.88 52.7 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.606 -0.938 . . . . 0.0 110.722 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.5 t -113.13 32.01 6.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.917 . . . . 0.0 110.244 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.945 HG21 ' HB2' ' A' ' 9' ' ' CYS . 15.0 t -72.58 -168.97 0.49 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.432 -0.793 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -127.04 92.38 3.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.489 -0.757 . . . . 0.0 110.429 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -82.17 -172.9 4.22 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.481 -0.762 . . . . 0.0 109.829 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 t -80.76 -75.49 0.27 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.07 -1.019 . . . . 0.0 110.751 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.0 p -162.78 125.23 2.71 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.281 -0.887 . . . . 0.0 110.141 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.28 28.34 64.19 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.497 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 26.3 m-85 -126.49 126.04 43.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.268 -1.136 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -105.47 132.3 51.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 110.187 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 4.8 t -85.24 130.12 34.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.567 -0.708 . . . . 0.0 110.162 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.2 OUTLIER -92.39 136.58 25.35 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.525 -0.734 . . . . 0.0 109.968 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.32 -28.3 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.808 1.425 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 m -86.72 -34.68 19.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.383 -0.823 . . . . 0.0 110.213 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.671 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 46.9 m0 -88.22 -22.24 24.09 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.548 -0.72 . . . . 0.0 110.664 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 26' ' ' TRP . 21.1 mmmt 66.96 15.36 10.13 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.85 -0.531 . . . . 0.0 112.032 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.671 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -131.66 166.97 20.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.804 -1.185 . . . . 0.0 110.803 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 3.8 t -104.9 133.08 50.31 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.431 -0.793 . . . . 0.0 110.639 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.546 HG13 ' CD1' ' A' ' 28' ' ' TRP . 4.3 m -136.02 171.96 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.627 -0.671 . . . . 0.0 109.967 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -49.86 142.62 8.67 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.36 -0.838 . . . . 0.0 110.728 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.05 177.84 4.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -129.09 68.87 80.54 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.474 -0.766 . . . . 0.0 110.19 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.315 -1.228 0 O-C-N 123.659 1.347 . . . . 0.0 110.534 -179.918 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.92 100.47 9.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.616 -0.932 . . . . 0.0 109.801 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.86 108.01 3.48 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.404 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -140.2 140.57 10.73 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 61.35 93.22 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.91 -0.759 . . . . 0.0 110.959 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.61 40.78 23.19 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.708 -0.62 . . . . 0.0 110.475 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.404 ' HB2' ' N ' ' A' ' 4' ' ' GLY . . . -88.1 130.6 34.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.425 -0.797 . . . . 0.0 109.916 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.3 110.84 1.72 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.697 ' SG ' HG21 ' A' ' 14' ' ' THR . 2.0 t -105.3 -72.3 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.655 -0.909 . . . . 0.0 109.553 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.4 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 6.0 t70 53.48 63.57 2.16 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.381 0.61 . . . . 0.0 110.822 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.48 126.2 0.93 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.56 -14.33 60.87 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.476 -1.014 . . . . 0.0 110.889 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.6 p -93.96 11.69 28.72 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.246 -0.909 . . . . 0.0 111.149 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.697 HG21 ' SG ' ' A' ' 9' ' ' CYS . 6.1 t -64.96 155.96 32.76 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.109 -0.994 . . . . 0.0 109.813 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -111.35 -18.92 12.79 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.311 -0.868 . . . . 0.0 111.257 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.6 m 55.62 -155.81 0.27 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.43 -0.794 . . . . 0.0 110.055 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.402 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 37.9 t -99.54 -104.47 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.131 -0.981 . . . . 0.0 109.412 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 t -131.7 106.0 7.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.989 -1.069 . . . . 0.0 109.753 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.37 53.53 2.61 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.477 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 75.0 m-85 -138.5 147.56 43.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.443 -1.033 . . . . 0.0 110.303 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -119.88 130.37 54.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.589 -0.694 . . . . 0.0 110.155 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.651 ' HB2' HG21 ' A' ' 14' ' ' THR . 37.9 t -74.94 138.29 42.23 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.544 -0.723 . . . . 0.0 110.158 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.5 OUTLIER -100.9 133.33 21.14 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.729 . . . . 0.0 110.24 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.29 -42.14 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 124.007 1.53 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.7 m -80.89 -24.68 38.12 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.55 -0.719 . . . . 0.0 110.865 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.619 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 45.3 m95 -98.96 -19.33 17.36 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.338 -0.851 . . . . 0.0 110.881 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 69.22 8.46 6.82 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 178.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.619 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.5 p90 -131.45 163.37 28.09 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.627 -1.296 . . . . 0.0 111.099 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.7 t -91.41 138.01 31.91 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.49 -0.757 . . . . 0.0 110.575 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.53 173.84 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.515 -0.74 . . . . 0.0 109.698 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -58.04 133.01 55.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.326 -0.859 . . . . 0.0 110.169 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.47 131.41 48.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.574 -0.703 . . . . 0.0 110.501 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -120.77 118.8 30.43 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.527 -0.733 . . . . 0.0 110.304 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 C--N 1.315 -1.224 0 O-C-N 123.797 1.419 . . . . 0.0 111.307 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 28.2 p -127.06 177.84 6.38 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.569 -0.959 . . . . 0.0 110.679 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.29 147.09 16.43 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.44 159.35 30.06 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.84 90.55 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.696 -0.885 . . . . 0.0 110.622 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.13 34.31 23.24 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.657 -0.652 . . . . 0.0 110.405 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.5 133.93 34.87 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.466 -0.771 . . . . 0.0 109.795 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.31 114.45 5.86 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.472 ' SG ' HG21 ' A' ' 14' ' ' THR . 0.1 OUTLIER -97.01 -61.48 1.4 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.842 . . . . 0.0 109.677 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.432 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 1.1 t70 54.11 56.23 7.28 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.766 -0.584 . . . . 0.0 111.164 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.11 127.22 1.01 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -16.08 56.19 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.491 -1.005 . . . . 0.0 111.247 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.74 35.49 4.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.244 -0.91 . . . . 0.0 110.209 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.472 HG21 ' SG ' ' A' ' 9' ' ' CYS . 6.1 t -71.66 178.28 3.66 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.482 -0.761 . . . . 0.0 110.533 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -117.34 120.27 37.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.458 -0.776 . . . . 0.0 110.461 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m -115.16 -171.12 1.89 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.535 -0.728 . . . . 0.0 110.038 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.8 m -81.37 -102.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.264 -0.897 . . . . 0.0 109.94 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.75 121.18 10.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.168 -0.958 . . . . 0.0 109.776 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 24.63 32.78 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 62.6 m-85 -128.51 126.38 40.31 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.356 -1.085 . . . . 0.0 109.539 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.41 143.24 43.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.4 -0.812 . . . . 0.0 110.713 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 19.4 t -78.77 126.4 30.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.687 -0.633 . . . . 0.0 110.155 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.13 137.33 42.98 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.469 -0.769 . . . . 0.0 110.147 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.57 -32.06 5.05 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.898 1.473 . . . . 0.0 110.964 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.6 m -86.44 -28.89 23.23 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.506 -0.746 . . . . 0.0 110.979 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.658 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 52.2 m95 -101.53 -22.89 14.4 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.388 -0.82 . . . . 0.0 111.061 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HG3' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 67.94 28.24 6.95 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.647 -0.658 . . . . 0.0 112.374 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.658 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 0.4 OUTLIER -135.77 171.27 14.71 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.772 -1.205 . . . . 0.0 110.412 178.055 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -97.53 125.11 42.05 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.088 -1.008 . . . . 0.0 110.145 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.552 HG13 ' CD1' ' A' ' 28' ' ' TRP . 15.6 m -124.72 163.44 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.543 -0.723 . . . . 0.0 110.241 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.83 131.1 49.85 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.537 -0.727 . . . . 0.0 110.399 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.99 154.49 20.53 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.653 -0.654 . . . . 0.0 110.362 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -124.72 123.96 25.62 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.38 -0.825 . . . . 0.0 110.352 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--N 1.313 -1.3 0 O-C-N 123.923 1.486 . . . . 0.0 110.809 179.871 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.528 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -108.07 97.48 7.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.602 -0.94 . . . . 0.0 109.92 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.05 111.97 4.19 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.92 149.85 21.82 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.455 ' HA ' HD13 ' A' ' 5' ' ' LEU . 3.1 mm? 57.54 84.83 0.09 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.737 -0.861 . . . . 0.0 111.574 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 ttt 56.87 37.1 28.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.701 -0.624 . . . . 0.0 110.98 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.15 101.71 14.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.492 -0.755 . . . . 0.0 110.09 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 28' ' ' TRP . . . -54.63 110.3 1.58 Allowed Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.531 ' SG ' HG21 ' A' ' 14' ' ' THR . 23.4 p -105.89 -40.53 5.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.476 -1.014 . . . . 0.0 110.285 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.9 t70 54.64 95.54 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.326 0.584 . . . . 0.0 111.311 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.2 120.07 1.04 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -17.42 62.43 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.642 -0.917 . . . . 0.0 110.228 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 t -117.4 31.15 6.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.449 -0.782 . . . . 0.0 110.022 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.531 HG21 ' SG ' ' A' ' 9' ' ' CYS . 11.1 t -78.97 158.75 27.91 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.251 -0.906 . . . . 0.0 109.997 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -114.62 112.88 23.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.8 m -81.01 -165.78 0.99 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.442 -0.787 . . . . 0.0 110.109 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -79.58 -77.61 0.18 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.084 -1.01 . . . . 0.0 110.266 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.87 123.14 1.18 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.387 -0.82 . . . . 0.0 109.694 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.49 29.91 54.67 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.497 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.6 m-85 -126.77 150.59 49.03 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.366 -1.079 . . . . 0.0 110.212 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -126.05 130.51 51.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.494 -0.754 . . . . 0.0 110.315 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 1.3 m -86.97 129.55 34.83 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.386 -0.821 . . . . 0.0 110.119 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.96 144.58 30.29 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.515 -0.741 . . . . 0.0 110.239 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.62 -41.51 1.11 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.83 1.437 . . . . 0.0 111.121 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.4 m -76.94 -34.35 57.64 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.521 -0.737 . . . . 0.0 110.729 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.665 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 42.0 m0 -89.51 -28.58 19.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.405 -0.809 . . . . 0.0 110.683 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 1.3 tppt? 70.33 10.29 7.21 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.914 -0.491 . . . . 0.0 112.185 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.665 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -120.79 166.51 13.65 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.767 -1.208 . . . . 0.0 110.827 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 1.7 t -101.83 129.24 48.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.637 -0.664 . . . . 0.0 110.385 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 28' ' ' TRP . 4.4 m -124.18 175.36 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.56 -0.713 . . . . 0.0 109.961 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CD2' HD21 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -62.68 138.21 58.45 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.389 -0.819 . . . . 0.0 110.498 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.63 -168.01 0.78 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.548 -0.72 . . . . 0.0 110.169 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -117.63 67.87 5.67 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.459 -0.775 . . . . 0.0 110.474 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 N--CA 1.488 1.16 0 O-C-N 123.585 1.308 . . . . 0.0 110.841 179.799 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.4 p -106.68 176.28 5.22 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.559 -0.965 . . . . 0.0 110.33 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.39 137.09 9.19 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . -152.64 150.34 22.13 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.5 87.76 0.09 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.722 -0.869 . . . . 0.0 110.906 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.8 mtt 56.77 37.22 28.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.752 -0.592 . . . . 0.0 110.479 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.406 ' HB2' ' N ' ' A' ' 4' ' ' GLY . . . -86.37 114.69 23.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.443 -0.785 . . . . 0.0 109.698 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.63 98.21 0.06 OUTLIER Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.924 ' HB2' HG21 ' A' ' 14' ' ' THR . 9.1 p -87.21 -38.42 16.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.573 -0.957 . . . . 0.0 110.097 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.482 ' HA ' ' HD2' ' A' ' 27' ' ' LYS . 22.5 m-20 51.12 82.78 0.06 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.267 0.556 . . . . 0.0 111.433 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 131.93 124.21 2.54 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -10.62 40.36 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.644 -0.915 . . . . 0.0 110.734 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 m -106.6 26.88 9.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.231 -0.918 . . . . 0.0 110.248 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.924 HG21 ' HB2' ' A' ' 9' ' ' CYS . 14.1 t -77.36 -179.7 5.89 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.291 -0.88 . . . . 0.0 110.716 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.24 105.52 7.71 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.514 -0.742 . . . . 0.0 110.009 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.9 m -82.47 -171.27 3.38 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 110.484 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.68 -76.06 0.32 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.217 -0.927 . . . . 0.0 110.683 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.3 p -163.8 131.97 3.62 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.345 -0.847 . . . . 0.0 110.237 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.32 24.23 77.17 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.568 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 30.0 m-85 -125.15 142.92 51.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.395 -1.062 . . . . 0.0 109.785 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.649 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -122.0 117.8 27.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.801 . . . . 0.0 110.316 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 28' ' ' TRP . 2.2 t -75.12 108.13 7.66 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.525 -0.735 . . . . 0.0 109.718 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.653 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -72.98 136.17 79.89 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 0.0 109.955 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.51 -28.79 14.16 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.95 1.5 . . . . 0.0 110.672 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -87.18 -35.08 18.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.39 -0.819 . . . . 0.0 110.255 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.674 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 47.3 m0 -87.38 -15.76 36.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.51 -0.744 . . . . 0.0 110.934 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 32.3 mmtm 61.68 15.84 7.26 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.723 -0.611 . . . . 0.0 112.344 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.674 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.2 p90 -132.55 167.29 20.27 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.838 -1.164 . . . . 0.0 110.6 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 20' ' ' TYR . 3.6 t -107.86 127.94 54.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.632 -0.667 . . . . 0.0 110.218 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.582 HG13 ' CD1' ' A' ' 28' ' ' TRP . 3.6 m -131.89 165.48 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.537 -0.727 . . . . 0.0 110.584 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -45.79 142.29 2.58 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.654 -0.654 . . . . 0.0 110.883 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . . . -126.02 144.02 50.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 0.0 110.579 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.93 131.19 27.12 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.555 -0.715 . . . . 0.0 110.056 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.314 -1.288 0 O-C-N 123.837 1.44 . . . . 0.0 110.645 -179.918 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.464 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.0 t -97.52 92.84 6.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.541 -0.976 . . . . 0.0 109.938 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -116.53 163.82 12.4 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.538 ' H ' ' HB2' ' A' ' 7' ' ' ALA . . . -179.32 140.77 4.5 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 61.17 93.93 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.851 -0.793 . . . . 0.0 111.061 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.2 mtp 55.91 42.61 28.61 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.679 -0.638 . . . . 0.0 109.979 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.783 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -86.18 115.7 23.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.608 -0.683 . . . . 0.0 110.049 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.9 110.16 2.24 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.537 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 7.4 p -113.67 -36.17 4.97 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.677 -0.896 . . . . 0.0 110.599 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.32 59.32 4.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.666 -0.647 . . . . 0.0 110.976 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.76 117.56 0.43 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -21.54 52.78 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.494 -1.003 . . . . 0.0 110.899 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -99.2 -12.41 20.46 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.434 -0.791 . . . . 0.0 110.806 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.537 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 54.1 m -56.67 132.97 53.46 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.348 -0.845 . . . . 0.0 110.506 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -94.26 175.41 6.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.576 -0.703 . . . . 0.0 110.347 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.9 m -124.68 -148.11 0.39 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.509 -0.744 . . . . 0.0 110.128 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 t -88.7 -71.51 0.59 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.084 -1.01 . . . . 0.0 110.782 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.9 p -161.45 119.83 2.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.411 -0.805 . . . . 0.0 110.342 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.43 26.03 48.76 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.69 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 74.9 m-85 -139.4 152.14 46.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.474 -1.015 . . . . 0.0 109.547 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.4 130.26 26.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.324 -0.86 . . . . 0.0 110.645 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 16.9 t -68.63 149.38 49.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.521 -0.737 . . . . 0.0 110.304 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.67 140.63 30.84 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.507 -0.746 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.29 -41.08 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.713 1.375 . . . . 0.0 111.185 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.0 m -72.63 -31.91 65.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.398 -0.814 . . . . 0.0 110.839 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.625 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 54.1 m95 -96.76 -20.43 18.23 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.399 -0.813 . . . . 0.0 110.475 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 5.5 tptt 70.37 8.81 6.77 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.673 -0.642 . . . . 0.0 112.25 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.625 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.7 p90 -136.77 169.0 18.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.723 -1.236 . . . . 0.0 110.757 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.783 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 11.4 t -89.17 145.6 25.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.557 -0.714 . . . . 0.0 110.922 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 27.8 m -132.69 -179.21 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -66.41 131.25 45.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.239 -0.913 . . . . 0.0 110.367 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.35 149.71 49.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.586 -0.696 . . . . 0.0 110.645 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -140.25 159.61 63.11 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.52 -0.737 . . . . 0.0 110.654 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 C--N 1.313 -1.307 0 O-C-N 123.937 1.493 . . . . 0.0 110.654 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.8 t -113.56 137.52 51.46 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.537 -0.978 . . . . 0.0 110.257 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.59 125.27 1.89 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.31 161.68 30.99 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 5' ' ' LEU . 1.7 mm? 55.4 84.28 0.08 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.74 -0.859 . . . . 0.0 111.109 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 56.25 40.48 29.94 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.62 -0.675 . . . . 0.0 110.46 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . . . -89.49 107.4 19.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.511 -0.743 . . . . 0.0 110.455 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.45 108.79 1.97 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.871 ' SG ' HG21 ' A' ' 14' ' ' THR . 27.2 p -110.61 -32.3 6.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.583 -0.951 . . . . 0.0 110.92 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 t70 59.86 73.46 0.48 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.653 -0.654 . . . . 0.0 110.584 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 174.01 124.27 0.78 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.446 ' HG2' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -61.67 -19.01 61.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.727 -0.867 . . . . 0.0 111.007 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.446 ' N ' ' HG2' ' A' ' 12' ' ' LYS . 64.6 p -134.54 35.15 3.19 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.449 -0.782 . . . . 0.0 110.063 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.871 HG21 ' SG ' ' A' ' 9' ' ' CYS . 12.3 t -64.95 161.69 18.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.435 -0.791 . . . . 0.0 110.595 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -100.6 115.21 29.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.407 -0.808 . . . . 0.0 110.296 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.5 m -94.39 -163.99 1.12 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.627 -0.671 . . . . 0.0 109.911 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.74 -76.79 0.22 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.05 -1.031 . . . . 0.0 110.6 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 p -163.47 126.75 2.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.483 -0.76 . . . . 0.0 109.917 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.04 17.21 80.28 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.429 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 38.4 m-85 -124.67 126.82 46.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.183 -1.186 . . . . 0.0 109.977 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.71 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -113.73 135.84 53.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.665 -0.647 . . . . 0.0 109.787 179.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 14' ' ' THR . 0.8 OUTLIER -85.1 138.36 32.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.587 -0.696 . . . . 0.0 110.332 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 9.3 t -98.47 140.19 21.66 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.643 -0.661 . . . . 0.0 110.436 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.24 -28.78 15.0 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.818 1.43 . . . . 0.0 110.9 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 m -86.28 -27.81 24.16 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.366 -0.834 . . . . 0.0 110.756 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.621 ' HB3' ' CE2' ' A' ' 28' ' ' TRP . 21.2 m0 -99.01 -27.54 13.81 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.279 -0.888 . . . . 0.0 110.701 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 26' ' ' TRP . 0.8 OUTLIER 75.01 -3.9 2.5 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.621 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 1.4 p90 -109.15 170.0 8.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.73 -1.231 . . . . 0.0 110.678 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 5.5 t -105.7 129.97 53.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.717 . . . . 0.0 110.032 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.548 HG13 ' CD1' ' A' ' 28' ' ' TRP . 3.3 m -135.73 174.33 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.682 -0.636 . . . . 0.0 109.929 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -54.71 128.53 33.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.452 -0.78 . . . . 0.0 110.724 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . . . -85.46 167.63 15.31 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.645 -0.659 . . . . 0.0 110.583 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -140.33 140.35 22.95 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.499 -0.75 . . . . 0.0 110.306 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 O-C-N 123.718 1.378 . . . . 0.0 110.811 -179.87 . . . . . . . . 0 0 . 1 stop_ save_